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Abstract 
Illicit Psychoactive Medication Use: Experiences of Medicalization and Normalization  
By 
Mark Pawson  
 
Advisor: Barbara Katz Rothman 
 
This dissertation explores illicit psychoactive medication use among young adults. 
Overwhelmingly, the literature on this drug trend, particularly among this population, is 
grounded in a study of pathology. However, my research demonstrates that this obscures a 
significant portion of how youth practice and make meaning of their consumption of these 
controversial medications. The following phenomenologically based dissertation presents and 
unpacks the experiences, practices, and perspectives of young adults who illicitly consume 
psychoactive medications. Through analyzing 162 interviews of 18-29 year olds who report 
recent misuse of a prescription stimulant, tranquilizer, sedative, and/or opioid, I present the ways 
youth medicalize and normalize particular consumption practices and context. By taking 
seriously the ways youth experience these drugs in day to day life this phenomenological study 
highlights how youth construct socially responsible practices of illicit drug use. The focus and 
timing of this research is significant as it relates to gaining a more comprehensive social and 
cultural understanding of a well-known drug trend ubiquitously framed as one of today’s major 
social problems in U.S. society.  
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Chapter 1- Introduction  
 
Much has been written about the history of mind altering drugs here in the United States. 
A great majority of this work has focused on studying drug addiction as well as various aspects 
of the war on drugs. Significantly less attention has been paid to analyzing some of the licit roles 
psychoactive substances play in American society. Medicines containing chemicals that affect 
the central nervous system rank among some of the most successful selling pharmaceuticals in 
U.S. history. However, the market for psychoactive pharmaceuticals has been notably volatile 
and the labelling of many of these medications as social problems has at times led to steep 
declines in production, popularity, and sales.  
Institutions like the American Medical Association (AMA), the Centers for Disease 
Control and Prevention (CDC), the National Institute of Health (NIH), as well as the President of 
the United States, and the U.S. congress have all at one time or another made claims that 
pharmaceuticals containing substances like cocaine, cannabis, alcohol, opioids, amphetamines, 
barbiturates, or benzodiazepines are socially problematic. Many federal laws have been passed in 
hopes of controlling these substances and limiting the social problems they may cause. For 
instance, the Harrison Narcotics Tax Act, the Volstead Act, and the Controlled Substances Act 
have all sought to limit the availability of these drugs. Furthermore, institutions like the Federal 
Drug Administration (FDA), the National Institute on Drug Abuse (NIDA), the Office of 
National Drug Control Policy (ONDCP), and the Drug Enforcement Administration (DEA) have 
been created to monitor and control the production and consumption of many of these 
substances.    
2 
 
Despite these laws and those agencies tasked with enforcing them, psychoactive 
medications remain among the most popular and top selling medications on the U.S. market. 
Sales for prescription stimulants and sedatives have more than doubled and the sale of 
prescription opiates has more than tripled since the 1990’s (SAMHSA, 2015). As with past 
booms in psycho-pharmaceutical sales, these medications popularity has been met with 
controversy as the illicit use of these medications has come to be labelled by health organizations 
and government institutions as a social problem. Concerns regarding the increasing availability 
of these psycho-pharmaceuticals are primarily not problematized in and of themselves, but only 
in their relation to corresponding rates of their “misuse”. The misuse of these medications has 
been defined by NIDA as using them in ways other than those specifically prescribed to you by 
your doctor for a medical condition (NIDA 2016). This may include using psychoactive 
medications obtained from a non-medical source, using more than the prescribed dose, as well as 
using them for a recreational purpose. Important to medical definitions of misuse is the 
distinction that misuse can occur whether or not one has a prescription for a particular psycho-
pharmaceutical. According to this definition, the most recent National Survey on Drug Use and 
Health claims that 15 million Americans age 12 and up reported misusing a psychoactive 
prescription drug at least once in the past year with an estimated 6.5 million having done so as 
recently as the past 30 days (SAMHSA 2015). Placed in the larger context of illicit drug use in 
the U.S., more people report the illicit use of a psychoactive pharmaceutical than use cocaine, 
heroin and methamphetamine combined (DEA 2017). In fact, psychoactive medication misuse is 
second only to marijuana when it comes to illicit drug use. As all practices of psychoactive 
misuse are in fact illicit drug behaviors, these two terms “misuse” and “illicit use” will be used 
interchangeably throughout much of the dissertation.   
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Similar to rates of drug use overall, rates of illicit psychoactive medication use have 
consistently been found to be highest among young adults. The most recent national data 
continues to report that they are twice as likely to engage in this behavior when compared to 
their counterparts in other age cohorts (SAMHSA 2015). Subsequently, youth also experience 
high rates of negative consequences associated with the illicit consumption of psychoactive 
medications. In 2014, nearly five young adults died each day from prescription drug overdoses, 
outnumbering those for both heroin and cocaine combined (SAMHSA, 2015). Deaths from 
psychoactive pharmaceutical overdose now also outnumber those killed in auto accidents (CDC 
2017). For every death due to overdose 119 youth were sent to the emergency room and 22 
entered some form of addiction treatment (SAMHSA DAWN 2014). While these rates dwarf the 
numbers of older adults overdosing and seeking addiction treatment for prescription drug misuse, 
their numbers are increasing (Scholl et al. 2018).  
As youth represent a high risk group for illicitly consuming psychoactive medications, 
they also represent a group whose involvement in this drug trend commands a lot of attention 
from media, law enforcement, politics, and public health. In fact, most all forms of substance use 
have been commonly framed as a social problem when engaged in by youth (Ferrell et al. 2004; 
Ferrell and Websdale 1999; Young 1972). However, drug scholars increasingly note the 
significance of recreational drug use among young adults as a common and unremarkable feature 
of their leisure time activities (Duff 2005; Measham and Shiner 2009; Parker, Aldridge and 
Measham 1998; Pennay and Moore 2010). These drug normalization scholars note that the 
transitional life cycle of young adulthood in late modern societies results in the deferment of 
many adult milestones for many youth. As such, they claim that time spent within leisure spaces 
become important sites within which youth accumulate different valued forms of social and 
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cultural capital (Measham, Aldridge and Parker 2001; Parker, Aldridge and Measham 1998). It is 
within this context of leisure, recreation, and pleasurable consumption that drug use emerges as a 
normalized aspects of young adult’s lives. While studies have yet to specifically analyze the 
normalization of psychoactive medication misuse among young adults, the concentration of 
prescriptions and corresponding high rates of illicit use among this particular generational cohort 
reveal a need to better understand how youth make meaning of these medications within their 
day to day lives.   
The vast amount of academic research studying illicit psychoactive medication use 
focuses on charting prevalence rates and correlates among youth as well as reporting on negative 
health outcomes of misuse such as addiction, overdose, and death. While these findings are no 
doubt useful epidemiological data, by narrowly focusing on addiction, overdose, and death 
researchers disregard the vast majority of misuse, which does not involve the medically defined 
attributes of addiction or incidence of overdose or death. Furthermore, as a result of its largely 
epidemiological focus, much of this research has been especially lacking in theoretical work. 
Analysis of the ways these substances are made meaningful within the everyday lives of those 
who illicitly consume them remains sorely under-researched. As this drug trend stretches on for 
more than two decades in the U.S., this dearth of knowledge is significant and there remains a 
dire need for medication misuse to be understood as a social and cultural process instead of just 
an epidemiological pattern to be measured. As such, this study sets out to present and unpack 
youth’s accounts of the social and cultural forces that inform and influence particular illicit use 
patterns and practices.  
 
Dissertation Overview  
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This dissertation explores experiential accounts of illicit psychoactive medication use 
among young adults. Overwhelmingly, the literature on this drug trend, particularly among this 
population, is grounded in a study of pathology. However, my research demonstrates that this 
obscures a significant portion of how youth make meaning of these popular pharmaceuticals. 
Through analyzing 162 interviews of 18-29 year olds who report recent misuse of a prescription 
stimulant, tranquilizer, sedative, and/or opioid, I present the ways youth medicalize and 
normalize particular consumption practices and context. By taking seriously the ways youth 
experience these drugs in day to day life this phenomenological study highlights how youth 
construct socially responsible practices of illicit drug use. The focus and timing of this research 
is significant as it relates to gaining a more comprehensive social and cultural understanding of a 
well-known drug trend ubiquitously framed as one of today’s major social problems in U.S. 
society.  
Chapter 2 of this dissertation will provide a historical overview of psychoactive 
medications within U.S. society. More specifically, I examine the ways these drugs have been 
produced, defined, legislated, marketed, and consumed in the U.S. throughout the 20th and 21st 
centuries. The cycle of psycho-pharmaceuticals popularity as well as the re-occurrence of it 
being constructed as a social problem across the modern and late modern era will be discussed as 
they provide important insight into the key players driving and responding to these reoccurring 
drug trends in American society. Attention to history also allows me to identify more effectively 
what is distinctive about the popularity of psychoactive medications today and to think more 
carefully about how this informs the ways they are illicitly consumed as well as how they are 
made meaningful as socially problematic.  
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The third chapter provides the theoretical underpinnings of this project beginning with an 
overview of the social constructionist and symbolic interactionist perspectives. Blending the 
complimentary approaches of social constructionism and symbolic interactionism, studies of 
medicalization, drug scares, and drug normalization are presented as analytic examples from 
which to make nuanced meaning of psychoactive medication misuse. Chapter 4 covers the 
methodological and analytical research conducted while also providing an in depth description of 
the study sample. The empirical chapters of the dissertation are grounded in a constructionist and 
interactionist framework for analyzing social problems (Holstein and Miller 1993; Loseke 2011; 
Spector and Kitsuse 1977). As such, the micro level experiences and beliefs described by youth 
are presented and made meaningful primarily as claims making activities on the topic of 
psychoactive medications and their illicit use.    
Chapter 5 will take a critical look at how youth go about constructing psycho-
pharmaceuticals as socially problematic. The specific context and conditions in which these 
medicines are framed as deviant and dangerous are detailed, discussed, and made meaningful, 
particularly as they relate to larger criticisms of U.S. medical practice and medical culture. By 
analyzing the micro level social problems work performed by youth, this chapter also highlights 
how not all patterns and practices of illicit psychoactive medication use are framed as 
problematic. Specifically, youth demonstrate how they construct responsible and socially 
acceptable forms of illicitly consuming these medications. The ways youth draw moral 
distinctions between practices of illicit consumption provides insight into how youth go about 
challenging aspects of medical authority. This boundary work also draws attention to the ways in 
which distinctions between deviance and medicine are constructed and enacted in everyday life.  
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Building on the study of patient centered processes of medicalization, chapter 6 explores 
the ways youth make meaning of illicitly consuming psycho-pharmaceuticals through the use of 
medical discourse. Youths practices of self-diagnosing illness and self-treating them through the 
illicit use of psychoactive medications are presented and unpacked as nuanced ways in which 
medicalization is experienced and enacted outside of the authority and control of a medical 
professional. In chapter 7 I analyze the claims making activities youth engage in when 
constructing these medications and their illicit consumption as a normative feature of their lives, 
especially within the social institutions of higher education and employment. While previous 
drug normalization trends have all been grounded within a context of leisure and pleasure, these 
youth make claims that reveal the normalization of illicit medication use for purposes of 
productivity. The expansion of drug normalizing trends from a leisure consumption practice to a 
work performance practice highlights the growing significance of psychoactive substances across 
many different aspects of everyday life.     
By interpreting the experiences of youth through constructionist and interactionist 
frameworks this dissertation reveals unique insight into how this drug trend is made meaningful 
as a valued cultural practice embedded within certain social context. These findings also draw 
attention to the pervasive ways in which youth challenge aspects of medical authority as they 
exert greater control over the management of their own health, illness, and wellbeing through 
their illicit use of psycho-pharmaceuticals. Through analyzing social problems work as it is 
performed at the micro level, this body of work also highlights the norms and values that shape 
specific understandings of these medications and their consumption as a social problem. In this 
way, this dissertation demonstrates the contested meanings afforded to these controversial 
medications. Most importantly, this analysis reveals the normalization of illicitly consuming 
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these medications within everyday dynamics of constructing and performing the self in situations 
of productivity.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
9 
 
Chapter 2- Literature Background 
 
The role of psychoactive medicines in American society has fluctuated over the past 
century. Their consumption trends are shaped by economic, cultural, and political forces. 
Pharmaceutical companies produce new psychoactive medications or identify new uses for old 
ones. Advertising, marketing, and media coverage enhance their popularity. And governments 
pass legislation that can ban or limit the availability and use of these substances. This chapter 
provides a brief historical account of the medicinal use and regulation of psychoactive 
substances, including amphetamines, barbiturates, benzodiazepines, cocaine, cannabis, and 
opioids. It then summarizes the larger impacts of their medical use on American culture.   
The vast expansion of the medical field is one of the most profound changes in modern 
American society (Clarke et al. 2009; Conrad 2005; Foucault 1973; Zola 1972). The 
development and proliferation of psychoactive medications played a pivotal role in the medical 
field’s evolution, which can be divided into three distinct eras. In the post-civil war America, the 
“patent medicine era” by and large covers the last three decades of the 19th century as well as the 
first two decades of the 20th century and is characterized by the wide availability of psychoactive 
medicines and by the first wave of government interventions aimed at curbing the prevalence of 
these medicines. The post-World War 2 era is characterized by the soaring popularity of 
amphetamine and barbiturate medications. This postwar boom for psychoactive medications was 
brought to a close by yet another wave of legislation and regulation, which later came to mark 
the start of America’s “war on drugs.”  Finally, from the 1980’s to current day, the late modern 
era saw the rise of benzodiazepines and the resurgence in popularity of amphetamine- and 
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opioid-based pharmaceuticals. By detailing the histories of these psycho-pharmaceutical drug 
eras, I highlight the various political and economic players driving these cyclical trends and 
reveal understudied aspects of medical expansion. These medications are important in American 
culture as both a mundane means of managing health and illness and as a source of deviance and 
problematic drug use. The history of psycho-pharmaceutical usage in the U.S. provides a 
foundation within which to contextualize youths’ current experiences of these controversial 
medical commodities. 
Patent medicine  
During much of the 1800s, the U.S. essentially had an unregulated medical market where 
any medicinal commodity produced could be sold directly to the public (Tomes 2016). A 
significant component of the rising pharmaceutical industry was a subset of products commonly 
referred to as “patent medicines.” Patent medicines were one of the fist commodities promoted 
by the burgeoning ad industry (Tomes 2016; Young 1961). Advertisers transformed the drugs 
iconic symbols of health, healing, prowess, and virtue in order to gain the attention and loyalty of 
customers to particular pharmaceutical brands (Tomes 2016; Young 1961). Many patent 
medicines were marketed with the promise of curing or relieving a wide range of relatively 
common conditions such as headaches, sore throats, gastrointestinal discomfort, fatigue, and 
sleeplessness (Tomes 2016; Young 1961). At the time, patent medicine manufacturers were not 
required to disclose any of the ingredients in their products, so consumers were ignorant of the 
components in the remedies they purchased. While some patent medicines were innocuous and 
succeeded because of large marketing and advertising campaigns, others contained some of the 
most powerful intoxicants: alcohol, morphine, cannabis, and cocaine (Booth 2015; Courtwright 
2009; Hodgson 2001; Musto 1999; Tomes 2016; Young 1961).  
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During the patent medicine era, opioids were found in hundreds of medications that were 
readily available to the general public without a prescription and marketed as safe and effective 
(Courtwright 2009; Hodgson 2001; Musto 1999; Young 1961). “Mrs. Winslow’s Soothing 
Syrup,” for example, contained morphine and was advertised to calm colicky and teething babies 
through the use of idealized images of nurturing mothers and serene infants (Tomes 2016).  
Heroin began as a brand name by Bayer Pharmaceuticals who patented, trademarked, and began 
selling diacetylmorphine as heroin hydrochloride in 1898 (Booth 2013; Courtwright 2009; Musto 
1999). At the time, it was advertised as an over-the-counter cough suppressant and a safer, non-
addictive alternative to morphine (Courtwright 2009; Hodgson 2001; Musto 1999). Competing 
pharmaceutical companies mixed heroin with a variety of other substances in order to achieve a 
unique patented product marketed as cure-alls for pneumonia, asthma, and whooping cough 
(Booth 2013; Courtwright 2009; Musto 1999; Young 1961). Laudanum, a tincture containing 
opium and wine, had been used throughout much of the 19th century to treat dysentery and 
yellow fever, but was also promoted during the patent medicine era as an over-the-counter 
remedy for common ailments such as diarrhea and menstrual cramps (Booth 2013; Hodgson 
2001). Similarly, cannabis extracts were sold as treatment for stomach pains, bowel problems, 
and sleeplessness (Booth 2013). Cocaine was commonly sold as an “instant cure” for toothaches, 
headaches, hunger, and exhaustion (Musto 1999; Rasmussen 2008b; Young 1961).   
Patent medicine companies became very profitable businesses in the first two decades of 
the 20th century, and their enormous market success was met with moral outrage by an emerging 
class of medical professionals, who, in their quest to become more professionalized and 
institutionalized, sought to distinguish their scientifically efficacious medicine from those 
dubiously sold directly to the public (Tomes 2016; Young 1961). As a means of establishing 
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distinctions between medicines, the American Medical Association (AMA) began to set strict 
rules and regulations for drug advertising in medical journals (Tomes 2016). These rules set 
medical standards that barred drugs that did not disclose their active ingredients or provide 
evidence of the clinical testing that scientifically proves its effective usage for treating a 
particular medical condition (Rasmussen 2008b; Tomes 2016). This move was seen by the patent 
medicine companies as an attempt by doctors and other medical professionals to discredit the 
sale and usage of patent medicines. In addition to the professional association of doctors, 
consumers were increasingly framing the unregulated market of psychoactive patent medicines 
as a social problem and pushed for regulations that would prevent unintentional poisoning and 
drug addiction, and prohibit deceptive and fraudulent advertising (Courtwright 2009; Musto 
1999; Tomes 2016). As a result, the federal government created the Food and Drug 
Administration and the Federal Trade Commission, the first ever federal government action to 
protect consumers. In the first federal law passed requiring certain substances to abide by 
specific rules and regulations, the Food and Drug Act of 1906 ordered that the contents and 
dosages of all products containing alcohol, cocaine, heroin, morphine, or cannabis be accurately 
labeled (Courtwright 2009; Musto 1999; Tomes 2016; Young 1961).  
Despite the new regulations, the availability to the public of opioid- and cocaine-infused 
patent medicines remained largely unchanged, and was therefore framed in medical journals and 
the media as socially problematic (Courtwright 2009; Musto 1999; Tomes 2016; Young 1961). 
An AMA publication claimed, for instance, that Mrs. Winslow’s Soothing Syrup was responsible 
for infant mortalities resulting from morphine overdoses (Musto 1999; Tomes 2016). Amid 
rising concerns that the sale of opium- and cocaine-based medical products were causing 
addiction, crime, and death, Congress passed the Harrison Narcotics Tax Act in 1914 
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(Courtwright 2009; Musto 1999; Young 1961). The act banned the over-the-counter sale of 
opioids and cocaine. It also drew legal lines between acceptable and unacceptable forms of 
advertising, and restricted the drugs’ use to prescription only. Finally, the new law required 
pharmacists to keep detailed records of all prescriptions filled for this new class of controlled 
substances. Not long after the Harrison Act was passed, other substances that were similarly 
being framed as social problems were also regulated. The Volstead Act of 1919 banned the sale 
of alcohol, except under the supervision of a licensed physician. The final federal law regulating 
psychoactive drugs to be passed during the patent medicine era was the Marihuana Tax Act of 
1937. Similar to the Harrison Act, this new law made marijuana use illegal outside of the 
supervision of a licensed physician. Thus, both the Harrison Act and Marihuana Tax Act sought 
to regulate intoxicating drugs like opioids, cocaine, and marijuana by placing their use solely 
under the control of medical professionals. As such, these laws mark the end of the patent drug 
era, a time during which psychoactive medical products could be accessed without professional 
permission.  
There were social, cultural, and financial interests involved in regulating the availability 
of these controversial medicines. The medical and pharmaceutical professions saw the easy 
access of psychoactive patent medicines as a threat to their interests, and wanted to consolidate 
their control over these popular substances (Starr 2008; Tomes 2016).  Legislation granted them 
such authority, and led to the emergence of cultural distinctions between the “doctors’ drugs,” 
which came to be seen as serious, powerful, and highly sought-after substances, and those that 
continued to be made easily available to the general public over the counter (Courtwright 2009; 
Musto 1999; Starr 2008; Tomes 2016). After these laws were passed, a major reason American 
patients decided to visit doctors was their desire to gain access to psychoactive medicines that 
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were now only available by prescription (Courtwright 2009; Musto 1999; Starr 2008; Tomes 
2016). Consequently, these laws designated doctors as gatekeepers and enabled the medical 
profession to gain sole command over highly sought-after psychoactive pharmaceuticals (Tomes 
2016).   
The interwar period of American history saw a rapid expansion of the medical field as it 
grew to encompass one of the largest industries in the U.S. economy: psychoactive 
pharmaceuticals (Tomes 2016). Interestingly, this happened at a time in which government 
intervention into medical consumer markets resulted in a precipitous decline in psychoactive 
pharmaceutical sales, but also consolidated the medical profession’s control over dispensing 
them. Thus, while the age of patent medicine demonstrates the powerful synergism between 
consumer capitalist forces like advertising and marketing with the sale of psychoactive 
pharmaceuticals, it also provides a preview of the ways governments will seek to legislate and 
regulate those forces in order to rein in the accessibility of these medications. This era also 
presents the first instances of framing psychoactive substances as social problems as the 
availability and use of cocaine, opioids, cannabis, and alcohol was demonized and used as a 
scapegoat for other larger societal issues at the time like crime and poverty. Craig Reinarman 
(1994b), whose work focuses on the historical reoccurrence of drug scares in American history, 
argues that the end of the patent drug era marks the start of this cyclical social trend. 
Furthermore, these laws mark moments in history when certain substances would be forever 
transformed from marketable medicines to “dangerous drugs” whose use is illegal outside of the 
supervision of medical professionals. Finally, and most importantly, this era demonstrates the 
beginning of a successful synergistic relationship between psychoactive medicines and consumer 
capitalism.  
15 
 
 Postwar Era  
By the time of the second World War, advances in the medical sciences and increased 
professionalization of the medical field in the U.S. had significantly altered the ways in which 
medicine was experienced (Foucault 1973; Silverman and Lee 1976; Starr 2008; Tomes 2016). 
The synthesis of new psychoactive medicines is a prime example of the advances that drove the 
expansion of the medical field into more and more aspects of American life (Grinspoon and 
Hedblom 1975; Rasmussen 2008b; Silverman and Lee 1976). New drugs like amphetamines and 
barbiturates expanded the medicalization of mental health as depression and anxiety were 
constructed as medical conditions that the AMA approved to be treated with psychoactive 
medications. These new drugs were viewed extremely favorably by doctors, providing them 
means to address common human conditions that previously were not medicalized and therefore 
lacked pharmaceutical remedies (Rasmussen 2008b; Smith 1988). The use of amphetamines and 
barbiturates to treat depression and anxiety was widely hailed as a significant advancement in 
modern medical science, and the drugs became immensely popular and profitable medicines 
throughout the postwar years (Grinspoon and Hedblom 1975; Rasmussen 2008a; Rasmussen 
2008b; Smith 1985; Tone 2008; Wesson and Smith 1972).   
The rise of amphetamines begins with the Benzedrine inhaler, which was medicinally 
sold as an over-the-counter decongestant starting in the early 1930s (Rasmussen 2008b). 
Benzedrine tablets, however, remained in the unique predicament of essentially being a medicine 
without an illness to treat, and therefore unable to be advertised in medical journals (Rasmussen 
2008b). In its search for medicinal marketability, Benzedrine pills were first unsuccessfully 
tested as a mental performance enhancer before finally being endorsed by the AMA in 1937 as 
the first pharmaceutical product designated to treat depression (Rasmussen 2006; Rasmussen 
2008b). Within a decade, the use of Benzedrine for depression would soar in popularity and 
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accrue over two million dollars in annual sales (Grinspoon and Hedblom 1975; Rasmussen 
2008b).   
A decade later a new and different amphetamine—methamphetamine—was introduced to 
the medical market as brand name Dexedrine. This type of amphetamine was approved by the 
AMA to be advertised as a treatment for weight control (Grinspoon and Hedblom 1975; 
Rasmussen 2008b). This not only expanded the list of diagnoses for which amphetamine-based 
medications could be prescribed, but was also a major force in establishing the medicalization of 
obesity (Rasmussen 2008b). By the end of the 1940s, Dexedrine sales more than doubled to 
account for around six million dollars in annual sales (Grinspoon and Hedblom 1975; Rasmussen 
2008b). As a result of their popularity for treating obesity and depression, amphetamine 
production more than quadrupled throughout the 1940s (Grinspoon and Hedblom 1975; 
Rasmussen 2008a; Rasmussen 2008b).  By the mid 1950s, sales of Benzedrine and Dexedrine 
would double yet again with the introduction of new time release capsule technology that 
reduced reported side effects of taking large doses of the CNS stimulant (Grinspoon and 
Hedblom 1975; Rasmussen 2008b). The popularity of amphetamine-based medications peaked 
in the late 1960s when nearly one in twenty Americans had an active prescription for some 
version of the drug (Grinspoon and Hedblom 1975; Rasmussen 2008b).The profound success of 
amphetamine-based pills not only benefited drug companies, but also served to expand the role 
that medical professionals played in diagnosing and managing symptoms of depression and 
obesity (Conrad 2008; Rasmussen 2008b). In this way, amphetamines were key innovations that 
helped to expand the medicalization of mental health conditions and normalize their treatment 
with psychoactive medications (Conrad 2008; Conrad and Schneider 1980; Tomes 2016).   
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The medicalization of mental health throughout the postwar era was mainly driven by the 
expansion of psychiatry’s role in the medical field (Conrad 2008; Conrad and Schneider 1980; 
Silverman and Lee 1976; Starr 2008; Tomes 2016). In addition to amphetamines, barbiturate-
based medications also saw their consumption increase as a result of mounting concerns over 
mental health in the postwar era. Barbiturate medications developed in the 1920s and are 
considered to be the first psychiatric medication as they were routinely prescribed to treat 
schizophrenia (Smith 1985; Tone 2008). However, barbiturates’ availability without a 
prescription also led to their common use as a sleep aid (Dundee and McIlroy 1982; López-
Muñoz, Ucha-Udabe and Alamo 2005). By the time of the Second World War, Americans were 
consuming over a billion barbiturate pills a year (Dundee and McIlroy 1982; Rasmussen 2008b). 
By the time the war ended, drug companies seeking to capitalize on the drug’s popularity had 
introduced more than 500 new formulas and brands of barbiturate-based medications 
(Rasmussen 2008a; Rasmussen 2008b; Tomes 2016). One new and unique formula combined 
both amphetamines and barbiturates into a single medication. These nuanced stimulant and 
sedative drug combinations not only drove increases in production and sales of both 
psychoactive substances, but also widened the scope of treatable psychological conditions as 
these combination drugs came to be the first anti-anxiety medications (Rasmussen 2008b; Tomes 
2016). The most successful barbiturate-amphetamine combination drug was trademarked as 
Dexamyl (Grinspoon and Hedblom 1975). Advertisements marketed the drug’s ability to enable 
adults to better deal with stress commonly experienced in both domestic and work life, thus 
establishing its suitability for a wide range of potential patients (Rasmussen 2008b; Smith 1985; 
Tomes 2016; Tone 2008). Dexamyl was enormously popular in the postwar era; sales rivaled 
those of top-selling Dexadrine (Grinspoon and Hedblom 1975; Rasmussen 2008a; Rasmussen 
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2008b). While Dexamyl continued to be a wildly popular psychoactive medication well into the 
late 1960s,  barbiturates in general saw their sales peak by the end of 1950s, as their usage was 
increasingly framed as socially problematic (Gabe and Bury 1988; Rasmussen 2008b; Smith 
1985; Tomes 2016).  
Throughout the 1940s and 50s, hospitals across the country reported steep increases in 
the number of barbiturate overdoses and deaths (McLaughlin 1973; Rasmussen 2008b; Wesson 
and Smith 1972). High profile celebrity deaths due to barbiturate overdose like Judy Garland and 
Marilyn Monroe were covered extensively by the media strengthened perceptions of these drugs 
as harmful (Gabe and Bury 1988; Tomes 2016). Consequently, barbiturates became the first 
psychoactive pharmaceutical since the patent medicine era whose use was labelled as a social 
problem. U.S. politicians held several congressional hearings discussing barbiturates as a 
significant social problem impacting the American public (Wesson and Smith 1972). One 
committee, assembled by President Kennedy to deal with drug dependence, estimated that 
pharmaceutical companies in the U.S. produced enough barbiturates to provide 30 pills per year 
to every U.S. citizen, and that a quarter million Americans were addicted to these medications 
(Wesson and Smith 1972). Politicians and the media both highlighted how the ubiquity of 
barbiturates was fueling their misuse and abuse among youth, who were increasingly being 
labeled by both political and media claims makers as America’s most “dangerous” drug using 
population (Fort 1969; Wesson and Smith 1972; Young 1972). Subsequently, some politicians 
were seeking immediate legislative action in order to significantly reduce the production and 
prescription of barbiturate drugs like Seconal and Nembutal (Rasmussen 2008b; Smith 1985; 
Tomes 2016; Tone 2008; Wesson and Smith 1972).  
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Like barbituates, amphetamine-based medications like the Benzedrine inhaler became 
characterized as social problems and as medicines whose availability was in need of government 
regulation (Jackson 1971; Rasmussen 2006; Rasmussen 2008a; Rasmussen 2008b). When used 
as directed, these over-the-counter inhalers provided a small dose of amphetamine to treat nasal 
congestion (Jackson 1971). However, if the inhaler was deconstructed, the significant quantity of 
amphetamine inside could instead be “misused” in one concentrated dose (Jackson 1971; 
Rasmussen 2008b). This practice of medicinal amphetamine misuse was made popular in jazz 
subcultures, but also spread to others such as the beatnik and mod subcultures (Becker 1963; 
Cohen 1972; Rasmussen 2008b; Young 1972). Medicinal amphetamines’ emergence as a 
popular recreational drug within subcultures significantly contributed to the reframing of 
amphetamines as a social problem, particularly among youth (Fort 1969; Young 1972). In the 
late 1960s, amphetamine misuse was labelled as the nation’s leading drug problem (Grinspoon 
and Hedblom 1975; Rasmussen 2008a; Rasmussen 2008b). Moreover, the media, lawmakers, 
and law enforcement declared that the United States was in the midst of a health crisis brought 
on by increases in psychoactive drug use; the high volume sales of both barbiturates and 
amphetamines was identified as a key component of that larger problem (Gabe and Bury 1988; 
Rasmussen 2008b; Smith 1991; Tomes 2016; Wesson and Smith 1972). Congressional hearings 
held throughout the late 1960s and early 1970s exposed drug marketing that politicians claimed 
encouraged the overprescribing of psychoactive medications (Bowes 1974; Pekkanen 1973; 
Wesson and Smith 1972).   
In response to claims that psychoactive medications were overprescribed and fueling 
problematic drug use, the federal government set out to solve the problem by regulating and 
restricting amphetamines and barbiturates. 1970 marked a watershed year for psychoactive 
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medications, as congress passed and President Nixon signed into law the Comprehensive Drug 
Abuse Prevention and Control Act. This piece of legislation created a classification system for 
controlling psychoactive substances. Specifically, the Controlled Substances Act created five 
different levels of scheduling based on a substance’s potential for abuse, accepted medical use, 
and potential for addiction. Schedule 1 drugs are those considered to have a high potential for 
abuse with no established medical purpose. Schedule 2 drugs are those with an established 
medical purpose whose use is recognized as being at high potential for abuse and the 
development of physical and psychological dependency like opioid medications and 
amphetamine medications. Schedule 3 drugs are those with a medical purpose identified as 
having a low to moderate potential for abuse and dependency like ketamine and steroids. 
Schedule 4 drugs are those with a medical purpose with a low potential for abuse and low risk or 
dependency like benzodiazepines. Schedule 5 drugs have a medical purpose with a very low risk 
of abuse or dependency.     
Drugs in certain categories are subject to stricter and more enforceable rules, restricting 
their production to only meeting a justified medical demand (Rasmussen 2008b; Tomes 2016). 
As a result, once popular psycho-pharmaceuticals like barbiturates, which were defined as 
Schedule 2 under the new system, now faced production quotas and strict restrictions on 
prescribing practices. Barbiturate use declined precipitously throughout the 1970’s, and their 
usage has shifted from being prescribed for common conditions like anxiety and insomnia to 
more exceptional conditions like epilepsy (Rasmussen 2008b; Smith 1988; Tone 2008). 
Amphetamines, on the other hand, were originally classified as Schedule 3, allowing their 
availability and use to remain high until they, too, were moved up to Schedule 2 and forced to 
adhere to stricter production and sales quotas (Grinspoon and Hedblom 1975; Rasmussen 
21 
 
2008b). Once rescheduled, the number of prescriptions written for these medications decreased 
tenfold from only a few years earlier, and amphetamine sales dropped by more than 60 percent 
(Rasmussen 2008b).  
While the criminalization of many psychoactive substances and the subsequent impacts 
of “the war on drugs” on incarceration rates have been exhaustively covered in academia, much 
less has been written about the impacts the Controlled Substances Act had on the country’s 
consumption of psychoactive pharmaceuticals. Just as the Harrison Narcotics Act led to a 
significant decrease in the consumption of opioid based medicines, new federal government 
regulation enacted in the early 1970s were able to decrease the availability and use of 
amphetamines and barbiturates (Rasmussen 2008b). However, some scholars point out that the 
decrease in the availability of medicinal amphetamines simply resulted in a sharp increase in 
black market amphetamine production and trafficking to meet users’ demand for the drug 
(Rasmussen 2008b). The emergence of a more potent, smokeable form of amphetamine, known 
as crystal meth, is largely attributed to the surge in production and consumption of black market 
amphetamines throughout the 1970s and 1980s (Rasmussen 2008b).    
The patent medicine era and the postwar pharmaceutical era share many commonalities 
in terms of the rise and fall of certain psychoactive substances. Just like the ads promoting 
cocaine, cannabis, and opioid use during the patent medicine age, media advertising for 
amphetamines and barbiturates during the 1940s, 50s and 60s focused on their ability to treat 
common conditions of everyday life (Rasmussen 2008b; Smith 1985; Tomes 2016; Tone 2008). 
However, an important distinction between the patent drug era and the postwar pharmaceutical 
era lies in how the success of barbiturates and amphetamines was largely enabled by those within 
the medical profession rather than outside it, as had occurred with opioids and cocaine earlier in 
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the 20th century (Rasmussen 2008b; Tomes 2016). The medical field’s embrace of psychoactive 
pharmaceuticals in the postwar era is part of a broader set of changes in the practice of medicine 
during this period (Conrad 2008; Conrad and Schneider 1980; Silverman and Lee 1976; Starr 
2008). Specifically, the medicalization of mental health, advances in pharmaceutical technology, 
and innovations in pharmaceutical advertising promoted and encouraged the consumption of 
psycho-pharmaceuticals as a normative way in which to treat relatively common problems 
related to depression, insomnia, and anxiety (Conrad 2008; Smith 1991; Tomes 2016; Tone 
2008). The increasing encroachment of medicine into daily life that emerged during the postwar 
years continued throughout the later part of the 20th century. In fact, despite tighter federal rules 
and regulations, it wouldn’t take long before a new cycle of psychoactive pharmaceutical 
consumption emerged within U.S. medical markets.   
 
The Late Modern Era 
Benzodiazepines   
As new federal rules and regulations restricted the production of barbiturates, sales of a 
less restricted psychoactive tranquilizer prescribed to treat insomnia and anxiety began to climb. 
Benzodiazepines, such as Valium, whose classification as a schedule 4 controlled substance 
made it much easier to produce and prescribe, soon gained immense popularity among both 
doctors and patients (Smith 1991; Tone 2008; Waldron 1977). In fact, Valium was initially 
promoted as a safer, non-addictive alternative to barbiturates (Greenblatt and Shader 1972; 
Greenblatt and Shader 1974). Aided by an aggressive marketing campaign, Valium quickly 
became the most prescribed brand of medicine in the Unites States during the 1970s (Herzberg 
2006; Smith 1988; Smith 1991; Tone 2008). By 1975, more than 70 million prescriptions were 
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filled for the medication (Blackwell 1973; Blackwell 1975). A prominent researcher on 
benzodiazepines noted that broad industry-defined indications for Valium’s usage, coupled with 
a lack of medical distinction between “normal” and “pathological” anxiety, was largely 
responsible for the high prescribing rates in the 1970s (Blackwell 1973; Blackwell 1975). By the 
late 1970s, patients and prescribers grew increasingly concerned about Valium’s claims of 
addictiveness (Herzberg 2006; Marshall, Georgievskava and Georgievsky 2009; Smith 1991; 
Tone 2008). Driven largely by the media and politicians, David Herzberg (2006) argues, the 
public response to Valium’s addictiveness was largely embellished when compared to actual 
rates of reported dependency, overdose, and death. Regardless, the construction of Valium as a 
social problem led the drug’s sales to plummet throughout the late 1970s. By 1980, sales of 
Valium had been cut in half from its peak sales in 1975 (Herzberg 2006; Marshall, 
Georgievskava and Georgievsky 2009; Smith 1991; Tone 2008).  
In her book on the history of tranquilizers in the U.S., Andrea Tone (2008) argues that 
rather than treating the Valium backlash as a defeat, its manufacturer, Upjohn, introduced a new 
benzodiazepine, which they marketed as a safer alternative to Valium called Xanax. During the 
1980s and 1990s, Xanax and other benzodiazepines like Ativan and Klonopin, which remained a 
class 4 substance, were marketed to treat a range of new and increasingly diagnosed psychiatric 
conditions (Conrad 2008; Tone 2008). Supported by diagnostic expansion in the DSM-III, there 
was tremendous growth in the diagnoses of anxiety-related disorders such as Generalized 
Anxiety Disorder (GAD) and Social Anxiety Disorder (SAD) (Conrad 2005; Conrad 2008; 
Conrad and Potter 2000; Tone 2008). Horwitz (2002) notes how small changes in the wording of 
criteria for anxiety-related disorders resulted in a steep increase in its diagnosis. 
Correspondingly, rates of prescriptions for benzodiazepines also rose to treat the symptoms of 
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these diagnoses (Tone 2008).  During this time period, Xanax also became the first medication 
approved to treat panic attacks and panic disorders, whose prevalence among Americans also 
increased throughout the late 20th and early 21st centuries (Lembke, Papac and Humphreys 2018; 
Olfson, King and Schoenbaum 2015; Tone 2008).  
Drug companies producing and selling benzodiazepines invested millions in promoting 
the visibility of panic- and anxiety-related disorders (Meier 2018; Tone 2008). Also contributing 
to the growth of sales was a shift in those writing prescriptions for benzodiazepines from 
psychiatrists to general practitioner physicians (Bachhuber et al. 2016; Tone 2008). By the turn 
of the century, benzodiazepines had become one of the most widely prescribed drugs in the 
United States, and the number of people prescribed the drug only continued to grow, increasing 
from 8 million at the turn of the of the century to over 13 million just a decade later (Bachhuber 
et al. 2016; Lembke, Papac and Humphreys 2018; Olfson, King and Schoenbaum 2015). 
Meanwhile, benzodiazepine production and sales tripled during this period, indicating that it 
wasn’t just that more people were being prescribed these drugs, but that larger doses of the drug 
were being prescribed as well (Lembke, Papac and Humphreys 2018). Speaking to the drug’s 
relevance to pop culture, Bloomberg News noted that Xanax was listed alongside car companies 
and alcoholic beverages as the most frequently-mentioned brands in Hip Hop music from 2014-
2017.  
Rates of fatal benzodiazepine overdoses have increased sevenfold in the past 20 years, 
and admission for benzodiazepine addiction treatment during this same time period grew six old 
(Bachhuber et al. 2016; Lembke, Papac and Humphreys 2018). Drug overdose deaths involving 
benzodiazepines rose from 1,135 in 1999 to 11,537 in 2017(CDC 2017). Similar to the celebrity 
deaths resulting from barbiturate overdoses that caught the public’s attention in the postwar era, 
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benzodiazepine overdoses were to blame for more recent high-profile deaths, including Heath 
Ledger, Whitney Houston, and Tom Petty. As these medications began to be framed as socially 
problematic both outside and within the medical field, benzodiazepines prescribing practices 
now advise the drugs only be used for short term treatment of anxiety, panic disorders, and 
insomnia (Lembke, Papac and Humphreys 2018). However, despite these changes in prescribing 
guidelines, the U.S. has yet to see a decline in the ubiquity of benzodiazepines use (Lembke, 
Papac and Humphreys 2018).  
 
Amphetamines 
Mirroring trends in sedative use, medical stimulant use also bounced back after its initial 
decline in the early 1970s. Before tighter restrictions were placed on psychoactive stimulant 
medications, they were mainly prescribed to treat weight loss and depression among adults 
(Conrad 1975; Rasmussen 2008b). In the late modern era, psychostimulant medications instead 
focused on treatment of what once was a rare condition found among children initially called 
hyperkinesis (Conrad 1975; Grinspoon and Singer 1973; Gross and Wilson 1974). The disorder 
was characterized by the presence of a short attention span, impulsivity, and hyperactivity among 
young children (Gross and Wilson 1974). Most criteria for diagnosis came from a child’s 
experience at school, where evidence of disruptive behaviors and difficulty concentrating on 
tasks was observed (Gross and Wilson 1974). In 1962, methylphenidate, a chemical cousin of 
amphetamine marketed as Ritalin, was approved for prescription to children to treat 
hyperactivity (Grinspoon and Singer 1973). By the mid-1970s, hyperkinesis had become the 
most common childhood psychiatric problem (Conrad 1975; Rasmussen 2008b). Subsequently, 
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the consumption of the psychostimulant commonly prescribed to treat it increased 200 percent 
(Conrad 2008; Rasmussen 2008b).  
With the publication of DSM-III in 1980, the American Psychiatric Association renamed 
the disorder “Attention Deficit Disorder” (ADD), further emphasizing a focus on medicalizing 
attentiveness (APA 1980; Conrad and Potter 2000; Karsch 2017). The disorder’s symptoms were 
also expanded beyond the context of school behaviors to cover areas of interpersonal relations 
and interactions (APA 1980; Conrad and Potter 2000; Karsch 2017). These updates not only 
broadened the range of symptoms and expanded the ways a diagnosis could be identified, but  
also expanded the population it could now be applied to, as a diagnosis without symptoms of 
hyperactivity were seen as the continued symptoms of the condition into adolescence (Conrad 
2008; Conrad and Potter 2000; Karsch 2017; Newcorn et al. 1989). In 1987 an updated version 
of the DSM again broadened the definition of the condition by expanding the context of 
inattentiveness and impulsiveness from the classroom to include the workplace (APA 1987; 
Conrad and Potter 2000). As such, the new diagnosis of Attention Deficit Hyperactivity Disorder 
suggested that the condition could persist into adulthood (Conrad and Potter 2000; Elia, 
Ambrosini and Rapoport 1999; Hallowell and Ratey 1994; Zametkin and Ernst 1999). As a result 
of diagnostic expansion, the number of patients taking Ritalin more than doubled throughout the 
1980s (DeGrandpre 1999; Rasmussen 2008b).   
Parent and advocacy groups emerged throughout the 1990s, such as Children and Adults 
with Attention Deficit Hyperactivity Disorder (CHADD), which sought to expand the visibility 
and understanding of the disorder (Conrad 2008; Conrad and Potter 2000; Jaffe 1995; 
Rasmussen 2008b). National conferences, publications, and advertising campaigns were 
sponsored by advocacy groups like CHADD to raise awareness of ADHD (Conrad 2008; Conrad 
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and Potter 2000; Diller 1996; Rasmussen 2008b). Much of this advocacy work also sought to 
officially alter and extend the diagnosis of ADHD into adulthood by framing it as a lifelong 
neurobiological disorder (Conrad 2008; Conrad and Potter 2000; Diller 1996). In 1997, the AMA 
announced that ADHD was not exclusively a childhood disorder that disappeared with age, but 
rather a chronic disorder that often persisted into adulthood (Conrad and Potter 2000). One 
researcher even went so far as to say that ADHD was the most common chronic undiagnosed 
psychiatric disorder among adults (Wender 1998).  
Treatment of ADHD with psychoactive stimulant medication increased eightfold during 
the 1990s, largely as a result of its expanded use among adults (Elia, Ambrosini and Rapoport 
1999; Zametkin and Ernst 1999). Methylphenidate production grew by 700 percent; meanwhile a 
new amphetamine-based medication—brand name Adderall—was introduced to the market in 
1996 and increased the production of amphetamines by over 200 percent in ten years 
(Rasmussen 2008b). Interestingly, despite the restrictions put in place at the height of the last 
peak in psychostimulant medication use, the DEA moved to increase production quotas for 
methylphenidate and amphetamine by over tenfold in order to meet the rising medical demand 
for psychoactive stimulant use throughout the late 20th and early 21st centuries (Rasmussen 
2008b). Diagnoses for disorders treated with amphetamines increased from tens of thousands in 
the early 1970s to tens of millions today (Rasmussen 2008). In fact, some have stated that 
today’s consumption of medical amphetamines rivals that of the “amphetamine medication 
epidemic” of the late 1960s (Rasmussen 2008b). Similar to the postwar era, as the production 
and prescription of amphetamines increased, issues related to the misuse of these medicinal 
amphetamines began to emerge. Between 2006 and 2011, Adderall misuse rose 67 percent, and 
ER visits went up 156 percent, with family and friends serving as the primary source (NIDA 
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2016). Particular attention has been directed at youths’ incorporation of these medications into 
college life and nightlife scenes (Kelly and Parsons 2007; Kelly et al. 2012; Kelly et al. 2013; 
McCabe et al. 2005; Teter et al. 2010; Teter et al. 2005; Teter et al. 2006).  
 
Opioids 
 Following the passage of the Harrison Act in 1914, the presence of opioid medications on 
the American medical market had remained relatively low and stable until the 1980s, when 
medical professionals began claiming that the risks of addiction were minimal within the context 
of treatment for chronic pain (Portenoy and Foley 1986; Porter and Jick 1980). New time-release 
opioid pills, commonly referred to as long-acting opioids, soon became the gold standard for 
pain management in hospice care, particularly among cancer patients, as it allowed them to sleep 
through the night without the use of an IV (Meier 2018). Throughout the 1990s, pain advocacy 
groups, such as the American Academy of Pain Medicine, and pharmaceutical companies sought 
to expand the scope of chronic pain diagnoses beyond of end-of-life care to include it as a 
symptom to be regularly checked at every doctor’s visit (Booth 2013; Manchikanti, Atluri and 
Hansen 2014; Meier 2018). Further, managed care organizations that provide health insurance 
recognized the cost-saving potential of opioid medications when compared to other pain 
management therapies (Meier 2018; Schatman 2011). Subsequently, some health insurance 
companies decided to only provide coverage for treating chronic pain with opioid prescriptions 
(Schatman 2011). As a result, prescriptions for opioid medications skyrocketed during the 1990s, 
and some claim that the monitoring of pain has become the fifth vital sign of medicine (Booth 
2013; Manchikanti, Atluri and Hansen 2014; Manchikanti, Fellows and Ailinani 2010; Meier 
2018). 
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 From the 1990s until the end of the first decade of the 21st century, opioid prescriptions 
grew by more than 500 percent (Manchikanti 2007; Manchikanti, Fellows and Ailinani 2010). 
One of the highest-selling opioids at that time was OxyContin, which was federally approved in 
1995 when prescribing strong opioids for the relief of chronic pain was becoming more 
acceptable within the medical field, particularly among primary care physicians (Manchikanti, 
Atluri and Hansen 2014; Meier 2018). Between 1996 and 2001, the number of OxyContin 
prescriptions in the United States surged from about 300,000 to nearly six million (Meier 2018). 
Sales continued to rise until its peak in 2010, earning $3.5 billion that year and ranking as the 
fifth-highest selling pharmaceutical brand for that year (Mack et al. 2010; Van Zee 2009). 
Additionally, during this period a new medication that combined hydrocodone with 
acetaminophen was classified as a Schedule 3 substance, thereby making it easier to produce and 
prescribe than other opioids, which remained categorized as Schedule 2 substances (Meier 2018). 
For much of the first decade of the 21st century, hydrocodone, used in combination drugs like 
Vicodin, became the top prescribed medication in the United States (Hernandez and Nelson 
2010; Meier 2018).  
Accompanying the rise in opioid use were corresponding increases in rates of overdose, 
death, and addiction treatment for opioid dependency (Hall et al. 2008; Manchikanti, Atluri and 
Hansen 2014). In fact, research would later show a direct correlation between prescription 
volume in an area and rates of abuse and overdose (Manchikanti, Atluri and Hansen 2014; Meier 
2012; Meier 2018).  From 1999 to 2017, over 215,000 people died in the United States from 
overdoses related to prescription opioids, which is more than the combined number of U.S. 
service members killed in Afghanistan, Iraq, and Vietnam combined (CDC 2017). Overdose 
deaths involving prescription opioids were five times higher in 2017 than in 1999, with more 
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than 40 people dying of drug overdoses involving prescription opioids (CDC 2017).  Moreover, 
throughout the first decade of the 21st century, unintentional overdose deaths involving opioid 
medications outnumbered those resulting from heroin and cocaine combined (Manchikanti, 
Atluri and Hansen 2014; Manchikanti, Fellows and Ailinani 2010; NIDA 2016). 
As the availability of prescription opioids was increasingly framed as a social problem, 
there was an increase in media coverage on the aggressive promotional advertising certain 
pharmaceutical companies engaged in. Specifically, Purdue Pharmaceuticals’ questionable 
marketing of OxyContin has been extensively covered in the news media (Meier 2007a; Meier 
2007b; Van Zee 2009). Some claim that in its first year on the market, they spent over $200 
million on advertising that claimed the medication was less likely than other opioid medications 
to be abused or cause dependence (Van Zee 2009). The DEA investigated the pharmaceutical 
company’s activities and in 2007 filed charges that the company had misbranded the drug with 
the intent to defraud or mislead medical practitioners and patients (Meier 2007a; Meier 2007b). 
Purdue pled guilty to felony charges, admitting that it had lied to doctors about OxyContin’s 
abuse potential (Meier 2007a; Meier 2007b). The company paid over $600 million in fines and 
its three top executives at the time pleaded guilty to misdemeanor charges. It was one of the 
harshest penalties ever imposed on a pharmaceutical company to date (Meier 2007a; Meier 
2007b). Furthermore, at least twenty-five government entities, ranging from states to small cities, 
have filed lawsuits against Purdue Pharmaceuticals to recover damages resulting from the opioid 
epidemic (Meier 2018). 
In an attempt to curtail the misuse of opioids, in 2014 the DEA, FDA, and CDC 
recommended reclassifying hydrocodone combination products from Schedule 3 to 2 
(Manchikanti, Atluri and Hansen 2014; Meier 2018). It was rescheduled, and prescriptions for 
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hydrocodone subsequently dropped significantly from 120 million in 2014 to 93.5 million in 
2015. Similarly, prescriptions for OxyContin fell 33 percent between 2012 and 2016 (Meier 
2018). Overall, today’s opioid prescription rates are around 30 percent lower than at their highest 
level in 2011, and much of that reduction is due to tighter regulations and the implementation of 
prescription monitoring programs (Green et al. 2012; Manchikanti, Atluri and Hansen 2014; 
Meier 2018). However, even with this reduction, rates of opioid prescriptions filled today are 
still approximately three times the number filled in 1999 (Guy Jr et al. 2017; Meier 2018). 
Highlighting their continued ubiquity, opioids were recently found to be the third most 
commonly prescribed class of medications in the United States with over 10 billion hydrocodone 
and oxycodone pills distributed to patients in 2016 alone (Meier 2018).  
The embrace of psychoactive pharmaceuticals by the medical community throughout the 
1990s and 2000s shares numerous similarities with both the patent medicine and postwar eras. 
Like both eras before it, the late modern boom in psuchoactive pharmaceuticals was driven in 
large part by pharmaceutical companies’ large investments into advertising and marketing their 
new psychoactive medications. The expansion of marketing these medications to consumers 
through the mediums of television and the internet, approved by the FDA and commonly 
referred to as “direct-to-consumer” advertising, greatly increased the presence of these 
pharmaceuticals in everyday life (Conrad and Leiter 2008; Donohue, Cevasco and Rosenthal 
2007; Figert 2011; Myers, Royne and Deitz 2011; Wilkes, Bell and Kravitz 2000). Additionally, 
the late modern era represents a return to the popularity of prescribing psychoactive mediations 
to children. The dramatic increase in the number of youths prescribed psycho-pharmaceuticals 
throughout the 1990s and early 2000s has led to a generational cohort some have referred to as 
“generation Rx” or “the medication generation” (Quintero, Peterson and Young 2006; Sharpe 
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2012). Throughout the 1990s and early 2000s the percentage of twelve- to seventeen-year-olds 
taking psychoactive medications increased six fold (Quintero, Peterson and Young 2006; 
Rafalovich 2004; Rasmussen 2008b; SAMHSA 2012). This generation of youth has grown up 
with a significantly higher proportion of their parents actively seeking diagnosis and treatment 
for their children’s as well as their own behavioral symptoms related to anxiety, depression, and 
hyperactivity (Loe 2008; Loe and Cuttino 2008; Rafalovich 2004; Rasmussen 2008b; Tone 
2008). In fact, recent findings indicate that all patients are acting more like medical consumers as 
they play a more active role in the construction of both diagnoses and treatment (Timmermans 
and Oh 2010; Tomes 2016).  
The impacts of coming of age in an era in which psycho-pharmaceuticals are advertised 
as common medical commodities have yet to be researched as they relate to perceptions and 
practices of psychoactive medication misuse. While research has addressed the misuse of these 
medications obtained through networks of friends and family members who are prescribed them 
(Ford 2008; Garnier-Dykstra et al. 2012; Inciardi et al. 2007; McCabe and Boyd 2005; McCabe 
et al. 2014), the ways the misuse of these drugs are made meaningful as an embedded feature of 
everyday life is in need of empirical analysis. In many ways, the health care system in the U.S. 
places the burden of making well-informed decisions about identifying and treating illnesses on 
individuals (Timmermans and Oh 2010; Tomes 2016). This burden may inform and influence 
individuals’ decisions to use psychoactive medications that are not prescribed to them, and to use 
those that are in ways other than directed. While the misuse of psychoactive pharmaceuticals in 
American society has generated heated medical and moral debates, the discipline of sociology 
has largely been absent from this discourse. Constructionist and interactionist perspectives on 
health, illness, deviance and drug use provide ideal frameworks for drawing out the contentious 
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and competing ways in which patterns and practices of psycho-pharmaceuticals are made 
meaningful. The next chapter provides a thorough review of the sociological literature on social 
constructionism and symbolic interactionism.  
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Chapter 3- Theoretical Background 
 
This chapter develops social constructionist and symbolic interactionist perspectives to 
provide the theoretical foundation for studying the role of psychoactive medications in society. 
The complimentary use of constructionist and interactionist theories facilitates exploration of 
both the macro-level processes that define and ascribe meanings to these medications, and the 
micro-level applications, performances, and experiences of those meanings. This chapter details 
constructionist research into the medical field and its expansion, as well as interactionist studies 
that examine how illness informs identity and selfhood. It also traces symbolic interactionism’s 
rich history of studying deviance, drug use, and drug users, and outlines the constructionist 
approach to studying drug use as a social problem.   
 
Social Constructionism  
 The social constructionist perspective is one of the major schools of theoretical thought in 
the discipline of sociology. Social constructionism focuses on the ways in which human actors 
legitimate, participate in, and reproduce the social worlds they inhabit (Berger and Luckmann 
1966). This phenomenological approach highlights the taken-for-granted reality and 
commonsense knowledge of everyday life and calls attention to the significance of these 
phenomena (Belgrave et al. 2004). Social constructionism critiques the positivistic assumption 
that objective knowledge of social conditions is obtainable through employing the scientific 
method. This is evident in the radical constructionist approach that conceptualizes all forms of 
knowledge as human products whose social existence not only influences human behavior, but 
also informs the meanings individuals within a given society apply to people, situations, objects, 
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and experiences (Berger and Luckmann 1966; Freidson 1972; Holstein and Miller 1993; Loseke 
2011).  
In their seminal book The Social Construction of Reality, Berger and Luckmann claim 
that realities are in a constant process of creation and maintenance through the interplay of 
history and social interaction. They argue that reality construction consists of three stages: 
externalization, objectification, and internalization. Externalization occurs when individuals or 
groups create a cultural product. This is followed by objectification, the process by which these 
cultural products become institutionalized and understood to be part of a society’s objective 
reality. Finally, internalization details the ways in which individuals are socialized into accepting 
these cultural products as taken-for-granted objective facts of reality (Berger and Luckmann 
1966). Through this process, cultural products are created and integrated into the available “stock 
of knowledge” within a particular society, becoming part of the taken-for-granted vocabulary of 
everyday life (Berger and Luckman 1966).  
 
Constructionist Perspectives on Health, Illness, and Medicine  
Constructionist studies provide important insights into the cultural production of health, 
illness, and medicine as social attributes. Constructionism states that conditions of health and 
illness do not socially exist without being identified and described as such (Brown 1995; Conrad 
and Barker 2010). Similarly, substances recognized as medicine are not inherently medical, but 
rather become labelled as such (Freidson 1972). Health, like disease diagnoses, is a socially 
negotiated state of being whose meanings are culturally and historically specific (Brown 1995; 
Conrad and Barker 2010). As such, medical sociologists applying a constructionist framework 
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tend to focus on studying the processes through which certain behaviors and experiences come to 
be known as medical conditions.  
Goffman’s (1963) work on stigma made significant contributions to constructionist 
understandings of medical aspects of social life. He showed that stigma is not inherent to any 
particular medical condition, but rather an attribute obtained through social interaction. By 
approaching the drastically different social meanings applied to illnesses with a critical lens, 
Goffman demonstrated how the assignment, experience, and enactment of stigma are social and 
cultural processes. Freidson (1972) took constructionist understandings of medicine a step 
further by examining “how signs and symptoms get to be labeled or diagnosed as an illness in 
the first place” (p. 12). Freidson analyzed the construction of medical knowledge and authority 
and showed that the institutions of medicine held a unique social monopoly over treating illness 
as they were solely authorized to define and label illness in society (Freidson 1972). Similarly, 
Foucault’s concept of the medical gaze revealed how the process of diagnosis is a means by 
which the medical field can exert its power and authority over society as it controls who and 
what is defined as “normal” and “abnormal” (Foucault 1973). In this way, constructionist studies 
reveal medicine to be a powerful mechanism of social control (Zola 1972).  
The medical field’s expansion during the latter part of the 20th century became a popular 
topic of research for many medical sociologists. Scholars observed a profound societal 
transformation as medicine increasingly permeated everyday life, defining more and more 
“conditions” in need of “treatment” (Foucault 1973; Freidson 1972; Zola 1972). Constructionist 
scholars referred to such expansion of medicine’s role in social life as the “medicalization” of 
society (Conrad and Schneider 1980; Zola 1972). Medicalization is defined as “the dynamic set 
of processes by which medical authorities, institutions, and ideologies come to (re)organize, 
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(re)define and (re)structure our everyday experiences, culture, and social life” (Simonds 2016). 
Though he did not use such terminology, Goffman (1968) first looked at the medicalization of 
mental illness in his study of insane asylums. Following Goffman’s initial research into the 
medicalization of deviance, Conrad and Schneider (1980) sought to demonstrate the continued 
expansion of the medical field to encompass behaviors such as alcoholism, opiate addiction, and 
child disobedience. Their work on the medicalization of deviance also recognized that medical 
institutions are not the sole drivers of medical expansion—advocacy groups like Alcoholics 
Anonymous played an important role in the paradigm shift from framing drug addiction as a 
medical rather than a moral problem. (Conrad and Schneider 1980). The claims-making activities 
that lay populations engage in demonstrates how patients are not merely passively labelled by 
medical institutions, but rather can be active agents in pressuring medical authorities to reframe 
particular behaviors or conditions as medical conditions that deserve medical treatment (Conrad 
2005; Conrad 2008; Conrad and Leiter 2004; Conrad and Potter 2000; Conrad and Schneider 
1980).  
The sociology of diagnosis expands the scope of constructionist studies of health, illness, 
and medicine by  demonstrating that diseases are not simply a biological event of the body, but 
are also cultural products of medical discourse (Turner 1992). Phil Brown (1995) argued that a 
constructionist study of disease diagnosis is needed because disease disgnosis is the social 
process through which health and illness are defined, classified, and made meaningful. From this 
perspective, we can understand the diagnostic process itself as a cultural practice that draws 
boundaries between medically acceptable and unacceptable states of being (Brown 1995). The 
sociological study of diagnosis also highlights the diverse range of interests involved in gaining 
the label of a medical diagnosis (Jutel 2009). For example, patients may seek out or reject the 
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legitimization and treatment associated with receiving a diagnosis (Brown 1995; Jutel 2009). 
Meanwhile, pharmaceutical companies can profit by marketing drugs to treat a new disease 
diagnoses (Jutel 2009).  
Constructionist sociological research is critical of how diagnoses are socially constructed. 
They are also interested in identifying who benefits from medical expansion and how these 
expansive medical forces impact society (Abraham 2007; Busfield 2006; Busfield 2007; Fox and 
Ward 2008). Introduced as a more specific focus of medicalization studies, the concept of 
pharmaceuticalization “denotes the translation or transformation of human conditions, 
capabilities and capacities into opportunities for pharmaceutical intervention. These processes 
potentially extend far beyond the realms of the strictly medical or the medicalized to encompass 
other non-medical uses for lifestyle, augmentation or enhancement purposes amongst ‘healthy’ 
people” (Williams, Martin and Gabe 2011). Most studies on pharmaceuticalization are critical of 
how these biotechnologies medicalize more and more aspects of everyday life, and argue that 
consumerism is producing an over-medicated society (Abraham 2010a; Fox and Ward 2008). In 
this way, a particular processes of medicalization is framed as a social problem (Abraham 2010a; 
Abraham 2010b; Ballard and Elston 2005; Bell and Figert 2012; Fox and Ward 2008; Williams, 
Martin and Gabe 2011).  
 
Constructionist Perspective on Social Problems  
Paralleling constructionist work on topics such as deviance and illness, the constructionist 
approach to studying social problems introduced a radical new way of understanding how 
society makes meaning of problems as cultural products (Best 1995; Loseke 2011; Spector and 
Kitsuse 1977). Like diseases, social problems do not socially exist until they are identified and 
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defined as such through processes of interaction (Spector and Kitsuse 1977). With regard to the 
sociological study of social problems, Blumer notes that “it would seem logical that students of 
social problems ought to study the process by which a society comes to recognize its social 
problems” (Blumer 1971) p300. In line with this critique, constructionist studies of social 
problems focus on how people, objects, and behaviors come to be socially defined as 
problematic (Best 1995; Loseke 2011; Spector and Kitsuse 1977). Constructionist studies of 
social problems are fundamentally concerned with uncovering the moral evaluations society 
makes about particular people, objects, or behaviors (Becker 1963; Best 1995; Loseke 2011; 
Spector and Kitsuse 1977). Building on Becker (1963), Cohen (1972), and Young (1972), which 
studied the ways in which certain social problems were produced and proliferated by politicians, 
the media, and other organizations, Spector and Kitsuse  (1977) demonstrated the importance of 
studying the processes of constructing social problems. Constructionist scholars demonstrate 
through empirical research that particular behaviors are labelled as social problems when they 
are believed to be both common and troublesome, and that something can and should be done to 
change that (Spector and Kitsuse 1977).  Constructionist approaches focus on those involved in 
identifying, defining, and resolving a particular problem. While Becker (1963) and others 
referred to those involved in social problems work as “moral entrepreneurs,”  the social 
constructionist literature now commonly refers to these actors as “claims makers” (Loseke 2011; 
Spector and Kitsuse 1977).  
 Drug use has been a common topic of study in social problems research. Labelling 
theorists such as Howard Becker (1963), Troy Duster (1970), and Stan Cohen (1972) studied 
drugs and drug users, and societal reactions to them. Specifically, they focused on the roles 
official agents of social control, such as the media, medicine, and law enforcement play in 
40 
 
developing definitions that stigmatize and marginalize drug users. Labelling theorists also note 
how social reactions against drug use are grounded in moral condemnation that frames drug 
users as pathological (Becker 1953; Becker 1963; Cohen 1972). Jock Young’s (1972) work 
examined the socio-historical contexts of drug use as well as particular substances’ attendant 
social meanings. Young (1972) noted that “one must not focus on the drug per se but the culture 
within which it is used and within which its use becomes intelligible”(p137). Zinberg (1984) 
built on Young by highlighting the importance of social factors such as set and setting to the 
construction and experience of drug use. He argued that it is not simply the physiological 
properties of a particular substance, but the mood of the user and the social context that give 
meaning to drug experiences. Additional constructionist work on drug use shows how contextual 
factors frame and shape not only the meanings of drug experiences, but also specific use patterns 
and practices (Duff 2007). Likewise, both Gusfield (1996) and Levine’s (1978) work on 
alcoholism articulates how the larger cultural and social context informs and influences the 
construction of specific substances as problematic at particular times in history.  
Craig Reinarman’s work highlights the consistent ways in which substances like alcohol, 
opium, cocaine, and cannabis have all been defined as socially problematic over the course of 
different time periods (Reinarman 1994a; Reinarman 2005; Reinarman and Levine 1989; 
Reinarman and Levine 2004; Reinarman and Levine 1997). Reinarman (1994a) claims that the 
rise and fall of public concerns regarding intoxicants are never solely about a specific substance, 
but instead reflect larger cultural, political, and historical factors. For instance, drugs are 
commonly framed as causing or exacerbating other larger social problems such as 
unemployment, crime, poverty, and indecency. Furthermore, the problematic aspects of drugs 
have repeatedly been blamed on marginalized populations, such as Chinese and Mexican 
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immigrants and African Americans (Reinarman 1994a; Reinarman and Levine 1997). Youth 
represent another population commonly problematized in terms of drug use, particularly those 
involved in subcultural music scenes (Young 1972; Young 2007). Reinarman (1994) refers to the 
cyclically reoccurring framing of psychoactive substances as social problems as “drug scares,” 
which are distinct from drug problems. Reinarman and Levine’s (1997) constructivist study of 
crack as a social problem showed how a drug whose use was low among the American public 
was framed as a national health and crime epidemic. They drew attention to the ways in which 
the media, law enforcement, and government incited and exacerbated the social problems 
surrounding the sale and consumption of this particular form of cocaine, particularly among low 
income urban minorities (Reinarman and Levine 1989; Reinarman and Levine 2004; Reinarman 
and Levine 1997). Importantly, research studying the construction of drugs as a social problem 
has highlighted the ways in which the criminalization of drug-using populations itself creates its 
own set of unique social problems (Bourgois 2003b; Bourgois and Schonberg 2009; Levine 
2003; Reinarman and Levine 2004; Reinarman and Levine 1997).  
While constructionist studies of drug use as a social problem have provided deeper 
understandings of how and why drugs are framed as socially problematic, much of this work 
analyzes social problems work at the institutional level. Many constructionist studies do not fully 
take into account the interactional and experiential aspects of social problems work (Gergen 
1991; Gubrium and Holstein 2000; Holstein and Gubrium 2007; Holstein and Miller 1993; 
Weinberg 2005). Applying a symbolic interactionist approach to studying social problems 
provides a micro-level analysis of how social problems work is practiced in daily life. Similar to 
social constructionism, the symbolic interactionist approach is deeply concerned with the 
centrality of meaning and understanding as they relate to human behavior and experience. The 
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differences between these theoretical approaches lie in their analytical foci. Whereas 
constructionism studies the definitional process and the macro- and meso-level players involved 
in these processes, symbolic interactionism focuses on the actions and experiences of individuals 
involved in the meaning-making process as it occurs in everyday life (Fine 1993). I now turn to a 
discussion of symbolic interactionism for an analysis that takes seriously the day-to-day 
experiential and interactive aspects of health, illness, medicine, deviance, and social problems.  
 
Symbolic Interactionism 
The theory of symbolic interactionism focuses on how the meanings we apply to objects, 
individuals, groups, events, and experiences are products of human interaction (Blumer 1969). 
Interactionist perspectives presuppose a reciprocal process in which actions, experiences, and 
meaning making inform and influence each other (Blumer 1969; Fine 1993; Snow 2001; 
Zerubavel 1991). Blumer outlined three premises upon which the theory of symbolic 
interactionism is built: (1) that human beings act towards things on the basis of the meanings 
those things hold for them; (2) that those meanings are created, modified, and maintained 
through social interaction; and (3) that meanings are also a part of an interpretive and 
experiential process at the level of the individual (Blumer 1969:2). Symbolic interactionism also 
elevates the importance of studying and theorizing selfhood and identity as social processes. 
Meade (1934) stated that the self is actively formulated in ways that permit individuals to cope 
with the ongoing demands of daily life, and thus is actively responding to the lived conditions of 
its constructions (Gubrium and Holstein 2000). Therefore, while emphasizing the constructed 
character of social reality, symbolic interactionism focuses on the processes of constructing 
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identity and performing selfhood as human accomplishments achieved through social interaction 
(Blumer 1969; Goffman 1959b; Snow 2001; Zerubavel 1991).   
Erving Goffman was among the first to highlight how individuals participate in the 
construction of their own social worlds, including aspects of identity, via ongoing interaction 
(Goffman 1959b). Goffman’s dramaturgical approach draws our attention to the performance of 
selfhood through the enactment of social roles (Goffman 1959b). In other words, by framing 
face-to-face interactions as carefully managed and staged performances, Goffman demonstrates 
how the socially-constructed self is actively involved in defining and managing social reality 
(Goffman 1959). His theoretical approach situates the self as a strategic manipulator, playing 
culturally-contextualized parts that conform to modes of socially acceptable comportment in 
order to avoid experiences of embarrassment and shame (Goffman 1959b; Goffman 1967). 
Moreover, dramaturgy also provides a framework for understanding how the body and 
experiences of embodiment are produced as it details how one does not simply have a body, but 
instead actively performs a body (Turner 1992). The performance of one’s body takes on 
additional pressures and meanings related to conforming to specific social roles and expectations 
within particular contexts (Goffman 1959b; Turner 1992).  
 
Labelling Theory 
Early applications of the interactionist framework focused on producing critical 
sociological accounts of deviance. By considering deviance to be a cultural product, like all other 
designations of social behavior, this radical approach sought to study the process through which 
individuals “become” deviant as well as the impacts of that label on presentations of self, identity 
work, and action (Becker 1963; Goffman 1963; Matza 1969). Howard Becker (1963) famously 
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stated that “[d]eviance is not inherent in an action but a quality bestowed upon it…it is created 
by society and is essentially the reaffirmation of moral meaning in everyday life…as such 
deviance requires interaction…it is social” (6-9). By combining theories of social 
constructionism and symbolic interactionism, labelling theorists called attention to the social 
construction of deviance as well as the significant meanings attributed to both the performances 
of deviant behavior and the development of deviant identities (Becker 1953; Matza 1964; Matza 
1969; Matza and Sykes 1961; Sykes and Matza 1957). Labelling theorists also drew on the social 
learning theory of deviance by articulating the concept of deviant careers in which an 
individual’s deviant identity and behaviors mature and evolve over the course of one’s biography 
(Becker 1963; Goffman 1959a; Goffman 1968; Matza 1969). This concept of career was also 
used to describe involvement in drug use and drug using subcultures (Becker 1963; Schur 1965; 
Young 1972). 
 
Symbolic Interactionism and Drug Use  
The sociological study of drugs was pioneered by Alfred Lindesmith (1938) who argued 
that the meanings people confer upon a drug’s effects shape how it is  experienced and practiced. 
Becker (1953; 1963; 1967) expanded upon this work by stating that a drug’s effect is mediated 
by the symbolic interpretations that individuals bestow upon them. In other words, the meaning 
of drug use is embodied in the discourse and symbolic representations of these experiences 
(Weinberg 1997). Becker (1953) examined the ways in which people learn to get high and 
articulated the process through which people learn to identify and appreciate the high produced 
from smoking marijuana. He also showed how drug users develop a repertoire of drug slang, 
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practice, and meanings in accordance with their socialization into particular drug using 
subcultures (1963).  
Interactionist studies were among the first to produce richly detailed descriptions of drug 
subcultures that uncovered the meanings that drug use holds for those involved in its everyday 
practice (Becker 1963; Cohen 1972; Finestone 1957; Johnson 1973; Young 1972). Ethnographic 
studies of drugs provide insight into the social settings in which drug use occurs as well as the 
ritualized patterns and practices performed by drug users (Bourgois 2003b; Bourgois and 
Schonberg 2009; Johnson 1973; Sterk 1999; Thornton 1995; Williams 1990). Interactionist 
studies have also focused on analyzing how identity work and selfhood are informed and 
influenced by drug use. For example, Ray’s (1961) interactionist study of drug relapse focused 
on how adhering to past and current drug using identities can shape decisions to abstain from or 
engage in drug use. Similarly, Denzin’s (1987) theory of the alcoholic describes a divided self in 
which one’s former identity as an alcoholic is in conflict with one’s recovery identity. It is this 
conflict over the loss of one’s past self that shapes cycles of relapse and recovery for former drug 
addicts (Denzin 1987). Kathryn Hughes (2007) builds on these studies and argues that practices 
of addiction can be crucial addicts’ processes of affirming and reaffirming aspects of their 
identity. The body of interactionist work on drug use and drug users provides significant 
contributions to our understandings of how these substances contain a complex set of social and 
cultural meanings for both users and non-users.  
 
Symbolic Interactionist study of Health and Illness  
Much like the interactionist studies that critically examined at how deviance is defined, 
labelled, experienced, and made meaningful, medical sociologists embracing the interactionist 
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approach also sought to analyze how individuals become labelled as “sick” and how sickness is 
then enacted and experienced. The symbolic interactionist approach to studying health and 
illness has led researchers to ask certain kinds of analytic questions about the day-to-day 
experiences of being labelled ill and how having a “sick” body is made meaningful in terms of 
embodiment, self, and identity (Charmaz 1993). While Parson’s (1951) concept of “the sick role” 
highlights the norms and values that society places on the ill, work from an interactionist 
approach takes the actual lived experiences of those suffering from particular illnesses as a 
serious analytic endeavor in meaning making (Charmaz 1999). Goffman (1961)embraced this 
approach as he explained the social experiences of patienthood and the ways individuals 
participate in the illness experience. He  also articulated the social construction and performance 
of stigma as it relates to illness (1963). By being critical of the drastically different social 
meanings applied to a variety of illnesses, Goffman demonstrated how the assignment, 
experience, and enactment of stigma are social and part of cultural processes (Goffman 1963).  
Sociologists have since studied the experiences of those labelled with a vast variety of 
diseases, from diabetes to dementia (Belgrave et al. 2004; Rajaram 1997). Those whose work 
most notably influenced the interactionist study of health and illness focused on contributing 
general understandings of how illness is experienced and enacted in terms of one’s identity, 
social roles, and sense of self. One of the most notable interactionist studies on health and illness 
is Michael Bury’s (1982) work, which focused on the experience of illness as a biographical 
break in one’s life. His study of those suffering from rheumatoid arthritis demonstrated how the 
onset and escalation of an illness can be experienced not only as disruptive to one’s sense of self, 
but also to one’s relationships, routines, and the meanings attributed to aspects of day-to-day life 
(Bury 1982).   
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Similarly, in her studies of those with debilitating chronic illnesses, Kathy Charmaz 
highlights how people learn new definitions of self and relinquish old ones as they enact their 
diagnosis and endow it with meaning (Charmaz 1983; Charmaz 1993; Charmaz 1999). 
Charmaz’s concept of the loss of self captures not only the changes in identity and selfhood, but 
also experiences of social isolation as those suffering from chronic illness are unable to fulfill 
previous social roles (Charmaz 1983). Gareth Williams’ (1984) concept of narrative 
reconstruction shows how people make sense of their condition in terms of the positive actions 
taken in response to one’s illness. Williams’ (1984) work also brought attention to the ways in 
which a current illness is framed in terms of one’s past actions and environment, thereby adding 
a moral  component to how illness and suffering is experienced and made meaningful. Charmaz 
(1999) would later build upon this as she unpacked narratives that outline the ways the sick are 
made meaningful in terms of their position on a moral hierarchy of suffering in which some are 
distinguished as deserving of care and sympathy while others are deserving of stigma and 
isolation, or are unrecognized as even experiencing legitimate suffering.  
 
Medicalization  
Sociological studies of medicalization lack an interactionist analysis of how this societal 
trend of medical expansion is experienced and made meaningful in everyday life (Figert 2011). 
The symbolic interactionist approach is well suited to analyze the ways in which processes of 
medicalization may become common resources for constructing meaning for many aspects of our 
social lives (Crawford 2006; Holstein and Gubrium 2007). For instance, some note that social 
practices related to health and illness are even embedded in everyday activities that extend 
beyond medicine to include aspects of lifestyle and embodiment (Conrad 2008; Crawford 2006). 
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In late modernity, health is a fundamental cultural value whose pursuit serves an ever-expanding 
economic sector that manufactures, advertises, and sells health products, knowledge, and 
services (Conrad 2008; Crawford 2006). From an interactionist perspective, the consumer turn in 
medicalization enables new forms of agency, subjectivity, and empowerment (Clarke et al. 2009; 
Conrad 2008). Within the context of an increasingly medicalized social world, managing one’s 
health also emerges as a new personal responsibility and American value (Clarke et al. 2009; 
Conrad 2008; Conrad and Leiter 2004). In a society that highly values health, identities, and 
beliefs, behaviors related to health are social practices that can draw symbolic boundaries 
marking status (Bourdieu 1984; Crawford 2006). In this way, we can understand the construction 
of health consciousness and the development of health management strategies to be core 
demands of adhering to American values, which is similar to Laureau’s (2003) concept of 
concerted cultivation, or what Loe (2008) adapted to the study of medicine and refers to as 
concerted medicalization.  
Building off of the meaning-making work uncovered in the analysis of illness narratives 
and identities, more recent studies have examined how individuals make meaning out of medical 
treatment as it relates to identity construction and presentations of selfhood (Davis-Bearman and 
Pestello 2005; Frank 2018; Karp 2006; Loe and Cuttino 2008). Medicine can be experienced as 
both a source of social control and as a mechanism of self-empowerment, and thus its influence 
over constructions of identity and selfhood are complex and multifaceted (Davis-Bearman and 
Pestello 2005; Karp 2006; Loe and Cuttino 2008; Zola 1972). One study on antidepressant use 
notes how these medications are constructed as either enabling or constraining the performance 
of one’s authentic and ideal self (Karp 2006). Similarly, Davis-Berman and Pestello’s (2005) 
work on psychiatric medication use among college students highlights how these medications 
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were thought to negatively affect one’s performance of self: students articulated a preference for 
their non-medicated self, which was described as a more natural and authentic self (Davis-
Bearman and Pestello 2005). Elaborating on the impacts pharmaceuticals can have on identity 
and selfhood, Loe and Cuttino’s (2008) work on youth who are prescribed psychostimulant 
medication highlights how these medications are experienced as integral to their identity as 
college students and their ability to conform to the social expectations of that institutional role. 
The concept of the medicated self, whether it be constructed as having a positive or negative 
impact on one’s practice of selfhood and construction of identity, takes seriously the notion that 
identity and individual worth is formed in relation to the consumption of particular medications 
(Davis-Bearman and Pestello 2005; Loe and Cuttino 2008).  
 
Implications for Study  
Building upon constructionist and interactionist work on health, illness, deviance, and 
drug use discussed above, I examine the meanings youth apply to various practices of their 
psycho-pharmaceutical use. Surprisingly, the individuals who misuse psychoactive medications 
are still largely neglected by academic inquiry, particularly as it relates to the growing presence 
of these medications and their misuse in daily life. As such, I explore and unpack the ways in 
which youth involved in this drug trend frame some patterns and practices of psychoactive 
medication misuse as a social problem and others as a normalized medicalized strategy for 
navigating a variety of common problems in their everyday lives. Finally, as I deal with young 
adults socialized into a highly medicalized culture, I pay particular attention to the ways misuse 
is made meaningful in terms of one’s presentation of self and identity within specific social 
contexts.   
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Medicalization research needs to be extended to better understand how medical forces 
shape lay perceptions and practices of medicine that take place outside of the purview of medical 
authority, particularly amongst those who have come of age in a highly pharmaceuticalized 
milieu (Barker 2008). Academic studies of psychoactive medication misuse do not pay enough 
attention to the sociality of drug use, despite no evidence indicating that these practices of misuse 
are any less social than the use of illegal drugs. Furthermore, the meanings afforded to the 
misuse of these complex medical commodities remains poorly understood and sorely 
undertheorized. The narratives of medication misuse presented in this dissertation help us to 
better understand how the boundaries between health, illness, and deviance are defined and 
negotiated in late modern life. Medical narratives allow us to study the “links between identity, 
experience, and ‘late modern’ cultures” (Bury 2001). Through an in-depth constructionist and 
interactionist analysis, I will demonstrate how youth make meaning out of the everyday cultural 
artifacts of psycho-pharmaceuticals.  
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Chapter 4: Methodology 
 
This dissertation was developed from a larger study funded by the NIH investigating the 
patterns and contexts of prescription drug misuse and its associated risks among young adults 
(ages 18-29) who are socially active in nightlife scenes. I was part of a team of researchers 
working on this project and served many different roles throughout the 5 years it was conducted, 
ranging from being an ethnographer during the initial formative phase of the study to eventually 
becoming the director of the project. The principle investigator for the project, entitled 
“Prescription Drug Abuse among Young Adults: Contexts and Risk”, Brian C. Kelly, Associate 
Professor from Purdue University, serves as on outside reader on my dissertation committee.  
This project consisted of three distinct research phases. Phase one consisted of a yearlong 
ethnographic study of illicit psychoactive medication use in nightlife scenes. Phase two consisted 
of brief surveys completed on drug use administered in nightlife scenes. Phase three consisted of 
a longitudinal mixed methods study of young adult’s illicit use of psychoactive medications. This 
dissertation is based off of the qualitative interviews conducted as a part of phase 3 of the 
project. 214 participants were qualitatively interviewed and the data drawn upon for this 
dissertation are derived from a subset of 162 participants who report illicit use of prescription 
opioids, tranquilizers, sedatives or stimulants. The qualitative interviews for this project were 
conducted between 2011 and 2013 and I was involved in conducting 25% of the interviews 
(N=41). All interviews analyzed for this project were digitally recorded and transcribed 
verbatim. Participants that were interviewed also completed computer assisted surveys, which 
provide the demographics used to describe specific characteristics of the sample.      
 
Sampling  
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This project was funded to explore the illicit consumption of psychoactive medications 
by young adults. This age group is of particular concern as their illicit consumption of these 
medications is significantly higher than other age groups (SAMHSA 2016). While most prior 
research of this age group has been conducted on college campuses, this particular project 
instead focused on youth involved in subcultural nightlife scenes. As nightlife is a significant site 
for youth drug use generally, the project sought to specifically study the integration of 
psychoactive medications within this context. The ethnographic phase of the project focused on 
embedding researchers within specific nightlife scenes throughout New York City. Upon the 
conclusion of a yearlong ethnographic investigation into illicit psychoactive medication use in 
nightlife, the ethnographic team identified a list of viable venues to be used to recruit research 
participants for the longitudinal study.  
In order to recruit a sample of young adult illicit medication users active in nightlife, the 
research team utilized a sampling method referred to as time-space sampling. Time-space 
sampling (TSS) was originally developed to capture hard-to-reach populations like marginalized 
minority communities, (MacKellar et al. 1996; Stueve et al. 2001), but is also useful for 
generating samples of location-based  populations (Grov, Kelly and Parsons 2009; Muhib et al. 
2001). Venues included bars, clubs, lounges, as well as performance venues were considered to 
be viable for recruitment on the days of the week they were regularly frequented by young 
adults, the general target population for the study. In order to construct the time space sampling 
framework, venues and the days/times that they were considered viable for recruitment were 
enumerated and randomly selected each month to produce recruitment shifts. Research recruiters 
were sent out on the days randomly selected to the venues randomly selected. At each venue, 
staff approached as many individuals as possible, aiming to achieve saturation within the venue. 
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Individuals were asked to complete a brief five minute screening survey for which they received 
no compensation. To be eligible for the study, individuals 18-29 years of age who live in the 
New York City area must report illicit use of a prescription opioids,  stimulant, tranquilizer, or 
sedative at least 3 times in the previous 180 days with at least one of those times occurring in the 
previous 90 days. If an individual was eligible, staff explained the project, and interested 
individuals were asked to provide contact information. Those eligible were contacted at a later 
date, rescreened for eligibility, and then scheduled for their baseline assessment. The baseline 
assessment entailed consenting participants into the study, the completion of a computer assisted 
survey, and the completion of the qualitative interview.  
 
Sample Characteristics 
 The study team’s quest to obtain a diverse sample informed the creation of enrollment 
cells based on gender identity and sexual identity. Four cells were utilized to enroll the final 
sample: straight men, straight women, gay and bisexual men, and lesbian and bisexual women. 
As a result of this enrollment structure the sample of those interviewed is very diverse. 28% of 
those interviewed identified as gay or bisexual men, meanwhile 24% of the sample identified as 
straight men. 22% of those interviewed identified as lesbian or bisexual women and 26% of the 
sample identified as straight women. 68% of the sample identified as white. Class diversity was 
also present in the sample as 35% identified as either rich or upper middle class, 40% identified 
as middle class, and 26% identified as either working class or poor. Class information was 
gathered based on a question about their parents’ social class background. This was done as 
many 18-29 year olds income may not accurately reflect the class background they were 
socialized within. The sample was well educated with 64% of the sample reporting having at 
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least a 4 year college degree, meanwhile 35% stated that they were either currently enrolled in 
college or had at least some college experience. The average age of those interviewed was 25.  
 
Measures 
The semi-structured interviews utilized critical incident techniques to draw out specific 
narratives about participants’ prescription drug misuse practices by probing for detailed stories 
about the first and last times they had engaged in these behaviors. Critical incident techniques 
help reduce recall bias, provide context for behaviors rooted within specific events, and are 
widely recognized as effective exploratory and investigative social science tools (Leonard and 
Ross 1997). Critical incident techniques are also ideal qualitative tools for accessing the 
profundities and complexities of human social and cultural life as the use of narratives grounds 
particular behaviors within a specific set of circumstances and situates them both in terms of 
time and space (Butterfield et al. 2005; O'Driscoll and Cooper 1996). As such, this 
methodological approach also embraces aspects of the sociological imagination as it attempts to 
explore the intersection of biography, history, and social structure as outlined by Mills (1959), 
whose work seeks to draw out how personal issues are embedded in particular places and times, 
and thereby informed and influenced by larger social forces.  
Moreover, personal narratives can aid in unpacking the meanings attributed to particular 
social practices while also revealing the social processes that shape the larger contexts these 
patterns of practice emerge from (Laslett 1999; Riessman 2000). By grounding actions and 
experiences within specific social context, narratives also allow participants space to reflect upon 
past experiences and emotions as they explore areas of personal importance with relation to the 
topic under study (Butterfield et al. 2005; O'Driscoll and Cooper 1996). As a result of gathering 
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data on behavior embedded within the details of a personal narrative, researchers are better able 
to gain a more holistic and deeper understanding of the motivations driving specific social 
phenomena and the cultural meanings attributed to them (Laslett 1999; Riessman 2000). 
The use of critical incident measures within the semi-structured qualitative interview 
guide were applied to each specific class of prescription drugs that the participant identified 
misusing in their lifetime (opioids, tranquilizers, sedatives, and stimulants). More specifically, 
participants were asked to provide stories of the first time that they recall misusing a particular 
type of prescription drug as well as the most recent instance of misusing it. Additionally, 
participants were asked their opinions on the prevalence of illicitly consuming psychoactive 
medications, how they typically access these medications, as well as what they and their peers 
value most about taking them. Interviews lasted anywhere from 26 minutes to 87 minutes 
depending on the participants range of experiences misusing different psychoactive medications.     
 
Analysis  
An interpretive phenomenological analysis (IPA) was employed to unpack the ways in 
which youth make meaning of their experiences illicitly consuming psychoactive 
pharmaceuticals. IPA is an inductive research method utilized to identify and analyze meaning 
making in the description of particular phenomena and entails a deep immersion within the data 
(Smith 2015). IPA aids researchers in the interpretive process of identifying how participants 
make meaning of their world (Larkin and Thompson 2012; Smith 2011). Phenomenological 
research approaches take seriously the significance of studying individual experiences even 
when that experience is not directly observed (Smith 1996). As such, IPA is ideal for narrative 
analysis as the replaying of experience through narration enables researchers the ability to study 
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participants use of a range of framing strategies and techniques used to signal how these 
experiences are contextualized, interpreted, and made meaningful (Larkin and Thompson 2012; 
Smith 2011). This analytic technique also compliments the theoretical approaches of social 
constructionism and symbolic interactionism. Both theories stress the importance of individual 
experience as well as the significance of social interaction in the construction of meaning. 
Additionally, while social constructionist studies direct their focus on more meso and macro 
level social forces that shape meaning making processes, symbolic interactionist studies focus on 
the more micro level aspects of meaning making as they relate to constructing identity and 
performances of selfhood. By making use of these complimentary research approaches, I aim to 
thoroughly explore how youth experience and make meaning of their illicit consumption of these 
controversial psychoactive medications. Specifically, I seek to draw attention to the social 
norms, values, and context that shape how particular patterns and practices of illicit use are 
experienced as either deviant drug behavior or normative practices of self-care and self-
improvement.       
IPA was performed utilizing NVIVO software. Several iterations of coding schemes were 
used as the codebook evolved in response to the data and my understanding of them. 
Specifically, preliminary coding and analysis focused on identifying themes and patterns in the 
ways youth experience these medications and made sense of their illicit use. These were 
important foundational steps in identifying unique experiential domains of illicitly consuming 
psychoactive medications. A subsequent wave of coding and analysis helped to synthesize a core 
set of experiential themes and develop relevant theoretical interpretations. A final wave of 
coding and analysis refined my pragmatic and theoretical understandings of the data and 
occurred throughout much of the writing process. A consistent return to the data throughout my 
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interpretation of it has produced a uniquely contextualized and in depth account of it. In the three 
empirical chapters that follow, I present excerpts of the stories that youth told about their 
experiences with and beliefs of psychoactive medications. I provide these snippets of narrative in 
order to demonstrate important patterns and themes in the ways these controversial medical 
products are socially constructed and experienced by those who are in many ways a driving force 
behind the perpetuation of this drug trend. These quotes have been edited for grammar, syntax, 
and clarity where appropriate. For instance hesitation phenomenon (e.g. “uh” and “um”) as well 
as common utterances in casual conversation (e.g. “like, “you know”) have been removed. 
General descriptive data of those participants quoted appear alongside their words, providing 
more contexts and meaning to them.  
The following empirical analysis focuses on how the illicit consumption of psychoactive 
medications are experienced, practiced, and made meaningful by young adults. The first chapter 
focuses on the contested ways in which youth make meaning of these medications and their 
illicit consumption as socially problematic. The next chapter sets out to demonstrate how youth 
go about medicalizing certain practices of illicit consumption. The last empirical chapter details 
the ways psychoactive medication misuse is made meaningful as a normalized strategy for 
navigating specific social and intuitional settings.  
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Chapter 5: Constructing Problems and Solutions 
 
Throughout the 20th and 21st centuries, drug use emerged as a reoccurring social problem 
in the United States. In chapter 2, I cover the social construction of psycho-pharmaceuticals as 
problematic across three distinct time periods. Within the era of patent medicine, easy access to 
commodities containing psychoactive drugs like opioids, cocaine, and cannabis were considered 
socially problematic by institutions of medicine and law (Tomes 2016; Young 1961). To resolve 
the problematic use of these medicines, federal laws were enacted to restrict their production and 
place their access under the authority of medical professionals (Tomes 2016; Young 1961).  
During the post-war era, journalists, law enforcement, and Congress identified the ubiquitous use 
of barbiturates and amphetamines as socially problematic (Rasmussen 2008b; Wesson and Smith 
1972). Once again, federal laws were enacted to address concerns. This time however, the vast 
majority of psychoactive substances were classified as controlled substances, and criminalized 
accordingly, marking the start of the “war on drugs.”  
Today, journalists, health organizations, and government agencies consider illicit consumption of 
psychoactive pharmaceuticals like amphetamine-based ADHD medications, benzodiazepine-
based anxiety medications, and opioid-based painkillers as constituting a national health 
epidemic (Manchikanti, Atluri and Hansen 2014; Meier 2018; Rasmussen 2008b; Tone 2008). 
While changes in prescribing practices for opioid medications have produced significant 
reductions in their circulation, prescriptions for opioids, as well as for amphetamines and 
benzodiazepines, remain at historically-high levels (Lembke, Papac and Humphreys 2018).   
Building on previous constructionist work on drugs as a social problem, this chapter focuses on 
unpacking the ways youth frame psycho-pharmaceuticals and their illicit consumption as 
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problematic. This chapter details the specific context and conditions in which youth construct the 
use of these medications as deviant and dangerous. My data reveal how those involved in the 
illicit consumption of psycho-pharmaceuticals problematize these medications in diverse ways. 
By analyzing the claims-making activities of young adults, this chapter demonstrates that not all 
uses of psychoactive medications are framed as socially problematic. Indeed, many young people 
view the utilization of these drugs as part of normative patterns of medication consumption. By 
constructing moral distinctions among various practices of consumption, the young adults 
presented in this chapter highlight the norms and values they draw upon to construct responsible, 
though illicit, use of psychoactive medications.   
The Constructionist Study of Social Problems  
The constructionist perspective on social problems focuses its analysis on the social actors and 
processes involved in defining conditions and people as socially problematic (Best 1995; Loseke 
2011; Spector and Kitsuse 1977). While Howard Becker (1963) first referred to those involved in 
social problems work as moral entrepreneurs. Today, they are commonly referred to as claims 
makers (Loseke 2011; Spector and Kitsuse 1977). Claims makers are defined as people who 
believe a particular object, group of people, or set of practices violates their moral values to such 
an extent that they feel compelled to persuade others that a social problem exists and needs to be 
corrected (Best 1995; Loseke 2011). In the process of convincing others of the existence of a 
social problem, claims makers engage in specific claims-making activities and strategies to 
construct a compelling and convincing social problems story (Best 1995; Loseke 2011).  
The strategic ways claims makers frame social problems provides analytic insight into how 
specific social problems are constructed and made meaningful (Best 1995; Loseke 2011; Spector 
and Kitsuse 1977). Loseke (2011) articulates three distinct types of frames commonly found in 
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social problems stories. Diagnostic frames define a social problem and assign blame to particular 
people for its persistence. Prognostic frames construct solutions for social problems. 
Motivational frames stimulate audience member’s emotions and generate feelings of moral 
outrage regarding particular social problems.  
Constructionist research on drug use as a social problem typically analyzes the themes, 
discourses, and images of drug users, dealers, and traffickers as commonly depicted in 
mainstream media (Adler 1993; Hartman and Golub 1999; Reinarman 1994a; Reinarman and 
Levine 1997; Taylor 2008). Research on the social construction of drug scares highlights media’s 
role in framing particular drugs as dangerous (Altheide 1997; Brownstein 1991; Orcutt and 
Turner 1993; Reinarman 1994a; Reinarman and Levine 1997). Moreover, media coverage 
typically presents extreme and rare outcomes of drug use as frequently occurring; a process 
Craig Reinarman refers to as the “routinization of caricature” (Reinarman 1994a). From a 
constructionist approach, the routinization of caricature represents a motivational frame as it 
seeks to persuade others to see drug use as a social problem through sensationalizing and 
exaggerating their effects. For instance, this framing technique is utilized to define certain drugs 
as instantly addictive as well as to identify particular drug users as violent predators (Brownstein 
1991; Hartman and Golub 1999; Reinarman and Duskin 1999). These frames become tropes 
relied upon by the public to make meaning of specific drugs and particular groups of people 
(Brownstein 1991; Hartman and Golub 1999; Reinarman and Duskin 1999; Reinarman and 
Levine 1997).  
Media depictions also commonly construct villains to blame for problems caused by drug use 
(Adler 1993; Brownstein 1991; Reinarman 1994a; Taylor 2008). Social problems villains are a 
type of diagnostic and motivational frame that assigns blame for a particular social problem. 
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They do so by criticizing and condemning particular people and behavior (Loseke 2011). For 
example, racial and ethnic minority men are frequently framed as social problems villains whose 
use and sale of illicit drugs are the root cause of other social problems like crime, unemployment, 
and poverty (Brownstein 1991; Ferrell and Websdale 1999; Hartman and Golub 1999; 
Reinarman 1994a; Reinarman and Levine 1997; Taylor 2008). In contrast, media depictions of 
drugs used primarily by whites, such as crystal meth and psychoactive pharmaceuticals, 
construct users as victims (Jenkins 1994; Orsini 2017; Pedersen, Sandberg and Copes 2015; 
Rasmussen 2008b). These frames combine to demonize inner city minority heroin and crack 
users, while they humanize prescription opioid users. We are to fear the former, but have fear for 
the latter—fear for their health and wellbeing (Hansen and Netherland 2016; Netherland and 
Hansen 2017; Netherland and Hansen 2016; Orsini 2017).  
By emphasizing the definitional processes that frame particular drugs, drug users, and drug 
behaviors as socially problematic, constructionist studies focus primarily on claims-making 
activities as they occur at the meso or macro levels (Conrad and Schneider 1980; Gusfield 1996; 
Hartman and Golub 1999; Herzberg 2006; Reinarman 1994a; Reinarman and Levine 2004; 
Taylor 2008). In doing so, constructionist studies pay less attention to the individuals involved in 
performing social problems work in everyday life (Gergen 1991; Gubrium and Holstein 2000; 
Holstein and Gubrium 2007; Holstein and Miller 1993; Weinberg 2005). Analysis of claims-
making activities that occur through routine interactions, enables sociologists to identify how 
people make meaning of the social worlds they inhabit, including how they maintain and modify 
symbolic boundaries (Holstein and Miller 1993; Lamont and Fournier 1992; Zerubavel 1991). 
Thus, stories and opinions shared within a community can be seen to function boundary-making 
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mechanisms that mark certain behaviors, groups of people, or cultural products as socially 
problematic (Holstein and Miller 1993; Loseke 2011).  
In their constructionist analysis of the medicalization of deviance, Conrad and Schneider (1980) 
argue that sociologists need to focus more on the claims-making activities of various groups that 
assert their definitions of medicine and deviance, as well as analyze how these categories are 
produced  and enacted. Given that psychoactive pharmaceuticals are socially defined as both 
legitimate medicine and illicit drugs, an exploration of how youth make meaning of those 
distinctions can illuminate how and why they frame psychoactive pharmaceuticals as either a 
social problem or social problems solution. By formulating social problems stories regarding 
psychoactive medication consumption, youth make claims that defend and justify their own 
uptake of these substances. I contend that their claims-making activities reveal an insider’s 
perspective on how symbolic boundaries are drawn, one that distinguishes between the 
responsible us of psycho-pharmaceuticals and the problematic use of drugs.  
Competing Constructions of Psychoactive Medications  
Two patterns of framing emerged from youths’ accounts of psychoactive medications and their 
consumption. One frame directs criticism at the medical field; it constructs psychoactive 
medications as over-prescribed by doctors and dangerously addictive. The second frame makes 
claims about certain illicit psychoactive medication consumption practices that are constructed as 
a social problem. These themes demonstrate that youth problematize psychoactive medications 
in divergent ways. By analyzing the claims-making activities at the micro level, this chapter 
reveals the norms and values that shape how and when psychoactive medications are 
problematized, but also how and why illicit consumption is made meaningful as a social 
problems solution.   
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Frame 1: Psychoactive Medication as a Social Problem 
 One component of the frame that constructs psychoactive medication as problematic, and 
a common theme in participants’ social problems talk, is the availability of psychoactive 
pharmaceuticals. Many young adults interviewed spoke at length about the over-prescription of 
these medications.  
Way too many people are prescribed them. So, I think that definitely causes a lot of problems now that the 
accessibility to those drugs is much higher. And I think also like T.V. and everything is just kind of like 
making it seem like it’s okay in terms of them promoting those drugs. (White/Upper Middle Class/ 
Female; 30049) 
--  
I think it’s [prescription drug misuse] a definite problem and I think people, young people especially, 
have easy access to these drugs and it’s not hard to find doctors that will just write a prescription without 
the person really needing it. (White/Upper Middle Class/Male; 30029) 
 
The young woman quoted above links over-prescription of psychoactive pharmaceuticals to their 
advertising on television. Research on the medicalization of everyday life supports her claims 
(Bar and Lillard 2014; Conrad and Leiter 2008; Donohue, Cevasco and Rosenthal 2007; Figert 
2011; Myers, Royne and Deitz 2011; Wilkes, Bell and Kravitz 2000). A loosened regulatory 
environment during the 1990s provided pharmaceutical companies more leniency to advertise 
their products directly to consumers, a practice commonly referred to as direct-to-consumer 
advertising or DTCA (Conrad and Leiter 2008; Myers, Royne and Deitz 2011; Tomes 2016; 
Wilkes, Bell and Kravitz 2000). Research shows that DTCA alters how individuals interact with 
health care professionals (Busfield 2006; Conrad and Leiter 2008; Fox and Ward 2008; Meier 
2007b; Meier 2018), with more patients taking an active role in requesting particular medications 
and frequently receiving them (Myers, Royne and Deitz 2011; Tomes 2016; Wilkes, Bell and 
Kravitz 2000). In this way, pharmaceutical advertising has contributed to medical expansion by 
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encouraging patients to be more proactive in assessing illness symptoms and selecting 
appropriate medical treatments.  
Notably, critique of pharmaceutical marketing is largely absent from meso- and macro-level 
diagnostic work on psychoactive mediations as a social problem. In addition to identifying the 
advertising of psychoactive mediations as problematic, youth implicate doctors in the over-
availability of these medications, particularly those who prescribe psychoactive drugs for those 
who do not “really” need them. Below are personal accounts from youth that illustrates how and 
why they construct the availability of psychoactive mediations as problematic.  
 
I have a lot of mixed feelings about prescription drugs. I have friends that have had real problems with 
them. So, that scares me. Adderall I think that’s like really over-prescribed and can be really detrimental, 
especially in college when almost everyone around me is using it on a weekly basis... I have plenty of 
friends that are prescribed Adderall. It’s really big on my campus. Our health services just hands them 
out. It’s a really big problem, actually...  I just want to reiterate again that I think prescription drugs are 
way over-prescribed. Especially for people my age that have anxiety problems and depression and don’t 
know any other way to cope with it besides taking drugs. I have a lot of friends that take Xanax and 
Klonopin; that have been taking it for years and I think that’s really not okay. I think the biggest problem 
is that people think it’s going to fix them, and you can’t just take drugs, because you’re just going to 
become dependent on these drugs, and it’s going to be the only way you think you can deal with your 
problems and that’s just not okay. (Mixed Race/Middle Class/Female; 30080) 
-- 
There’s just so many different kinds of drugs now that are out there to control these weird emotional 
problems that we have that need to be maintained, but I mean they’re really powerful, really addictive, 
potent drugs that can be abused. So I’m very much opposed to [taking] that as a means to live your life 
and maintain the things that are happening within you in order to function in the world. I mean people 
end up abusing those drugs and it just seems like they are more of an issue than a way to solve said 
problem. (Latinx/ Upper Middle Class/Female 30183) 
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The quotations above demonstrate how and why two young women problematize the availability 
and consumption of psychoactive medications, whether they are legal or not. Specifically, one 
woman notes how amphetamines and benzodiazepines are problematically over-prescribed to 
young adults and how this negatively affects their ability to develop healthy coping mechanism. 
Further, she argues that regularly consuming these pharmaceuticals can be more problematic 
than the illnesses they are prescribed to treat, particularly because they are addictive. As such, 
both women were disapproving of taking psycho-pharmaceuticals regularly to treat symptoms of 
anxiety, depression, and inattentiveness.  
Such claims-making activities also highlight how youth problematize aspects of the 
medicalization of everyday life. This is particularly visible in the comments of one woman who 
states that new pharmaceutical products pathologize particular human emotions. Furthermore, 
she notes that by problematizing certain emotions, the medical field advocates medical treatment 
as a means to treat and resolve common human experiences. As such, this young woman 
problematized the pharmaceuticalization of mental health in U.S. society. These sentiments are 
similarly echoed in much of the sociological work that interrogates the expansion of 
pharmaceuticals into aspects of everyday life (Bell and Figert 2012; Busfield 2006; Fox and 
Ward 2008; Williams, Coveney and Gabe 2013).  
Other participants link the over-prescription and over-consumption of medications to 
fundamental changes in users’ personalities and identities. 
People who regularly take sedatives or stimulants I think are almost as bad as those abusing it. That’s the 
same as misusing it to me. It’s changing who you are. It’s changing everything about how you think. So, if 
a parent doesn’t want to deal with their child, they put them on drugs at age 5 and is now a drug addict. 
And it’s okay, because the doctor said it would help them, but that’s still a 5 year old drug addict. 
(White/Upper Middle Class/Male; 30093) 
-- 
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I feel like doctors are really quick to medicate people for ADD and stuff like anxiety. It’s really common 
and so a lot of drugs are out there. I sometimes question who really needs it and who just thinks they need 
it. (White/Middle Class/Female 30072) 
 
The young man quoted above claims that regularly consuming psychoactive medications 
negatively alters who one is and how one thinks. Studies on patients taking psychotropic 
medication, like antidepressants, also detail how they experience their medications as negatively 
impacting their sense of self, framing their “medicated self” as unnatural and inauthentic (Davis-
Bearman and Pestello 2005; Karp 2006). Similarly, interactionist studies of drug addicts, 
particularly recovering drug addicts, describe being addicted to drugs as a process involving a 
loss of self (Denzin 1987). Reflective of those findings, this young man constructs psychoactive 
medications as a social problem by claiming that regular consumption of them creates drug-
addicted patients who are transformed and experience a loss of self. This young man assigns 
responsibility for these consequences to parents and doctors who make decisions to put children 
on addictive psychoactive medications as a means to control them. As such, this young man not 
only problematizes psychoactive medications and those who prescribe them, but also the larger 
culture of relying on medicine as a mechanism of social control (Zola 1972). It is a concern 
echoed by the young woman who highlights how doctors’ reliance on prescribing medications 
results in the over-medicalization of society, as many people come to think that they need 
medication to navigate daily life. These narratives make clear that young people identify medical 
professionals as responsible for making psychoactive medications a social problem. Doctors, 
therefore, are constructed as a common diagnostic frame for making sense of psychoactive 
medications as a social problem.  
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Another component of the frame that constructs psychoactive medication as a social problem is 
the construction of medical professionals and pharmaceutical firms as villains. Young adults 
specifically engaged in social problems work by constructing villains to hold responsible for 
psychoactive medications being socially problematic Many participants were critical of doctors 
who they view as having a tendency to over-diagnose particular conditions and over-prescribe 
psychoactive medications used to treat them. The following comments detail how youth frame 
doctors and their prescribing practices as particularly socially problematic:  
It’s [painkillers] super addictive. People just really get hooked and I just think a lot of people have huge 
issues with them right now, because it is a prescription drug and it's so readily available to a lot of 
people. Doctors are assholes a lot of time and they’ll just keep writing prescriptions and then people get 
hooked and find other ways to get it because it’s just everywhere. (Latinx/Middle Class/Male; 30056) 
-- 
Well I recently attended the funeral, first one I’ve ever been to, of a friend who overdosed on prescription 
painkillers. I just see so many bad things from the painkillers and the sedatives. Personally that’s the 
biggest problem I’ve had, myself. I find them extremely addictive and I think they’re prescribed way too 
freely without the doctors really knowing what they’re prescribing. It’s really appalling to me. I’ve gotten 
Xanax prescribed to me while I was also getting them [prescribed] elsewhere. I’m like “they’re really 
gonna do this to me”? It just seems so easy and the doctors just seem sadly so uneducated about it. Cause 
I definitely am highly addicted. I get withdrawals and stuff. So, that sucks. (White/Upper Middle Class/ 
Female 30387)  
 
The remarks above demonstrate how youth engage in both diagnostic and motivational framing 
when speaking about doctors and their role in making psychoactive medications a social 
problem. First, they identify doctors as being responsible for over-prescribing highly addictive 
medications. Second, they assign blame by using language that is intended to elicit revulsion 
with respect to doctors, their prescribing practices, and the problems that emerge from the over-
supply of psychoactive medications. This was particularly present in one young woman’s 
experience of losing a friend to an opioid medication overdose as well as her own experience 
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receiving prescriptions for benzodiazepines from multiple medical professionals simultaneously 
while struggling with addiction.   
Doctors are not just neutral actors in a medical system in which psychoactive medications are 
readily available; rather, in the narratives of some young people, doctors create drug addicts by 
over-prescribing psychoactive medications. Specifically, these youth identify the actions of bad 
doctors who practice medicine in ways that actually harm their patients. Interestingly though, in 
this social problems frame these youth do not afford patients the same agency, but rather see 
them as passive recipients of medical advice and treatments.  The following quotations further 
illustrate how youth focus on constructing doctors as social problems villains, while continuing 
to frame patients without any sense of agency.    
 
They’ve been prescribing more drugs than they’ve ever prescribed and kids are being prescribed 
prescription drugs when they’re like 5. I mean they’re making drug addicts, you know. It’s just like a 
common thing; Pills, pills, pills, and more pills. And it’s just money. It’s horrible, it’s really horrible. So, 
there’s more pills, so much money to be made on kids. (White/Working Class/ Male; 30186) 
-- 
I just feel like it’s so easy to get a prescription out of a doctor. You know some doctors don’t even care, 
but other doctors you can just know what the symptoms are and they’ll just prescribe it to you. So if you 
go to someone who is more liberal about prescribing them it’s easy to get it (White/ Upper Middle 
Class/Female; 30021) 
 
These claims making activities construct doctors and their unscrupulous prescribing practices as 
socially problematic. This theme of doctors-as-villains contains larger critiques of the medical 
professionals and institutions as being immoral actors that can cause harm to patients in their 
pursuit of profits.  
This social problems frame mirrors those frequently used by the media to make sense of illegal 
drug dealers. Historically, the most common villains constructed in drug-related social problems 
69 
 
stories are those who supply drugs to the public (Bourgois 2003a; Bourgois 2003b; Reinarman 
and Levine 1997; Williams 1990). In fact, one participant specifically frames some doctors as “a 
legalized type of drug dealer” (30289). 
In the claims-making activities of the young adults in this study, we see how they  problematize 
aspects of the U.S. medical profession by relying on other social problems stories of problematic 
drugs and those who profit from them. The domain expansion of social problem stories from 
drug dealers to doctors makes clear how successful claims making activities are designed to draw 
from larger cultural values that typically trigger moral outrage (Jenness 1995; Loseke 2011), like 
the stigma that surrounds those who profit from transforming people into drug addicts. 
Moreover, youths’ claims making activities again highlight the unique insight that micro level 
social problems work provide as we find the structure of medical practice in the U.S. is held 
responsible for these addictive medications being over-prescribed. A critique wholly absent from 
meso and macro level constructions of psychoactive medications as a social problem.       
Related to youth’s construction of doctors as social problems villains is a focus on their role in 
supplying addictive medications to children. This attention to prescribing psychoactive 
medications to children, while absent from macro and meso level analyses, is not historically 
unique. Children are frequently used in social problems stories about drugs, particularly as they 
are effective motivational frames for constructing those who take advantage of their innocence 
and naivety as morally condemnable (Murphy and Rosenbaum 1999; Reinarman and Duskin 
1999; Reinarman and Levine 1997). For instance, in the patent medicine era providing certain 
psychoactive medications to children was a large focus of the social problems work that 
informed the first wave of legislation seeking to control the availability of psychoactive 
substances (Hodgson 2001; Young 1961). Additionally, certain drug scares were also 
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problematized through stories of highly addictive drugs like heroin and crack-cocaine being 
consumed by children (Ferrell and Websdale 1999; Reinarman and Levine 1997). 
 Just as some youth constructed doctors as social problems villains, others identified 
pharmaceutical companies as socially problematic.  
 
I think it’s a massive industry. The drug companies are not sad that people are abusing their drugs 
because they are making money off of it. We all have emotional problems. People that struggle with self-
worth and self-love makes them more vulnerable to using prescription drugs and abusing them and not 
giving themselves the right kind of care. (White/Working Class/Female; 30198) 
-- 
I think also the fact that so many people around us take prescription drugs. If it’s okay in our society to 
medicate prescription wise then we’re gonna think it’s okay that we don’t need a prescription…So I think 
it’s a social thing ‘cause the ease of getting them comes along with that there’s more market. It’s a huge 
industry and I mean the pharmaceutical industry has its tentacles in a lot of different things so it’s not 
slowing down anytime soon. (White/Middle Class/Female; 30139) 
 
The two young women quoted above cast the pharmaceutical industry as social problems villains 
that profit from manufacturing and marketing addictive products. In particular, one young 
woman problematizes how the pharmaceutical industry has marketed its products to more 
domains of social life. Sociologists refer to this process as the “pharmaceuticalization of society” 
(Abraham 2010a; Fox and Ward 2008; Williams, Martin and Gabe 2011). Much of this work 
interrogates the ever-expanding application of pharmaceuticals into ordinary aspects of life, such 
as sleep and sex (Fox and Ward 2008; Williams, Coveney and Gabe 2013).  
Additionally, one young woman quoted above connects the pharmaceuticalization of society to 
the illicit consumption of psychoactive mediations. Specifically, she asserts that their ubiquitous 
presence serves to normalize decisions to take psychoactive medications without a prescription. 
These data reveal how youth criticize the larger medical culture in the U.S. as producing 
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problematic drug use. Additionally, these claims demonstrate how processes of 
pharmaceuticalization inform and influence young adults decisions to challenge aspects of 
medical authority with their practices of illicit psychoactive medication use, as they consume 
these medications without consulting a medical professional and receiving their tacit approval to 
do so. 
Other participants gave personal accounts that illustrate the ways they see the medical culture in 
the United States as fueling drug addiction.  
 
I’m from the Upper East Side and I was in therapy for 13 years, and it was constant giving out 
prescriptions. It was kind of weird and I mean a lot of kids I knew were on Xanax. A lot of them were on 
Adderall, and it was like “well, I have high anxiety,” and I’m like “do you have high anxiety? Or do you 
just go in to the shrink and they’re like, over-emphasizing about it?” I have this whole thing about 
marketing and the pushing of the medical companies to the doctors, and how they push them on you like 
“hey, try this out,” and it’s like, well, you don’t really fucking need this. And there’s a lot of pressure 
coming from the neighborhood that I come from you know? It’s just all elitist bullshit where they’re really 
trying to pump out the best kids, but on what [psychoactive medications]? You know, at what cost? 
Because most of these kid get addicted. (Mixed Race/Upper Middle Class/Female; 30019) 
 
This young woman recounts feeling a lot of pressure to excel in life while being raised in an 
upscale New York City neighborhood. Many of her peers turned to psychoactive medications for 
help, which she frames as problematic because it leads to addiction. This woman’s experience 
illustrates how those from particular social class backgrounds may experience more pressure to 
make use of psychoactive medications from the doctors, parents, and peers in their social 
networks. Moreover, because of these pressures, those from advantaged social class background 
may have social networks that contain more individuals with prescriptions thereby compounding 
their likelihood of engaging in the illicit consumption of these psychoactive medications. While 
research has shown that persons from higher socioeconomic backgrounds may be more likely to 
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be prescribed psychoactive medications than their lower-SES counterparts (Shim 2010; Simoni 
and Drentea 2016), this research has yet to connect these rates to prevalence of illicit 
consumption of these medications.  
This upper middle class woman is also very critical of the relationship between pharmaceutical 
companies and doctors. Specifically, she describes cooperation between drug companies and 
doctors in order to make money from drug-dependent patients. These claims making activities 
cast the medical field as exploitative and driven by concerns about profit more than the 
wellbeing of their patients. The corrupting influence of profit motives on the practice of 
medicine has been covered extensively by both media and academia (Meier 2018; Rasmussen 
2008b; Tomes 2016). Referred to as “the doctor’s dilemma,” profit incentives embedded in 
practicing medicine in the U.S. encourage doctors to over-diagnose and over-prescribe 
pharmaceutical treatments to their patients (Tomes 2016). Recent research on the pharmaceutical 
industry demonstrates how certain companies are involved in more than simply marketing 
medications; they are also marketing the symptoms and diagnoses their medications are 
approved to treat (Moynihan and Cassels 2008; Moynihan et al. 2002; Tomes 2016). Framed by 
the pharmaceutical industry as a way to foster a more informed and engaged public, these 
advertisements are also seen as a way to generate greater consumer demand for its products by 
“selling sickness” (Moynihan and Cassels 2008; Moynihan et al. 2002; Tomes 2016). While 
young adults do not explicitly articulate these concepts, they use language that nonetheless 
problematizes how pharmaceutical companies and doctors push psychoactive medications onto 
patients. Unsurprisingly, these larger criticisms of the profit incentive embedded in medical 
practice in the U.S. are decidedly absent from meso and macro level social problems work on 
illicit psychoactive medication use.   
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Opioid Medications as a Social Problem  
Within the frame that constructs psychoactive medications as a social problem, many young 
adults engage in social problems work specifically with regards to the availability of opioid 
based pain killer medications.  
I think these drugs are obviously a problem. They’re not regulated enough, and I think that people are 
prescribing Oxycodone too much. I know a lot of people that are now heroin addicts because of it. 
Because it’s [Oxycodone] so accessible and it’s legal. (White/Middle Class/Female; 30076) 
-- 
I had gotten my wisdom teeth taken out and we have this family doctor, he’s a friend of my dad’s, who’s a 
dentist. He loaded me up with painkillers totally unnecessarily. I got hydrocodone and oxycodone, and I 
mean I was like “this is awesome!”, but in retrospect, I didn’t need them. So you know, I used them for 
the first couple of days and after that I had all those left over and so I actually sold some to my friends 
and I was taking them for fun, like experimenting with them (White/Middle Class/Female; 30139) 
-- 
I had a minor surgery April of last year; so almost a year ago. And I think that my doctor’s a giant wuss 
and they prescribed me a bunch of painkillers that I never actually needed. So, I had a bunch of 
Percocet’s sitting at my house. (White/Middle Class/Female; 30177) 
 
These youth villainize doctors for unnecessarily over-prescribing opioid medications to 
themselves and the American public. Interestingly, one young woman blames institutions tasked 
with regulating opioid medications for their over-availability. She even questions whether such 
medications should be legal due to how dangerously addictive they are. These claims making 
activities highlight how some participants identify the medical field as in need of greater 
oversight and regulation due to the harm its products are causing patients. Additionally, youth 
described how those who become addicted to prescribed opioids frequently transition into using 
street-based versions like heroin. This frame has been a common trope present in media coverage 
and is most commonly cited as one of the top issues fueling the nations opioid epidemic 
(Compton, Boyle and Wargo 2015; Manchikanti, Atluri and Hansen 2014; Meier 2018).  
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Youth framed one brand of opioids as particularly problematic, OxyContin. Over the last decade, 
extensive media coverage has constructed OxyContin and its manufacturer, Purdue 
Pharmaceuticals, as a social problem (Meier 2018; Tough 2001). The DEA investigated the 
advertising and marketing of OxyContin, and in 2007 filed against Purdue Pharmaceuticals, 
alleging that it had misbranded the drug as non-addictive with the intent to defraud or mislead 
medical practitioners and patients (Meier 2007a; Meier 2007b). Purdue pled guilty to felony 
charges, admitting that it lied to doctors about OxyContin’s abuse potential (Meier 2007a; Meier 
2007b).  
Relatedly, youth spoke at length about the addictiveness of OxyContin. Many distinctly 
described the drug as too dangerous to consume even once.  
 
I think just the potency of these things; like painkillers are just extremely powerful, almost unassumingly 
powerful. It’s like a little tablet advertised to help rather than hinder, but it’s so addictive and super 
powerful. I think that it allows for abuse because of naiveté or ignorance, someone can take it and, you 
know, just take too much or just get hooked very easily. (White/Middle Class/Male; 30239) 
-- 
I had a bunch of friends who had problems with it [OxyContin] in college. My best friend growing up had 
a big problem with it. Another friend of mine had a big problem with it. I mean the biggest thing I’ve seen 
is people seem to get addicted to it really easily and then they pretty much don’t do anything else 
(White/Upper Middle Class/Male; 30271) 
-- 
Yeah they’re [painkillers] so addicting. Like I said, lots of kids start using Vicodin or Percocet you know, 
you don’t really think it’s that bad because it was prescribed to you. So they have this like deceptive 
nature where you don’t really think it’s gonna be that bad and then you know you start with Vicodin and 
Percocet and you move to Oxycontin and then move up to Heroin because you’re addicted. So yeah, I 
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mean I think that that’s really, really bad so I think that prescription pain killers are really risky. 
(White/Middle Class/Male; 30068) 
-- 
All of my experiences with painkillers like Vicodin or Percocet and the generic forms of them. I haven’t 
really thought twice about taking them, but I’ve been offered Oxycontin before and I would not touch that 
shit. I feel like that shit’s really scary and it’s basically like doing heroin. I don’t know, that shit just 
freaks me out. Cause, like, that’s like a serious drug. That’s like a serious, serious drug. (White/ Rich 
/Female; 30002) 
 
These quotations above demonstrate how youth construct OxyContin as a social problem. Many 
participants mentioned that it is “very easy” to get addicted to this medication and, therefore, 
stigmatized its use. Framing some drugs as instantly addictive has contributed to the construction 
of other drugs as a social problem (Reinarman and Levine 1997). Reproducing common tropes 
of the power of addiction, these youth frame opioid medications like OxyContin as dangerous to 
consume and therefore socially problematic.  
Unlike other drug scares however, we find that youth do not speak negatively about those who 
become addicted to opioid medications. Instead of demonizing those who become addicted to 
opioid medications, these youth engage in claims making activities that frame the medications, 
themselves, and those who produce, regulate, and prescribe them as socially problematic. In fact, 
many young adults, particularly those whose friends or family members had become addicted to 
OxyContin, constructed opioid addicts as victims who were deceived and exploited by doctors 
and the pharmaceutical industry.  
Scholars note how the current opioid epidemic is constructed in very different terms than was  
the heroin epidemic of the 1970s (Hansen and Netherland 2016; Netherland and Hansen 2017; 
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Netherland and Hansen 2016; Orsini 2017). Specifically, white opioid addicts are currently cast 
as sympathetic victims rather than immoral criminals as heroin addicts were once and still are 
portrayed (Hansen and Netherland 2016; Netherland and Hansen 2017; Netherland and Hansen 
2016; Orsini 2017). That stark distinctions are made between these two groups of opioid users 
reveals how race shapes perceptions of drug problems (Hansen and Netherland 2016; Hartman 
and Golub 1999; Netherland and Hansen 2017; Reinarman and Levine 1997).  
Further, that young adults focus their social problems discourse on the pharmacological 
properties of opioid medications and not on the user follows the framing largely adopted and 
portrayed through mainstream media outlets on opioid medications. While white participants’ 
engagement in social problems work was not limited to opioids, the racial aspects of the opioid 
epidemic certainly inform and influence how they construct and make meaning of these 
medications as a social problem. Participants’ proximity to those with addictions to opioid 
medications no doubt informs their decisions to cast opioid users as victims and assign blame to 
those who create and distribute psychoactive medications.     
Youth who sought to frame psychoactive medications and their availability as a social problem 
engage in social problems work that construct doctors and pharmaceutical companies as largely 
responsible for turning medical patients into drug addicts. Much of their claims making activities 
were critical of how these medications have come to dominate the ways Americans experience 
and navigate their everyday lives. By problematizing the pharmacetuicalization of society, young 
adults in this study construct psychoactive medications as precipitating more social harm than 
good. While some youth frame key upstream players within the U.S. medical profession as 
baring responsibility for the problems of psychoactive medications in society, many other youth 
construct this social problem in distinctly different terms.   
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Frame 2: Constructing Responsible Misuse  
 Not all youth framed doctors and pharmaceutical companies as social problems villains. 
In fact, many did not frame psychoactive medications as socially problematic at all. Rather, they 
sought to draw distinctions between problematic and acceptable practices and patterns of 
consuming such medications, as illustrated by the following remarks. 
 
I think it’s more of a problem with people rather than the drugs… It would be nice if people could do 
them responsibly in a way that doesn’t bring negative attention to drugs.  I definitely do. (White/ Upper 
Middle Class/Male; 30037) 
-- 
When I’m like super stressed out or something happens and if someone’s taking Xanax, I’ll be like “Oh 
hey I’ll take one”. I feel like as long as you’re responsible and not an idiot about it, it could be very safe. 
(Asian/ Poor/Female; 30287) 
 
 Both participants quoted above identify particular people and their irresponsible use of 
psychoactive medications as the problem rather than the medications, themselves. The notion 
that illicit consumption of psychoactive medications can be done “responsibly” was a prominent 
claim in the narratives of many youth, particularly when they sought to make sense of their own 
illicit use of medications. Young adults frame distinctions between responsible and problematic 
consumption in terms of the quantity and frequency of consumption, as well as the intended 
purpose of taking medications.     
Controlling Consumption     
 Youth frequently engage in claims-making behaviors that define their own practices of 
misuse as acceptable in contrast to the actions of others, which they define as problematic. The 
following quotations highlight how youth distinguish between quantities and frequencies of 
consumption they deem acceptable and those they cast as problematic.  
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It’s a pretty casual topic. I was stressed out the other day. So, my friend gave me Xanax... If I’m freaking 
out and my friend has a Xanax then I’ll probably take like a quarter of it. That’s about it. I don’t really sit 
there and take a whole bunch of them. (Mixed Race/Working Class/Male; 30265) 
-- 
Most people who I know take things for school, if we want to get things done in a week that would 
normally take a month or two months. In terms of stimulants it helps them get work done pretty fast. It 
helps them stay focused and concentrate on what they have to do. Sedatives, it helps my friends to relax 
and calm them down if they are having a really stressful day, but it is mostly stimulants for school or 
work. Painkillers, if someone is having a rough day. I’m not as worried or feel like it’s going to end up 
harming me if it’s only for tests or just occasionally; definitely not a regular basis.  As long as I don’t see 
it interfering with important things like family, work, and school then I don’t worry about it. (White/ 
Upper Middle Class/Female; 30151) 
 
The above quotations demonstrate important ways in which youth frame acceptable patterns and 
practices of consuming psychoactive medications. First, youth frame their own consumption as 
moderate and controlled. They stress that taking medications without a prescription is acceptable 
if engaged in occasionally to help get through a difficult situation, such as being stressed, 
anxious, overwhelmed with work, or unable to sleep. Moreover, they characterize their 
consumption as being under control, given that they avoid consuming large doses and do not 
allow it to interfere with other aspects of their lives.  
Howard Becker’s (1963) work illustrates the importance of maintaining control over one’s drug-
use, given the ways in which drug-dependent persons are highly stigmatized in American 
society. In Becker’s study, marijuana users rationalized their drug use by noting that it was not 
addictive and, thus, was not stigmatized as some other drugs were  (Becker 1963). Having 
control over one’s drug consumption then becomes a “symbol of the harmlessness of the 
practice” thereby justifying it as responsible and acceptable (Becker 1963 p74). 
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The importance of avoiding drug dependence is illustrated in the narratives of the young men 
quoted below. Their comments demonstrate how they draw distinctions between problematic and 
responsible practices of illicit medication consumption.      
 
We’re all moderate. Everyone’s super duper moderate and everyone generally does the same thing which 
is [take] Xanax when I want to go to sleep. That’s the thing, nobody’s like crazy; nobody’ s going out and 
seeking it out. (Latinx/Working Class/ Male; 30100) 
-- 
I mean when you’re taking them on a daily basis that’s it. You’re just kind of living in a fog like a zombie. 
And I mean you’re also just running away from your problems, and not confronting or dealing with your 
life. You’re just kind of like blocking it out. But sometimes, you know, I’d get to the point where it would 
just be so extreme, these feelings of anxiety; those periods are when I tend to use them. I was just taking 
them like semi-regularly rather than feeling this feeling [of anxiety].  (White/Upper Middle Class/Male; 
30066) 
 
The claims-making activities of these men can be seen as rationalizing their own consumption of 
psychoactive medications; they define their behavior in ways that distinguish them from other 
use practices that they deem to be problematic.  
For instance, they see those who consume psychoactive medications regularly as irresponsible 
because they risk developing a dependence on these substances. One young man describes how 
people who take benzodiazepines everyday are like “zombies.” This depiction of problematic 
consumption focuses on the ways drug addiction, as an illness, results in the loss of self 
(Charmaz 1983; Denzin 1987; Weinberg 2013), a condition the men in this study seek to avoid. 
As a result, they construct their own consumption of psychoactive medications as a responsible 
practice of moderation and control that aids in the attainment of a more valued self instead of a 
de-valued self. The another young man quoted above frames his consumption and that of his 
friends as acceptably moderate and controlled because they do not engage in drug-seeking 
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behaviors, which they describe as acting “crazy.” Both quotations highlight how young adults 
stigmatize addiction, constructing addicts as either less than human or not fully in control of their 
behavior.   
Other participations drew distinctions between acceptable and problematic consumption in terms 
of one’s responsibility to control one’s consumption:  
 
I just feel like I have control over my use of them. I think the number one proof of that is I never really run 
out of it and go looking for more. And I’m not prescribed it [Xanax]. So, I don’t have an endless supply of 
it. So, I like to think that I’m in control of my use of them especially compared to some people that I know 
that I guess have more of an addictive personality and have more of a dependency on them. These 
[Xanax] I use pretty regularly, but definitely not daily. And another thing that helps me is just knowing 
that it’s there for me if I wanna take it and I think that other people might not have such will power. If it’s 
there, they’ll just rely on it (White/Middle Class/Male; 30046) 
-- 
I don’t see myself as one of those prescription drug users who really needs it or actively seeks it out all 
the time. You know if I wanted to seek it out it’ll be easy enough to find it. Once in a while I get them, but 
you know it’s not something that I absolutely need in my life or compromise other things like my finances 
or whatever. (White/Middle Class/Female; 30127) 
 
One young man constructs his own consumption as responsible because he does not take Xanax 
daily in comparison to those with addictive personalities who do not demonstrate the willpower 
to abstain from consuming these addicting medications more frequently. Dominant public and 
political discourse constructs drug addiction as a function of individual pathology (Fraser and 
Moore 2011; Moore 2012). Therefore, it is not surprising that some youth reproduce such 
discourse in their own social problems work on psychoactive medication use. Needing to 
consume such medications on a frequent basis, seeking them out, and compromising one’s 
finances all comprise patterns of consumption that these young adults construct as socially 
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problematic. Conversely, the absence of these out-of-control drug-seeking behaviors is indicative 
of one’s ability to practice illicit psychoactive medication consumption responsibly.  
Constructions of responsible forms of illegal behavior are intriguing from a sociological 
standpoint. They highlight the existence of tensions between the law, on the one hand, and the 
values and norms of some segments of society, on the other. Through constructions of 
responsible ways to illicitly consume psychoactive medications, youth reveal how they challenge 
both the authority of law and medicine. Moreover, by reframing their illegal behavior, youth 
seek to justifying their deviant behavior through claims making activities.  
Neutralizations are defined as “justifications for deviance that are seen as valid by the delinquent 
but not by the legal system” (Sykes and Matza 1957 p.666). Sykes and Matza (1957) noted that 
individuals “drift” in and out of participating in deviant behavior and that individuals engage in 
claims-making activities that seek to morally justify their participation in deviance. 
Neutralization theory has been used to help explain a wide variety of deviant and criminal 
behaviors including drug use (Maruna and Copes 2005). A common technique of neutralization 
cited in drug research is the claim that one’s drug use is neither socially problematic or harmful 
to anyone (Peretti‐Watel 2003; Priest and McGrath III 1970). Youths’ claims-making draws 
heavily upon the notion that their behaviors do not produce any problems or harm. They claim 
that their consumption of psychoactive medication consumption is harmless because they avoid 
use patterns that are commonly associated with the development of drug addiction. By grounding 
their illicit use of these controlled substances within the discourse of socially-responsible 
consumption practices, these youths renegotiate their behaviors, and ultimately themselves, as 
moral and responsible, despite engaging in illegal behavior.   
 
Responsible Purposes  
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 Constructions of responsible psychoactive medication consumption not only stressed 
moderation and control, but also focused on the context and purpose of consumption. The 
following section highlights how consuming these medications for pleasure is socially 
problematic.          
 
To me, somebody who abuses drugs or is a drug addict is someone who does it to get high and feel good, 
first of all, and who is unreliable and self-harming. I don’t feel good. I feel better, but it doesn’t make me 
forget about anything, it doesn’t make me feel a high, it doesn’t feel good. I still do everything that I need 
to do, and it allows me to be micro without getting distracted by the macro. For me, someone who’s a 
drug addict has them flipped and uses it to escape and I don’t think I do that. So, I guess I needed to 
justify myself. I think that is kinda like an important difference. You know, it’s not about the high; it’s 
about everything else you can do. (White/Middle Class/Female; 30157)  
 
This young woman engages in boundary work as she makes claims that her illicit consumption 
of Adderall is acceptable because it is not for purposes of pleasure or escapism.  Instead, she 
frames her illicit consumption as resolving her problems and as such feels compelled to justify 
her illicit consumption of psycho-pharmaceuticals as being distinctly different from problematic 
practices of drug abuse and addiction. This articulation of justification, while evident in others 
claims making activities, draws attention to how employing techniques of neutralization seek to 
not only rationalize participation in illegal behavior, but also to preserve the deviants’ sense of 
self as a moral and law-abiding citizen (Stadler and Benson 2012; Sykes and Matza 1957). By 
constructing particular practices of illicit medication consumption as problematic, youths 
categorize their behaviors as responsible and distancing themselves from problematic 
populations.  
The following quotations provide more detail about how youth problematize the experience of 
consuming these medications for purposes of pleasure:  
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The real misuse of it is people taking it to go out and drinking too much on it, especially mixing it with 
other drugs. That is super dangerous.  My friend’s hometown, she knows a handful of kids who’ve 
already died of taking too much Oxy and drinking on it. Which is like such a bad combo. So, I know it’s a 
real problem, but I think it’s just about like being informed of it. I mean I don’t really condone taking 
Adderall to work, but it just works for me. And I don’t abuse it. I don’t like snort it to go out. It’s more so 
to fulfill my studying or writing needs; work really. I know a lot of people don’t do it that way and misuse 
it. (Asian/ Poor/ Female; 30287) 
 -- 
I don’t know anybody who uses it recreationally. I only know people who use it to get shit done, but not 
just studying, like if you need to clean your apartment or something. Sometimes just coffee doesn’t do it. 
Sadly, but true and this goes for really legitimate, you know, responsible people who have real jobs and 
real lives (White/Rich/Female; 30002) 
 
 These quotations highlight pleasure as a core value that shapes distinctions between 
problematic and responsible practices of consuming psychoactive medications. They show that 
hedonistic consumption of psychoactive medications is a defining characteristic of problematic 
use. One woman notes that the “real misuse” of psychoactive medication entails consuming them 
to party and get high. They define snorting these medications as abusing them, and combining 
them with other drugs as “super dangerous.” In comparison, these youths frame their own 
consumption for purposes of work as being effective and socially acceptable. Another woman 
similarly claims that she and her friends do not consume these drugs for fun, but rather to 
navigate their mainstream lives and successful occupations.  
These claims-making activities construct some practices of illicit psychoactive medication use as 
responsible and socially acceptable by contextualizing them within valued societal activities of 
production. Jock Young’s work on psychoactive substances in society reveals that where drug 
taking is linked to productivity it is not only socially acceptable, but even at times encouraged, 
while those substances that are seen as undermining productivity are typically problematized and 
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demonized (Young 1972). By framing their own consumption of psychoactive medications as 
helping them to achieve valued societal goals, such as succeeding in school and in the 
workplace, youths can frame their illicit consumption of these medications as responsible. 
Neutralization studies of white collar criminals highlight similar claims of justifying certain 
deviant behaviors as a necessity or normative practice within the context of the workplace 
(Coleman 2001; Stadler and Benson 2012).       
While some make meaning of responsible consumption by constructing it as helping them be 
productive—a valued societal principle—others neutralize the deviance associated with taking 
someone else’s psycho-pharmaceuticals by articulating their purpose of self-treating an illness.    
 
P: Well, I’ve actually recently taken Ativan in the morning to try and make myself be happier or less 
stressed out. I’m a very tense person and I think that’s supposed to be an anti-anxiety medicine. So, this 
was not supposed to be like partying, I was just trying to better myself . . . the way that I am taking them 
now is quite harmless even though they are not my own prescription. So, I think that recreationally 
though that’s not okay 
 
I: I just want to double check, when you say using it recreationally isn’t okay? 
 
P: I mean just trying to have fun. I took the Ativan to try to better myself. I was trying to be more normal, 
which is not the same. (White/Working Class/Female; 30084) 
-- 
I think prescription drugs are prescribed for a reason. It wouldn’t be prescribed if they shouldn’t be used 
at all. [Misuse] can help people. So, I think it depends how you use it, but I think it [misuse] could 
actually help someone . . .  So, I take them when I have problems sleeping. That’s my biggest problem. 
And if I just want to relax, they help me relax. I have really bad anxiety. I don’t know what else to do. 
There’s nothing else that I could take. It’s not like if I could have tea I’ll feel better (White/Working 
Class/Female; 30114) 
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By framing their illicit consumption as treating an illness, the above women claim that their 
illicit use of psychoactive medicines is not only responsible, but necessary. One young woman 
notes that her consumption of these medications is the only thing that helps her relax and sleep. 
She also justifies her illicit consumption by stating that it helps resolve a problem she faces, and 
that others are prescribed these medications for very similar reasons. In this way, the illicit 
consumption of psychoactive medications is made meaningful not as a social problem, but as a 
social problems solution.   
Similarly, the other young woman explains that taking Ativan helps her be less tense and 
happier, emotional states that she defines as normative and healthy. By framing her illicit 
consumption of a benzodiazepine to treat stress as “harmless,” she reveals how she does not 
problematize the way her consumption challenges aspects of medical authority, but instead 
values how it helps her be “more normal.”  Both women’s claims-making activities draw 
attention to how youth frame these medications as helpful medical tools and that by taking them 
to treat experiences they define as illnesses they renegotiate their behavior as responsible.   
The following quotation provides a more in-depth examination of the ways responsible 
consumption is grounded in a discourse of treating illness.  
 
I mean, people call it recreational, but then they also have a very helpful purpose in many people’s lives. 
I mean, I guess people call it abuse, but other people call it helping themselves or bettering their current 
situation. So, people often get very anxious depending on whether or not they’re stressed out with school 
or stressed at work and so I think that at times sedatives are important, because anxiety can lead to not 
being able to deal with things around you. Furthermore, especially when it comes to stimulants, I think 
that they are very necessary. You know, the average human doesn’t have the attention span to do a lot of 
work for a long period of time, and the fact that we’re required to work eight literally plus hours a day is 
out of control, you know? Sometimes you have to do more than that! So, stimulants totally help. I mean, I 
have the attention span of like a worm. So, I know for a fact that I’m more productive and I’m a better 
worker when I take stimulants. (Black/Middle Class/ Male; 30122) 
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This young man notes how distinctions between legal and illegal use of psychoactive 
medications can be arbitrary, and at times hypocritical, as these medications can help people be 
healthier and more productive, whether they are taken with or without a prescription. His point 
reemphasizes how youth challenge medical professionals’ power to control who takes these 
medications; to the young adults, the purpose of taking the medications is more important than 
the means by which they acquire them. This young man also demonstrates how these 
medications help to resolve problems of everyday life, such as long working hours in late 
modern economies (Burke and Cooper 2008; Perlow 1999; Sullivan and Gershuny 2004; Young 
2007). This is further evident when the young man explains that consuming these medications is 
an important practice that helps him to navigate the demands of late modern life. He 
problematizes his short attention span, which counts as an essential component of success in 
today’s workforce (Gergen 1991; Gubrium and Holstein 2000). The three youths quoted above 
all describe how their engagement in illegal behavior actually helps them to achieve a sense of 
normality and social conformity. The ability of these medications to enable conformity to 
societal expectations is one that these youths value greatly, and it represents a defining aspect of 
how they construct notions of responsible illicit medication consumption. Sykes and Matza 
(1957) noted how some deviants justify their behavior by making claims that other norms and 
values sometimes supersede the law. Similarly, these youths claim that the necessity to treat 
anxiety, inattention, and stress renders their illegal pharmaceutical consumption normative as it 
resolves pathological experiences and enables them be productive and successful members of 
society.   
 
Conclusion  
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 As both a legitimate source to treat medically-diagnosed illnesses and a source of deviant 
drug use, psychoactive medications occupy a unique sociocultural legal location. Exploring how 
youth navigate these distinctions provides insight into why this drug-use trend is prevalent 
despite its construction as a social problem by various institutions of law, medicine, and media. 
The various ways youth construct psychoactive medications and their consumption as a social 
problem reveal a great deal about the underlying belief systems that they draw upon when 
making meaning of these popular pharmaceuticals. While some young adults construct these 
medications, and the larger medical system that produces them and provides access to them, as 
socially problematic, others are much more specific in how they locate the problematic aspects 
of these medications. In fact, some don’t construct the medications as problematic at all, but 
identify those that engage in irresponsible consumption of them and subsequently develop drug 
addictions as problematic.  
 Those who problematize aspects of U.S. medical practice and culture highlight how  
social problems work on this drug trend at the meso- and macro- levels lacks criticism of the 
medical field and their role in enabling the ubiquity of psychoactive medications. I argue that 
some young adults’ personal experiences with the problematic aspects of these medications 
shape how they make meaning of this drug trend and where they locate blame for its emergence 
and perpetuation. In this way, the analysis of micro-level claims-making activities reveals that 
youth locate blame for this social problem in different ways than does the social problems work 
employed by the medical field, law enforcement, government organizations, and most media 
representations.           
While some blame medical field actors for psychoactive medications being socially problematic, 
others assign blame for this social problem downstream to individuals who irresponsibly 
88 
 
consume these pharmaceuticals. These claims demonstrate that those who do not moderate their 
consumption of these medications, or those who take them to get high and have fun, are engaged 
in dangerous and deviant behavior because they risk becoming drug addicts. Craig Reinarman 
states that the norms and values of American individualism resonate with focusing in on specific 
drug use behaviors as a way to make meaning of drugs as a social problem (Reinarman 1994a; 
Reinarman 2005; Reinarman and Duskin 1999). Furthermore, these claims-making activities 
reveal how a lack of control over one’s drug use is a focal point that these youth articulate in 
order to distance and distinguish themselves from those whose irresponsible consumption 
represents the “real” social problem. Research has shown how drug users seek to resist the 
stigma associated with drug use by distancing themselves from the stereotypical characteristics 
and behaviors of drug addicts (Becker 1963; Boeri 2004; Copes, Hochstetler and Williams 
2008). This distancing is accomplished through claims-making activities that seek to draw 
symbolic boundaries between themselves and a problematic “other” (Becker 1963; Boeri 2004; 
Copes, Hochstetler and Williams 2008; Perrone 2009). This boundary work is particularly 
important for drug users, as they recognize that the general public may not distinguish between 
responsible and problematic drug using populations (Copes 2016; Copes, Hochstetler and 
Williams 2008). The structure of qualitative interviews may therefore encourage those who 
illicitly consume psychoactive medication to engage in certain forms of boundary work.   
By taking seriously the perspectives of those who illicitly consume these medications, I uncover 
an insider’s understanding of how illicitly consuming these medications is simultaneously 
problematizes and embraced. This analysis also demonstrates how some youth make meaning of 
their illicit consumption of psychoactive medications by framing them as a social problems 
solution. Indeed, many youths expressed how they value these medications and their ability to 
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help them navigate problems in their day-to-day lives. In this way, these youths reveal their 
engagement in illegal behavior as a means of conforming to societal expectations. Furthermore, 
these claims-making activities highlight how youths challenge aspects of medical authority as 
they go about constructing their consumption of these medications outside of the supervision of a 
medical professional as a responsible way in which to treat pathology.  
When youth construct responsible psychoactive medication consumption, they use language that 
stresses important American values such as moderation, productivity, and self-care. Their 
endeavors to conform to the societal norms and values of responsible consumption patterns 
demonstrate how they justify their behaviors, prioritizing aspects of their health and success over 
legal and medical definitions of problematic drug use. In his seminal work on drugs in society, 
Jock Young (1972) argued that it is important to delineate between which forms of drug use are 
integrated and embraced by some cultures, and which are problematized and stigmatized. Youths 
claims-making activities reveal that cultural conventions serve to normalize the drugs’ illegal 
medication consumption. My analysis highlights how the boundaries between legal and 
controlled illicit use of these pharmaceuticals appear significantly blurred to these youths. 
Distinctions between deviance and medicine therefore also become blurred. Sykes and Matza 
(1957) concluded their now famous article on techniques of neutralization by urging future 
researchers to focus on the subjective worlds and belief systems of deviants. While these youths 
reject the notion that they are deviant, by doing so they also reveal how their behavior represents 
a challenge to both legal and medical definitions of problematic consumption of psychoactive 
medications. The construction of new frameworks from which these youths make meaning of 
illicit psycho-pharmaceutical use demonstrates how this popular drug trend resonates with other 
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cultural values, such as the importance of taking responsibility for one’s health, wellbeing, and 
success in society.   
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Chapter 6: Medicalization and Challenging of Medical Authority 
 
This chapter explores how young adults frame their consumption of psychoactive 
medication through the use of medical discourse. These youths’ experiences demonstrate how 
illicit use of psychoactive medications is made meaningful as a medicalized social practice. By 
describing their consumption in terms of a therapeutic treatment, youth reveal how they apply 
medical knowledge and language to describe and identify common human experiences as 
symptoms of illness.    
Medicalization describes a process through which human experiences and conditions 
come to be defined as medical problems in need of medical solutions (Conrad 2008). The 
increasing medicalization of society is one of the most significant changes in U.S. culture 
(Clarke et al. 2003). As a constructionist framework for understanding the increasing roles of 
medicine in everyday life, medicalization studies draw attention to the definitional processes 
involved in producing, maintaining, and expanding medical diagnoses and treatments. 
Medicalization studies have examined the construction of addiction, depression, and inattention 
as medical problems in need of medical solutions, most often in the form of pharmaceuticals 
(Conrad 1975; Conrad 2008; Conrad and Potter 2000; Conrad and Schneider 1980).  
From a social constructionist perspective, the diagnostic process is a cultural practice that 
delineates the boundaries between medically acceptable and unacceptable states of being (Brown 
1995; Jutel 2009; Jutel 2014). As such, the diagnostic process is central to medicalization 
(Brown 1995; Conrad and Potter 2000). The sociological study of medical diagnosis also 
demonstrates the diverse range of organizational, economic, and personal interests involved in 
creating, expanding, and receiving medical diagnoses (Jutel 2009; Jutel 2014). Medical 
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sociologists have long highlighted the transformative nature that receiving a medical diagnosis 
can have for patients (Broom and Woodward 1996; Brown 1995; Bury 1982). While diagnosis 
identifies an illness, the experience of receiving and living with an illness is one constructed by 
people who feel and act on symptoms in a multitude of ways (Brown 1995; Bury 1982; Charmaz 
1983; Charmaz 1993; Loe and Cuttino 2008).   
Changes in the structure and organization of health care in the U.S. have produced a 
system that encourages medical patients to be more proactive and act more like medical 
consumers making informed choices within a medical marketplace (Conrad 2008; Tomes 2016). 
Patients’ increasing involvement in medical decision-making is a driving force of medicalization 
(Conrad 2005; Conrad and Leiter 2008; Conrad and Schneider 1980; Guadagnoli and Ward 
1998). Social movement organizations that mobilize around alcoholism and PTSD, for example, 
have significantly contributed to the recognition of those experiences as medical conditions 
requiring medical treatment (Broom and Woodward 1996; Conrad and Schneider 1980; Epstein 
1996; Scott 1990). Similarly, Conrad and Potter’s (2000) study of ADHD demonstrates how 
advocacy groups, medical experts, and the pharmaceutical industry contributed to the expansion 
of the disorder from one that solely impacts children to one that also affects adults. In this way, 
the diagnostic expansion of ADHD demonstrates how stakeholders from within and outside of 
the medical field participate in the definitional expansion of a particular illness. Building off of 
the constructionist work on domain expansion in the study of social problems, in which certain 
claims-making activities were observed to widen the scope of an existing social problem, the 
concept of diagnostic expansion highlights the claims making activities involved in expanding 
the definition of an established medical diagnosis (Conrad and Potter 2000).  
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Of particular interest to this chapter are the roles lay populations play in expanding the 
scope of a medical diagnosis through everyday actions and interactions (Belgrave et al. 2004; 
Hardey 1999; Kangas 2001). Distinctions between lay and expert medical knowledge have been 
well researched within the field of medical sociology (Arksey 1994; Prior 2003; Williams and 
Popay 1994). This is particularly important as the dissemination of expert medical knowledge 
through the internet has resulted in a significantly more medically informed lay public (Conrad 
2008; Kangas 2001; Radley 1994). One study demonstrates how people construct and make 
sense of illnesses, like depression, by relying on an amalgamation of expert medical knowledge, 
media representations, and personal experiences (Kangas 2001). Moreover, media popularization 
of illnesses and pharmaceutical treatments can have profound impacts on lay populations’ 
decisions to seek out specific diagnoses and treatment from medical experts (Conrad and Leiter 
2008; Conrad and Potter 2000). As such, both the democratization of medical knowledge and the 
popularization of pharmaceutical treatments increase lay populations’ ability to engage in 
processes of medicalization (Conrad and Potter 2000).   
Anxiety, inattentiveness, and pain have become common medicalized complaints that are 
highly susceptible to diagnostic expansion as the diagnosis of these symptoms is solely reliant 
upon the patients’ ability to describe what they are  experiencing (Conrad 2008; Rasmussen 
2008b). In this way, the misuse of commonly-prescribed pharmaceutical remedies to treat these 
symptoms presents an interesting new arena in which to study how medicalization is enacted and 
experienced in U.S. society. I assert that by reclaiming illicit use of psycho-pharmaceuticals as a 
medicalized social practice, these youth reveal common mechanisms through which people 
decide to medically define and act on certain experiences in daily life.  
 
Self-Diagnosis and the Medicalization of Illicit Consumption   
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 Some young adults construct their consumption of psychoactive medications as decisions 
to treat illness, and specifically illnesses that are self-diagnosed. The following narrative 
demonstrates how illicit use of others’ medication is made meaningful in terms of health, illness, 
and agency.  
 
I think among my peers and myself, there is so much information out there about illness and 
medication, and so much accessibility to treat yourself for so many different things. Go on 
WebMD and figure out what you have and I think that probably contributes a lot to the 
prevalence of prescription drug misuse. And, among my peers you know, to feel like almost 
immediate access to information is enough to warrant to treat yourself. You know, I would prefer 
to take an anti-anxiety pill myself when I need it than have a doctor prescribe it to me... I mean 
it’s so far out of my character to even take drugs, just because I don’t like to be out of control of 
myself. But things just got to such an overwhelming point that to me, I felt so out of control in that 
state, that [misusing a friend’s Xanax prescription] felt like a way to control how I was feeling. 
(Latinx/Working Class/Female; 30308)  
 
This quotation reveals a crucially important framework within which youth make 
meaning of their illicit consumption of psychoactive medications. Today’s youth value having 
personal control over their health and prefer to rely on their own knowledge of illness and their 
informal access to pharmaceutical treatments as a management strategy. Sociological work on 
the process of diagnosis reveals that possessing the authority to make a medical diagnosis and 
assign an appropriate treatment is a significant source of power for the institutions of medicine 
(Jutel and Nettleton 2011; Lupton and Jutel 2015). As such, these consumption practices 
challenge medical authorities’ dominance over the identification, definition, and pharmaceutical 
treatment of illnesses. The young woman above makes it clear that she and her peers feel 
confident in their ability to self-diagnose an illness with help from medical information on the 
internet and to treat that illness with the illicit use of others’ psychoactive medications.  
95 
 
Giddens (1991) highlights how the internet provides access to information that has the 
potential to significantly shape the development of new and unique coping strategies for 
navigating risks. Health-related information is one of the most searched subject matters online, 
and its availability has increased individuals’ involvement in health-related decision making 
(Conrad and Leiter 2008; Hardey 1999; Shilling 2002). The internet not only provides 
information about medical conditions, their symptoms, and common ways to treat them, but also 
frequently provides access to diagnostic criteria and instruments (Crawford 2004; Hardey 1999; 
Lupton 2013; Lupton and Jutel 2015; Shilling 2002). Online illness screening tools are 
technologies that further medicalization (Abraham 2010a; Conrad 2008; Ebeling 2011; Horwitz 
and Wakefield 2007; Lupton and Jutel 2015). The availability of expert medical knowledge 
online is one of many forces contributing to the increasingly active role patients play in medical 
decision-making processes (Barker 2008; Ebeling 2011; Lupton 2013; Lupton and Jutel 2015). 
Patients today are more empowered and informed to self-diagnose and self-medicate 
(Andreassen and Trondsen 2010; Ebeling 2011; Lupton and Jutel 2015; Suziedelyte 2012). The 
popularization of self-diagnosis is particularly pronounced for mood disorders such as anxiety 
and depression, as well as other disorders like ADHD, as their diagnostic criteria are based solely 
on subjective experiences and are therefore more susceptible to forces of medical expansion, 
particularly in terms of lay experience and interpretation (Conrad 2008; Conrad and Barker 
2010; Horwitz and Wakefield 2007; Maturo and Conrad 2009).   
While pharmaceutical companies have embraced the notion of providing medical 
consumers with expert medical knowledge regarding illness symptoms, diagnostic criteria, and 
pharmaceutical treatments (Clarke et al. 2009; Conrad and Leiter 2008; Ebeling 2011; Lupton 
2013; Lupton and Jutel 2015; Tomes 2016), providing legal access to psychoactive 
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pharmaceuticals remains solely within the purview of a medical professional. However, some 
youth describe this protocol as impractical and unhelpful. The young woman above notes that 
she would rather have complete control over her access to and consumption of these medications 
rather than allow a doctor to determine how and when she takes anti-anxiety medications like 
Xanax. By articulating her desire for control over her illness treatment as opposed to 
surrendering such control to a medical professional, she challenges aspects of medical authority 
and its power to legally provide access to pharmaceutical therapies, particularly those whose 
psychoactive properties have historically been identified as problematic when accessed and 
consumed outside the purview of a medical professional. Illicit psycho-pharmaceutical use is 
therefore a means by which some youth resist aspects of medical dominance.   
The following quotation expands upon claims-making activities that frame the illicit 
consumption of psychoactive medications in terms of illness identification and treatment:       
 
I’ve never been prescribed [Xanax] before even though I’ve described having panic attacks and 
symptoms of social anxiety to doctors. I’ve seen a lot of psychologists and psychiatrists 
throughout my adolescence and young adult life and I’ve never be prescribed it for some reason. 
I always get prescribed antidepressants, which I don’t really like taking. So, when I started taking 
Xanax and Klonopin right after I graduated [from college], I just noticed that it helped me a lot 
in social situations, and so I always felt like I should be on it . . . Xanax just helps me put aside all 
of my anxious feelings, anxiety, all of my nervousness about meeting new people and just makes 
me feel like more of a normal person . . . Even though I’ve been diagnosed with depression, I 
don’t really feel like I’m depressed. I feel like it’s more like a social-anxiety thing, and somehow 
I’ve not been able to get that across to the doctors that I’ve been seeing. (White/Upper Middle 
Class/ Female; 30083) 
 
This young woman expresses that she has been unable to receive a diagnosis from a 
doctor that corresponds with her illness experience, which she understands to be anxiety, not her 
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doctor’s diagnosis of depression. These claims highlight the interactionist aspects of the 
diagnostic process, which involves a negotiation between a patient’s experience and a medical 
expert’s professional opinion of those symptomatic experiences (Jutel 2009; Jutel 2014; Jutel and 
Nettleton 2011). Thus, a medical diagnosis can become the site of conflict between medical 
authority and patients (Barker 2009). Many studies highlight how patients make use of their own 
medical knowledge to challenge the medical diagnosis and treatment prescribed by medical 
experts (Hardey 1999; Horwitz and Wakefield 2007; Kangas 2001; Lupton 1997). Sociologist 
Deborah Lupton (1997) notes that “medical discourse and practices are variously taken up, 
negotiated or transformed by members of the lay populace” (94). The young woman’s 
disagreement with the medical diagnosis provided to her, and her subsequent decision to illicitly 
consume Xanax and Klonopin to treat her self-diagnosed social anxiety, further demonstrates 
how youth challenge aspects of medical authority.   
The claims-making activities described above reveal how illicit psycho-pharmaceutical 
use is a mechanism through which youth medicalize certain feelings and experiences, such as 
being nervous around new people. In fact, for some it is only by consuming psychoactive 
medications that they’re able to identify the presence of an illness. In this way, illicit 
consumption of psychoactive medications functions as a mechanism that allows individuals to 
engage in processes of medicalization outside of the context of medical supervision. Sociologists 
argue that people in the U.S. behave much more like informed medical consumers, making 
informed medical choices within a medical marketplace, as opposed to patients passively 
receiving medical orders from medical professionals (Fox, Ward and O’Rourke 2005; Lupton 
2013; Lupton and Jutel 2015; Tomes 2016). This shift in behavior is known as the consumer turn 
in medicalization (Conrad 2008). Youth construct their consumption of controlled substances in 
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terms of a consumer’s right to treat illness and “feel like more of a normal person.” By deciding 
to self-diagnose and self-treat, these youth, as medical consumers, de-professionalize the practice 
of medicine and challenge the role of medical professionals in controlling access to both medical 
diagnoses and psychoactive pharmaceuticals.    
The following young woman demonstrates additional ways in which the illicit uptake of 
psychoactive medications is made meaningful through the use of medical discourse.   
It’s having such a crazy schedule with being out and stuff at 6 in the morning, going to school, 
having to work on schoolwork, going to work til midnight, getting home at 1 in the morning. It’s 
super intense and I’ve kind of diagnosed myself with SAD, seasonal affective disorder. I’m like 
super depressed in the winters. I don’t know, I kind of just like that [Adderall] helps me function 
and get my stuff done so I don’t feel like I’m completely useless. (Mixed Race/Middle 
Class/Female; 30168) 
 
The above excerpt highlights how a young woman makes sense of her illicit consumption 
of Adderall as a way to treat her self-diagnosed seasonal depression. She claims that as a result 
of being depressed in the wintertime she is unable to adequately perform in her roles as an 
employee and a college student. She therefore turns to psychoactive medications to help her 
manage her depression and complete her tasks. Interestingly, during the postwar era, 
amphetamines were popular medications prescribed by doctors to treat depression (Rasmussen 
2006; Rasmussen 2008b). While amphetamines are no longer deemed appropriate treatment for 
depression, through her own experimentation this young woman found that illicitly consuming 
Adderall was a suitable means of self-treating her self-diagnosed illness. In this way, illicit 
consumption of psychoactive medications becomes a mechanism through which youth engage in 
processes of medicalization outside of the purview of medical authority, or what some have 
called “self-medicalization” (Conrad 2005; Fainzang 2013). The concept of self-medicalization 
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demonstrates how acts of self-diagnosis and self-medication are based on the dissemination and 
popularization of medial discourse on disease diagnosis as well as on beliefs regarding the 
pharmaceutical industry (Clarke et al. 2009; Fainzang 2013).  
The following quotation also draws attention to how youth construct particular diagnoses 
and treatments through their illicit consumption of psychoactive pharmaceuticals.  
 
I have a lot of anxiety. So, I really like [misusing Xanax] because it really calms me down. I’m 
anxious a lot. So, I kind of use it for what it’s meant for, but I haven’t bothered to go to the doctor 
to, like, get my own prescription. I just like that it really calms me down and relaxes me and 
makes it easier to sleep. I take it to fall asleep sometimes because I also don’t sleep very well. So 
yeah, sedatives, I’m not really using it for fun as much as I am self-medicating. I guess I’d feel 
more guilty about it if I was just doing it for fun. I’d be worried about that, but for the most part 
I’m doing it because I need it. I feel more justified about it and I don’t feel guilty because I’m 
like, “It’s fine, I needed this Xanax.” (White/Working Class/ Female 30085) 
 
This young woman constructs an illness narrative around experiencing anxiety and 
having trouble sleeping. Medical sociologists point out that sleep is increasingly being 
medicalized in society, particularly through the consumption of sleep aid medications (Williams 
2002; Williams, Coveney and Gabe 2013). Similarly, the claims-making activities that this 
young woman engages in frame her experiences of anxiousness and difficulties sleeping as 
abnormalities that require pharmaceutical treatment. In this way, this young woman constructs 
her illicit consumption of Xanax as a form of pharmaceuticalization, in which unpleasant 
experiences are made meaningful as human conditions that require pharmaceutical remedies 
(Abraham 2010a; Bell and Figert 2012; Busfield 2006; Fox and Ward 2008; Nichter and 
Vuckovic 1994; Williams, Gabe and Davis 2008; Williams, Martin and Gabe 2011). Further, this 
young woman specifically states that she takes Xanax out of a perceived need and not for 
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recreation. She also articulates how this “need” allows her to alleviate the guilt of engaging in 
illegal drug use. As covered in the last chapter, statements like this signify how the use of 
medical discourse functions as a form a deviance neutralization (Sykes and Matza 1957). 
Moreover, she comments that she hasn’t “bothered” to seek out a medical diagnosis and 
prescription from a medical doctor. This draws our attention to how some youth frame visiting a 
medical professional as an inconvenience. The next set of quotations builds off this notion that 
going to see a doctor is something youth see as unnecessary.  
 
I know that I don’t have a prescription for it. I know that it’s not right, but I’m not abusing it in a 
way. I’m using it for its intended purposes. I can go to the doctor and I can get the prescription 
by telling them the reason I’m using it and he would give it to me. I just haven’t done that yet . . . 
they’re so readily available in this country, it’s hard not to have a friend or someone that doesn’t 
have a prescription. You know? It seems like everybody has one or knows someone that has one. 
(White/Working Class/ Male; 30153) 
-- 
If I’m going to take Xanax, which is pretty much the only thing that I use on a regular basis, it’s 
just for my own wellbeing. I’ve been prescribed it in the past . . . It’s actually post-college that 
I’ve started using it a lot because I was prescribed it for a while and I never got a new 
prescription and I have tons of friends that are prescribed Xanax. (White/Upper Middle Class/ 
Female; 30025) 
  
Both narratives note that the ease in accessing benzodiazepines through networks of 
friends provides a strong disincentive to seek out these medications by visiting a medical 
professional, even for those who have received a prior diagnosis and prescriptions for those 
drugs in the past. Lovell (2006) uses the term “pharmaceutical leakage” to describe the informal 
availability of diverted opioid medications like buprenorphine in France. This concept also draws 
attention to the larger cultural contexts in which illicit pharmaceutical practices emerge (Vrecko 
2015). By taking seriously young adults’ preferences for accessing psychoactive medications 
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through informal networks, we see how these claims-making activities reveal how medical 
markets that popularize and make medications widely available can actually discourage some 
from seeking diagnoses and treatment from a medical professional. In fact, the young man above 
claims that having informal access to psychoactive medications through social networks is an 
unremarkable aspects of living in a highly medicalized society. Meanwhile, the young woman 
notes how she hasn’t gone to the doctor to get refills for her Xanax prescription, because they’re 
so readily available through friends who have prescriptions. In this way, the pharmaceutical 
leakage of psychoactive medications enables and empowers these youth to self-diagnose and 
self-medicate.  
The illicit consumption of Xanax is also made meaningful as way of maintaining 
personal wellbeing. Key to the medicalization in U.S. society is the rise of health maintenance as 
an important cultural practice in everyday life (Crawford 1980; Crawford 2006). The increasing 
cultural importance of medical self-care and health management is an important feature of 
medicalization in today’s consumerist society, where health has become a commodity (Conrad 
2008; Crawford 1980; Crawford 2006; Figert 2011; Maturo and Conrad 2009; Turner and Turner 
2004). Studies of the pharmaceuticalization of everyday life claim that even healthy people are 
encouraged to maximize their physical and emotional wellbeing through self-medication (Bell 
and Figert 2012; Bröer and Besseling 2017; Coveney, Gabe and Williams 2011). So while some 
justify their illicit consumption in order to treat illness, others justify their use of these 
medications as a wellness practice. In this way, psychoactive medication consumption is also 
made meaningful as a mechanism that expands processes of “healthization,” as youth make 
meaning of consuming these medical products in terms of a healthism discourse (Barker 2014; 
Lupton 2012).   
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The following excerpts present a young woman and a young man who engage in claims-
making activities that justify their illicit consumption of psychoactive medications as a result of 
inadequacies of health care structure and the abundance of psychoactive medications available 
through peer networks.  
 
I like taking Xanax. I have anxiety disorders and I used to have prescriptions for it. Like, I 
literally feel like I take it medically for myself just like with other prescriptions right now. Cause 
my health insurance right now doesn’t cover mental health. It covers two sessions a year, it’s 
ridiculous. So, I feel like it’s so much easier for me to ask a friend for half a Xanax bar than to go 
through the entire process of, like, getting diagnosed [again] and prescriptions and whatever.  
(White/Working Class/Female; 30306) 
-- 
If I were to go see a psychiatrist or someone they would probably write me a prescription for 
[Xanax]. It’s just that I haven’t done that. So, I don’t think I’m abusing any of the prescription 
drugs that I use. I just think I’m using them for the right reasons even though it is illegal. I think 
that if I were to go get checked out and speak to somebody that they probably would have no 
problem writing me a prescription and I guess I would be a little bit safer in taking them, but like 
I said, I have control over my use of them so it doesn’t worry me too much. (White/Middle Class/ 
Male; 30046) 
 
The young woman above notes that her health insurance plan doesn’t adequately cover 
mental health services, which prevents her from obtaining her own benzodiazepine prescription. 
Meanwhile, the ease of accessing Xanax from a friend  makes the process of navigating medical 
institutions appear burdensome and inefficient. This experience highlights how the structure of 
health care systems and pharmaceutical markets in the United States impacts how youth decide 
to access psychoactive medications. The shortcomings of the American health care system may 
also provide youth with ample means to neutralize the deviance associated with misusing these 
medications as they explain how they could obtain a medical diagnoses and legal prescription if 
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doctors were more accessible and accommodating. When the young man defines his 
consumption as controlled and “for the right reasons,” and therefore not worrisome or 
problematic, he attempts to minimize the deviance associated with engaging in illegal drug use. 
By stressing the context and intent of their illicit use of these medications, these youth reveal 
how treating illness and maintaining health are valued cultural goals whose pursuit marks their 
consumption practices as acceptable and normative.  
The following set of quotations demonstrates how youth engage in claims-making 
activities that blur the definitional boundaries between licit and illicit use of these psychoactive 
medications.   
So I guess there could be some good things about using stimulants, but it’s kind of funny because 
some people say you’re abusing Adderall if you use it to, say, stay up and do homework all night, 
but I’ve had a doctor prescribe it to me for just that. Because I couldn’t focus as long as I needed 
to. So, there is definitely a gray area between what is okay and what’s not okay, you know?  I 
think it’s kind of the same thing with things like Xanax. Some people say it’s not a good thing to 
take Xanax just because you’re stressed out and you need to be able to cope without it, but I’ve 
had a couple of doctors prescribe me Xanax for that exact reason, for when you’re feeling 
overwhelmed and you need some help mentally straightening stuff out. So there’s a gray area. 
(White/Middle Class/Male; 30477) 
-- 
[The prevalence of medication misuse] is interesting, ‘cause there seems to be more trust in the 
medical world or in, like, official science than in anything else. So if it’s prescribed to someone 
you know you can just kind of rationalize taking something like that. (White/Upper Middle Class/ 
Male; 30293) 
-- 
If it’s okay in our society to medicate prescription- wise then we’re gonna think it’s okay that we 
don’t need a prescription. (White/Middle Class/ Female; 30139) 
 
These youth discuss how drawing distinctions between legal and illegal use of 
psychoactive medications is not as clear cut as one might think. Rather, they claim that there is 
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“a grey area” where certain illicit consumption practices are indistinguishable from licit ones. 
One young man states that this is especially true for illicit consumption practices that are aimed 
at treating experiences that mirror symptoms these medications are commonly prescribed to 
alleviate. This young man’s claims-making activities highlight how the distinction between legal 
and illegal consumption is not related to the purpose of consumption, but simply to the absence 
of a medical professional authorizing such consumption. The agency that many youth enact 
when making decisions to treat a self-diagnosed illness with someone else’s psychoactive 
medications challenges the power and control that the medical field holds over patients, the 
process of diagnosis, and the prescription of medical treatments. One young man highlights that 
in light of society’s trust in science and medicine, he and his peers feel justified to illicitly 
consume psychoactive medications. This sentiment is echoed by a young woman who justifies 
her illicit use of psychoactive medications because it is acceptable to take these medications 
under the supervision of medical authority. These claims make clear how youth challenge the 
role that medical professionals play in granting legal access to psychoactive medications as they 
reclaim their illicit consumption as a normative practice of self-treating illness and maintaining 
health.   
 
Learning to Self-Diagnose and Misuse Medications  
 Youths’ accounts of first accessing psychoactive medications and experiencing their 
effects illuminate how youth construct their consumption of these medications. Through the use 
of critical incident techniques, youth were provided the space to tell in-depth stories about the 
first time they had illicitly consumed a particular class of psychoactive medications. 
Surprisingly, many of these stories involved family members offering their psychoactive 
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medications to youth in order to treat experiences they identify as symptoms of illness that are in 
need of pharmaceutical treatment.    
 
I really didn’t know much [about Valium] other than it made my uncle feel better with his anxiety. 
I had no idea before my uncle told me that it was used for anxiety treatment . . . My uncle had the 
same problems as me and the same symptoms: the feeling in the chest and the general sense of 
worry and anxiety. And it took him explaining his symptoms to me to understand my own 
[experiences]. ‘Cause when I first started feeling the symptoms I wouldn’t have classified them as 
anxiety until my uncle told me he has anxiety and that this medicine made him feel a lot better . . . 
When I took my first one it almost immediately took away the feeling in my chest, which was my 
primary concern. You know, I was a little bit worried about where I was headed. What direction I 
was going in. Like, “I can’t find work. I can’t find an internship. What am I gonna do?” So, I was 
thinking I just really wanted to get rid of that feeling in my chest, but I was hesitant to take what 
my uncle gave me because I wasn’t prescribed it, but when it kicked in I was, like, mad at myself 
for having not tried it before because it made me feel so much better. I started to laugh about my 
problems and I was very relaxed and I stopped worrying. It was weird, because I wasn’t worried 
about specific things it was just sort of like a general sense of worry and anxiety and I was like, 
“Why is this happening to me?” And I came to understand that it might be genetic because 
almost my mom’s entire side of her family has had anxiety problems. (White/ Middle Class/ Male; 
30046) 
 
The above excerpt demonstrates how one young man recalls learning to identify and 
define a certain experience as an illness in need of pharmaceutical treatment. Specifically, he 
constructs an illness narrative in which a family member—his uncle—is able to help him identify 
that he is experiencing anxiety. Furthermore, the uncle stated that his Valium prescription helps 
to treat his own experiences of anxiety and offered some to the young man. At first the young 
man resisted the idea of taking a psychoactive medication that wasn’t prescribed to him by a 
medical expert, but after consuming his uncle’s benzodiazepine he remembers feeling a bit 
angered by the fact that those beliefs may have prevented him from learning how best to identify 
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and treat the anxiety he was experiencing. Through this illness narrative we can see how youth 
may learn to challenge medical authority and take control over the identification and treatment of 
their own illnesses by relying on the experiences and medications providided by their family 
members.   
Previous scholarly work highlights how we learn about illness and how we experience 
illness not only through interactions with medical professionals, but also through our social 
networks (Kleinman 2004; Kleinman, Eisenberg and Good 1978; Liu, King and Bearman 2010). 
The illness narrative presented above shows how interactions with family members can not only 
shape the identification and understandings of the illness experience, but can also play an active 
role in supplying youth with psycho-pharmaceuticals to carry out practices of self-care. 
Psychoactive medications, like Valium, act as mechanisms that organize and make sense of the 
discomfort this young man was experiencing and having trouble understanding (Jutel 2014). 
Further, through interacting with his extended family, he is able to make meaning of his 
experiences of worry and stress in terms of his family’s genetic pre-disposition for suffering 
from anxiety. While this young man’s first experience taking a benzodiazepine helped him to 
formulate a coherent understanding of what anxiety feels like and how to alleviate it, this process 
also reveals how the illicit use of psychoactive medications emerges as a practice that 
medicalizes certain human experiences, like being worried about one’s transition into the world 
of employment.   
Other young adults told similar stories of illicitly consuming psychoactive medications 
through the recommendation of a family member:  
 
I was able to get some prescription meds through family members. My mom had them lying 
around.  I just ask for them, because usually I took them for my menstrual cramps, but that’s, like, 
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where my occasional prescription drug use or misuse happens. But yet, it’s easy. I just get them 
from my mom. I don’t pay for them or anything, but I mean I take them responsibly (Latinx / 
Working Class/ Female; 30073) 
-- 
I remember the codeine, just taking 2 pills and falling asleep. I had, like, extreme cramps. I was 
lying on the kitchen floor and my mom just told me to take two and it just knocked me out . . . She 
always has Xanax and she takes it to kind of relieve stress. So if I’m stressing out or whatever 
she’ll give me like a fourth or like a half. We were sitting around drinking wine and she just gave 
me one to pop because I was complaining about being stressed.  (Mixed Race/Middle Class/ 
Female; 30168) 
-- 
I used it when I caught my period. I used to take Aleve, Ibuprofen, Midol, you know, Motrin, 
which is all the same thing. Nothing helped. My godmother, you know she takes prescription pills 
from the doctor because she’s all alone, she’s sick, has high cholesterol, stuff like that. And 
basically I was having pain, I took, like, five Aleves and nothing happened. She said, “Listen, this 
is, if you want it, it helps the pain, but that’s up to you if you want it. I don’t want to force you to 
take something that is going to bother you, but this is a painkiller and it helps to hopefully stop 
the pain. You know, if you want it you take it, if you don’t, you don’t have to.” Me, I wanted to 
take it, because I was in pain and when I took it, it just helped my cramps go down, and ever 
since then it just, it wasn’t a habit to take it, but whenever I had my time of the month I used it 
and it relaxed me. (Latinx/ Middle Class/ Female 30031) 
 
These young women’s initiation into taking someone else’s opioid medication was often 
contextualized within experiences of mothers or older sisters offering to help alleviate the pain of 
menstrual cramping. Taking opioid medications to endure the pain and discomfort of 
menstruation emerged as one of the few gendered experiences of illicit medication use. Women’s 
reproductive health has been a popular topic of medicalization research (Conrad 1992; Rothman 
2000; Simonds, Rothman and Norman 2007), and while much of that work focuses on how the 
medical field frames women’s bodies and experiences in terms of medical discourse (Bell 1987; 
Ehrenreich and English 1979; Lupton 2012), others note the ways in which women as patients 
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are involved in processes of medicalizing aspects of their bodies, particularly their reproductive 
health (Bransen 1992; Oinas 1998). These data reveal how young women navigate menstruation 
pain outside of the medical field by accessing and consuming family members’ opioid 
medications. These practices therefore highlight a unique way women challenge medical 
authority by managing aspects of their reproductive health through the help of family members.      
The concept of pharmaceutical leakage focuses mainly on the diversion of opioid 
medications within networks of drug-using peers (Lovell 2006). However, the above data 
demonstrate how pharmaceutical leakage takes place among women within their extended 
family. For instance, one woman notes how her uptake of her godmother’s opioid medication 
became her strategy for treating menstrual discomfort. While these claims-making activities 
highlight how menstruation is made meaningful in terms of pharmaceutical discourse, they also 
demonstrate how women act on their own health by illicitly consuming opioid medications to 
alleviate pain and discomfort. As details regarding their menstrual discomfort were not provided, 
I cannot definitively state whether or not these women suffered from undiagnosed endometriosis 
or some other reproductive health problem. However, practices of treating ordinary menstrual 
discomfort with opioid medications may confirm previous research that finds that as a result of 
medicalization, individuals are less tolerable of pain and more likely to turn to medication to 
resolve minor discomforts (Barker 2009; Kleinman 1988). In this way, my findings demonstrate 
how women are socialized by family members into recognizing menstrual discomfort as an 
acceptable condition to routinely treat with opioids.  
Another young woman mentions that the opioid medication she obtains from her mother 
to treat menstrual cramping is the only form of illicit psychoactive medication use that she 
engages in. She says that she is taking her mother’s opioids “responsibly” because of her 
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purposeful consumption to treat pain. This again draws attention to how youth construct 
“responsible” forms of illicit psychoactive medication consumption in which they employ claims 
about the frequency of use and purpose of use to neutralize deviance. We also see how one 
woman learns from family members that experiencing stress is another condition suitable for 
psycho-pharmaceutical intervention. Examples of the ways youth experience and make meaning 
of stress, worry, pain, and discomfort demonstrate how illnesses are increasingly identified and 
acted upon outside of the supervision of medical experts by consuming family member’s 
psychoactive medications.   
 
Medicalizing Shyness  
Further demonstrating how psychoactive medication consumption serves as a mechanism 
through which youth medicalize everyday experiences, I present and unpack claims-making 
activities that frame experiences of shyness as necessitating pharmaceutical intervention.  
P: It’s really only like Xanax or [other] Benzos, I get really anxious and overwhelmed and it just 
makes me feel so much better. It makes me feel so much more myself and calm. So, occasionally 
I’ll just have a little tiny bit of one if I’m going to be meeting people I’m shy around . . . I tend to 
gravitate towards Xanax or its cousins just because it helps me feel more confident and more 
relaxed. So, I feel like I actually make better decisions when I’m on it. I feel like I make more 
true-to-myself kind of actions and decisions because I’m not inhibited by all my anxieties. So, that 
is the appeal to me. I can actually make things happen that I want to happen 
 
I: Can you give me an example of something? 
 
P: Just being too shy to actually go for somebody that you have a crush on, or, you know, talking 
to somebody who is maybe an impressive person in your field, or something that you’d never 
have the nerve to do otherwise. And good things come out of those sorts of things you know. So, 
you have to take risks in life and it just makes me at least more able to take those risks . . . I feel 
like I’m somebody who could actually get prescribed it. I’ve never tried, and mostly just because 
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I’m lazy, but I feel like I’ve had panic attacks, and, like, I get extremely overwhelmed by social 
situations, and I feel like it might be appropriate that I actually need it prescription-wise, and 
basically I’m just self-medicating. I mean, I’m sort of considering actually trying to get a 
prescription, because it’s weird feeling like I am abusing it even though it’s probably warranted, 
you know what I mean? (White/Upper Middle Class/Female; 30034) 
 
The young woman above expresses that there are positive outcomes of her illicit 
benzodiazepines consumption, such as creating important business opportunities or initiating 
romantic relationships. Framing her uptake of Xanax and other benzodiazepines as a way to 
achieve valued societal goals reveals how some youth consider these pills as tools that enable 
them to accumulate social, cultural, and economic capital. This young woman also discusses her 
illicit medication use in relation to her identity and performance of self when in social situations. 
She speaks about how these medications help her perform in ways that cohere with her 
perceptions of her true capacities. These claims of accessing a more authentic sense of self 
highlight the role these medications play in identity work practices. More specifically, she 
constructs her performance of self in social situations as shy and unable to initiate interaction 
with others. She also uses medical discourse to articulate her experiences: she feels like she has 
panic attacks, despite never having received a medical diagnosis validating such experiences. As 
such, she justifies her illicit consumption of Xanax as a solution to her sociality problems. 
Furthermore, she claims that she could obtain a medical diagnosis, and receive a prescription for 
a benzodiazepine, if she were to seek medical attention. However, she claims that she has not yet 
had the motivation to do so. She thus demonstrates how accessing psychoactive mediations 
illicitly is meaningful as a more efficient way in which to treat illness when compared to the time 
and effort it takes to do so through the medical field.  
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Previous work on anti-depressants and amphetamines demonstrate how consuming these 
specific medications influences the construction of a medicated self (Davis-Bearman and 
Pestello 2005; Karp 2006; Loe and Cuttino 2008). Typically, studies of the medicated self focus 
on the ways these medications are experienced as producing an inauthentic self (Davis-Bearman 
and Pestello 2005; Karp 2006; Loe and Cuttino 2008). However, unlike the work that largely 
focuses on how certain medications produce problems related to selfhood, the young woman 
above embraces her medicated self. In this way, illicit consumption of psychoactive medications 
is a mechanism that draws distinctions between young adults’ inauthentic “sick” self and their 
authentic “healthy” self.  
Adding to the above findings, the following quotations provide more evidence of how 
youth are medicalizing shyness and engaging in acts of identity work through their illicit 
consumption of psychoactive medications.  
 
I like Adderall, because I’m a shy person. Especially around new people and sometimes it kind of 
makes you feel happier. So, it’s that confidence when you’re around all these people, and 
someone introduces you to someone, and you’ll have a conversation with them, or something, but 
you’re talking to someone, and I think it makes you feel like you’re socializing, and I think it 
makes you feel better, like, “Wow, I’m really getting out there meeting people.” (White/Middle 
Class/Female; 30072)  
-- 
Really the most major thing is if I’m feeling like really uptight and tense, and like really anxious, 
it’s, like, really effective at making those feelings subside.  I mean, that’s really why I’m attracted 
to sedatives most, is for the particular thing that I’m trying to achieve.  So that’s really what I like 
about it. (White/Upper Middle Class/Male; 30066) 
-- 
I like Adderall or Vyvanse, because when I’m depressed or anxious I feel like I’m unproductive 
and anti-social, and I just like feeling like I’m a better version of myself. And I feel like I’m more 
productive, and that I’m more friendly, and that I just feel like that’s what I’m supposed to be like 
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but I haven’t like fixed my head enough to be that person yet. (White/Working Class/Female; 
30306) 
 
 These anecdotes highlight how some youth understand their difficulties as a problem that 
can be resolved with the illicit consumption of amphetamines or benzodiazepines. When they 
claim that being being shy, uptight, and anti-social are states that require pharmaceutical 
intervention, the youth highlight how the illicit consumption of these medications serves to 
widen the social definitions of diagnostic criteria for social anxiety disorders. Previous work on 
depression demonstrates how the popularization of the illness in American culture shapes how 
some people medicalize general states of sadness (Horwitz and Wakefield 2007). By applying 
the medical discourse of depression to describe and make meaning of experiences of sadness, 
Horowitz and Wakefield highlight how lay individuals engage in acts of medical expansion.  
Additionally, amphetamines are discussed in terms of performing an authentic self. While 
previous work on those who are prescribed amphetamines demonstrates that many youth 
construct their identities and sense of self while on the medication as inauthentic (Loe and 
Cuttino 2008), we see how two young women embrace the performance of self that illicitly 
consuming these medications enables. Similar to the ways youth discussed benzodiazepines 
helping them to perform in social situations, both these women state that they are able to 
overcome their shyness and perform in socially-appropriate and productive ways. One woman 
specifically highlights how her friendlier demeanor while on amphetamines reflects a set of 
behaviors that she knows she will one day be capable of performing without the medication. She 
recognizes she still has more identity work to accomplish before she can “become” that person.    
 
Medicalizing Stress 
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 Youth frequently frame their personal accounts of stress in terms of illness. The 
following excerpts provide insight into how youth make meaning of stress a suitable condition to 
treat with the illicit consumption of psychoactive medications.      
  
A lot of young people are stressed out because of a lack of money. They’re coming out of college 
without any kind of jobs and it’s just stressful. The feelings of worthlessness, loss of hope and 
stuff; so a lot of people have fallen to these drugs in order to make themselves feel better because 
they feel like, “Hey, I can get on with my day, I can do what I need to do.” (Black/Middle Class/ 
Female; 30372) 
-- 
I was really stressed and kind of out of it for a while. So, I was using [Klonopin] just to kind of 
deal with my anxiety and help myself just calm down and be able to go out and deal with things. 
(White/Upper Middle Class/Female; 30049) 
-- 
I have been using Xanax for myself very frequently recently. I don’t have a prescription. I just 
know someone who does. And they don’t really use their prescription. So I basically have been 
using them on my own . . . sedatives, you know, they calm me down. I have a tendency towards 
anxiety and so I like knowing that I kinda have a way out if I have a Xanax . . . I simply use it 
because I’m feeling stressed out, or I’ve had a rough day, or I’m hung over, or I’m feeling 
nervous. And I use them for what I’m assuming they’re designed to be used for, which is to 
diffuse anxiety, which is something that runs in my family. (White/Upper Middle Class/Male; 
30294) 
 
The above stories demonstrate two key points about youth’s illicit consumption of 
psychoactive medications. First, these youth claim that stress pervades their lives. Second, 
illicitly consuming psychoactive medications helps them to cope with stress and continue to be 
productive members of society. These youth thus highlight how stress is an experience that they 
medicalize by treating it with pharmaceuticals.  
The main stressors the youth discussed were transitions into the workforce, not having 
enough money, and feeling overwhelmed with working multiple jobs, or working while also 
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attending college. Youth therefore problematize many of the attributes commonly associated 
with being a young adult in late modernity. Jeffrey Arnett’s (2015) concept of “emerging 
adulthood” describes this transitional time in youths’ lives. In late modern societies it generally 
takes longer for youth to reach the social and cultural milestones that mark one’s entry into the 
status of full adulthood. Economic changes of late modern societies, which require both a highly-
skilled and versatile workforce, are frequently identified as the driving factors delaying the 
achievement of adult milestones.  Many youth find themselves instead investing more time 
during their twenties and into their thirties developing their social and cultural capital in 
preparation for entering a highly-competitive job market (Arnett 2015). As a result of the longer 
road to reaching stable, well-paid, and prestigious employment, youth realize delays in achieving 
other milestones typically associated with adulthood, thus fostering experiences of feeling adult 
in some ways, but not in others (Arnett 2015).  
Subsequently, many youth find navigating their twenties and early thirties to be 
challenging and stressful (Arnett 2015; Smith et al 2011). Smith et al. (2011) problematizes the 
deferment of adulthood in ways that highlight the challenges of becoming adult in late modern 
societies. Moreover, they claim that the instability and uncertainty experienced during this 
transitional time period can increase the prevalence of a range of mental health issues, such as 
depression and anxiety. The misuse of psycho-pharmaceuticals as strategies that enable youth to 
cope with being stressed and anxious makes sense within the larger context of youths’ struggle 
with the transition into stable professional employment. Some youth are not only medicalizing 
the stress and anxiety they are experiencing, but are also expanding the ways these conditions are 
defined as illnesses that require pharmaceutical intervention. As such, emerging adulthood can 
be made meaningful as a lifecycle that informs pharmaceuticalization processes.   
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The following quotation draws attention to the value of illicit consumption of 
psychoactive pharmaceuticals to managing and controlling stress. 
 
I also think that they like the idea of playing psychotherapist for themselves. They feel anxiety 
and they like the control that they feel by taking a certain drug to alleviate their anxiety or to 
bring about another desired result. I think the control is a part of it. Like, controlling uncertainty 
and managing the stress that comes with uncertainty. (White/Middle Class/Male; 30156) 
 
Youth value the ability to control their emotional well-being. They value the ability to 
relieve feelings of stress and anxiety that accompany uncertainty, a common feature of many 
young adults’ lives as they transition into taking on the responsibilities of adulthood (Arnett 
2015; Smith et al., 2011). By illicitly consuming psychoactive medications, youth take control of 
uncertainty and attendant stress and anxiety. While recognizing that only medical doctors may 
legally prescribe psychoactive medications, this young man notes that youth can challenge 
protocol through practices of illicit consumption, and are able to alleviate stress, anxiety, and 
uncertainty on their own. In this way, the illicit consumption of psychoactive medications is a 
way for youth to gain more control over their health, their well-being, and their ability to live 
productive and fulfilling lives.     
 
Conclusion  
 Illich’s (1976) concept of medical imperialism focuses on medical institutions as the 
dominant and driving force of medicalization. He and other early medicalization scholars 
claimed that all forms of social suffering would soon be defined by medical experts as medical 
conditions in need of medical treatment (Illich 1976; Zola 1972). Previous work on the 
medicalization of deviance highlights the role that psychoactive medications play in processes of 
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medicalization (Conrad and Schneider 1980). However, medical experts were still identified as 
the key players shaping processes of medicalizing deviance (Conrad 2005). Expanding the 
players involved medicalization, Peter Conrad (2008) acknowledged the complex set of cultural 
and economic forces and factors driving the expansion of medicine in American society. As a 
result, concepts of medicalization came to focus more on how society defines a problem in 
medical terms and resolves it with the use of medical products. The youth presented in this 
chapter use medical discourse to define their illicit consumption of psychoactive medications. 
Their stories of shyness, nervousness, menstrual pain, and stress all highlight how they frame 
these experiences in terms of illnesses that are best dealt with through pharmaceutical treatment. 
By self-diagnosing and self-treating, these young adults reveal their illicit consumption of 
psychoactive medications as a mechanism of self-medicalization (Conrad 2005; Fainzang 2013). 
Paradoxically, self-medicalization challenge aspects of medical authority while at the same time 
continuing to expand the scope of human experience defined through the language of medicine 
(Conrad 2005; Conrad 2008). Barker (2009) claims that patients in a highly medicalized society 
may be socialized to experience unpleasant emotions in terms of illnesses that need medical 
treatment. The young adults’ claims-making activities presented above highlight how they come 
to learn and define emotional states such as being shy, stressed, and overwhelmed as illnesses 
suitable to self-treat with the use of others psychoactive medications.  
  The self-medicalization of emotional states, such as being nervous and worrying, are 
examples of how consuming these pharmaceuticals informs and influences decisions to 
pathologize common yet unpleasant human experiences. In his critique of medicine in U.S. 
society, Klienman (1988) states that norms and values of personal freedom and the pursuit of 
happiness combine to create beliefs among Americans that they are medical consumers who 
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have a right to be free from suffering. The claims-making activities detailed in this chapter 
demonstrate how youth frame their illicit consumption of others’ psycho-pharmaceuticals as 
responsible self-care practices. By framing their uptake of psychoactive medications within the 
context of solving problems they encounter in their day-to-day lives, youth highlight how they 
make meaning of these practices in terms of taking personal responsibility and control over 
identifying and treating illness. In this way, youth reframe and reclaim illegal drug consumption 
as a form of agency and power, aided by the democratization of medical knowledge and the 
growth of patient empowerment within medical decision-making in the United States (Lupton 
2012; Lupton 2013; Lupton and Jutel 2015). The sociology of diagnosis shows that providing a 
diagnosis is a significant source of power that the medical field exerts over patients (Jutel 2014; 
Jutel and Nettleton 2011). Youth not only challenge this authority through acts of self-diagnosis 
and self-treatment, but also contest medical diagnoses they receive from medical professions 
with their own experiences treating illness symptoms with others psychoactive medications.  
 The role that pharmaceutical leakage plays in medicalization processes is crucial—
without an over-supply of psychoactive medications circulating among young adults’ social 
networks, they would not have the capabilities to resist the medical field’s dominance over 
granting access to desired medications (Lovell 2006). In this way, acts of self-diagnosis and 
illicit psychoactive medication use are made possible through the expansion of U.S. 
pharmaceutical markets. The ubiquity of these medications among social networks is a strong 
disincentive for youth to consult medical experts. In fact, some youth are socialized to identify 
and treat certain illnesses outside of the context of a medical professional through family 
members who counsel them to define certain experiences as suitable for consuming the 
psychoactive medications the family members make available to them. These social learning 
118 
 
processes also normalize a consumption practice otherwise labelled as deviant and illegal by the 
legal and medical institutions.   
Rather than framing psychoactive medication use in terms of deviant drug use, as is most 
commonly done by meso- and macro-level claims-makers, the examination of micro-level 
claims-making activities highlights how individuals construct and make meaning of these 
behaviors in terms of efficiency and agency. These micro level claims-making activities reveal 
that consuming illicit psychoactive medication challenges the dominant role medical experts play 
in controlling both diagnostic and therapeutic processes. Subsequently, these claims demonstrate 
more than a simple way for youth to justify and neutralize their illegal behavior; they also 
demonstrate transformations in the way medical knowledge is created, disseminated, and 
maintained through practices of pharmaceutical consumption and human interaction (Clarke 
2003).  Symbolic interactionists have long noted the importance of how people make meaning of 
the social worlds they inhabit in everyday life (Gubrium and Holstein 2000; Lamont and 
Fournier 1992; Lamont and Molnár 2002; Zerubavel 1991). I argue that these youths’ claims-
making activities reveal how lay populations draw distinctions between healthy and ill bodies as 
they detail which behaviors are considered abnormal and in need of pharmaceutical treatment.   
The democratization of medical knowledge and popularization of treatments offer youth 
a way to gain more control over their own bodies, capabilities, identities, and performance of self 
(Lupton 2012). Illicit consumption of medications such as Xanax, Adderall, and Vicodin plays 
an important role regarding how youth relate to their own bodily and emotional experiences. IN 
fact, some young adults even frame their misuse of these medications as allowing for a more 
authentic performance of identity and selfhood. Bury (2001) states that by analyzing illness 
narratives, we are able to explore how people connect aspects of their identities with experiences 
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of illness and illness treatment. Studies focusing on exploring the construction of identity in 
relation to pharmaceutical uptake draw attention to the ways in which medicine can impact how 
people make meaning of what it means to perform an authentic and inauthentic self in social 
interaction (Karp 2006; Davis-Bearman and Pestello 2010; Loe and Cuttino 2008). Illicit 
medication use is similarly made meaningful as enabling youth to access and perform a more 
authentic sense of self as they seek to conform to societal expectations of behavior. Linking 
medications to identity is a unique process whereby decisions to self-medicate symbolize not 
only a means of reclaiming one’s health, but also a mechanism through which to achieve a more 
valued sense of self. In this way, these medications are a means to resolve difficulties with social 
interaction and reflects how these medical products have become meaningful as technologies that 
enable the self to conform to societal norms of comportment (Foucault 1988; Lupton 1997). 
Medical sociologists note how pharmaceuticals are a driving force in the continued 
medicalization of everyday life (Bell and Figert 2012; Busfield 2006; Clarke et al. 2003; Conrad 
2008; Fox and Ward 2008; Williams, Martin and Gabe 2011). Moreover, studies highlight how 
medications can transform patients’ and the general public’s expectations of normal and 
pathological experiences (Coveney, Gabe and Williams 2011; Fox, Ward and O’Rourke 2005; 
Fox and Ward 2008; Williams, Coveney and Gabe 2013). Focusing specifically on the surge in 
use of anti-depressants, Horwitz and Wakefield (2007) argue that people are increasingly over-
medicalizing normal experiences of sadness. Similarly, I find that through their illicit access to 
psychoactive medications, youths may also be over-medicalizing normal experiences of worry, 
shyness, stress, and nervousness. I argue that these findings show that illicit psychoactive 
medication consumption is an ever-present part of the continued medicalization of everyday life. 
However, this medical expansion is significantly taking place outside of the purview of medical 
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authorities, aided by the democratization of medical knowledge, the transformation of patients 
into consumers, and the leakage of over-prescribed psycho-pharmaceuticals through social 
networks. These factors converge to empower youth to take control of managing their own 
health and illness, as they value the agency and efficiency that illicit pharmaceutical 
consumption provides them. I encourage medicalization scholars to focus more on analyzing 
experiences of self-medicalization, and to recognize that resistance to medical authority in 
everyday life through practices of self-diagnosis and self-treatment represents a significant force 
of medical expansion.  
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Chapter 7: Drug Normalization  
 
Chapter 6 presents narratives that highlight the normalization of illicit psychoactive 
medication use among young adults in U.S. society. Young adults construct these medications as 
an unremarkable and at times essential aspects of their everyday life, particularly when 
describing their experiences within the social institutions of education and employment. The 
normalization of illicit psychoactive medication use among youth mirrors other drug normalizing 
trends among this age group (Hathaway, Comeau and Erickson 2011; Measham, Aldridge and 
Parker 2001; Mostaghim and Hathaway 2013; Parker, Aldridge and Measham 1998). However, 
while previous research on drug normalization focuses on the increasing engagement in and 
tolerance of certain forms of recreational drug use, the following accounts of normalization 
expand upon this to account for the ways psychoactive medications are normalized for purposes 
of production.     
 
Drug Normalization Thesis  
The concept of normalization describes how behaviors that were once deemed deviant or 
stigmatized within a society become more conventional, less remarkable, and at times even 
valued. Parker, Aldridge, and Measham (1998) apply this concept to make sense of the growing 
societal acceptance of recreational drug use, particularly among young adults. Highlighting how 
all forms of illegal drug use were once by and large associated with pathological behavior, the 
drug normalization thesis emphasizes that recreational drug practices are increasingly seen as a 
common aspect of young adults consumption based leisure activities (Parker, Aldridge and 
Measham 1998). Drug normalization occurs among youth due to their unique social experiences 
within an extended transitional lifecycle stage (Parker, Aldridge and Measham 1998). 
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Transitions into adulthood in many late modern societies are commonly characterized by a delay 
in the attainment of adult milestones (Arnett 2000; Arnett 2015). Instead, the pursuit of leisure 
and exploration of various social roles and cultural practices become important and valued 
developmental goals for young adults (Arnett 2000; Arnett 2015). Included within this leisure 
and experimentation is an increase in the use of psychoactive substances (Arnett 2005; 
Schulenberg and Maggs 2002; Smith, Christoffersen and Davidson 2011).    
Parker, Aldridge, and Measham (1998) claim that the social importance of “leisure-
pleasure landscapes” for young adults in late modernity provides the context within which 
recreational drug use becomes a normative feature of their free time.  Importantly, the 
normalization thesis does not account for excessive drug use and the development of addiction 
related behaviors, which remain problematized and stigmatized (MacDonald and Marsh 2002; 
O’Gorman 2016; Parker, Aldridge and Measham 1998). Instead, the normalization thesis 
recognizes how drug users practice “sensible recreational” drug use by policing patterns of 
addiction through constructing norms for use based on drug related knowledge (Cheung and 
Cheung 2006; Egginton and Parker 2002). Normalization theorists also claim that youth are more 
knowledgeable about drug use and that this shapes the ways they accommodate and value 
particular aspects of drug use within certain cultural context (Parker 2005; Shildrick 2002). Even 
those youth who choose not to partake in drug use themselves increasingly construct recreational 
drug use as an unremarkable feature of their social and cultural worlds and therefor is not 
considered to be deviant, despite legal specifications labelling them otherwise (Parker, Aldridge 
and Measham 1998).  
Five core criteria comprise the normalization of recreational drug use among young 
adults: increasing access and availability of drugs, increasing rates of drug experimentation, 
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increasing rates of regular recreational use, increasingly lax attitudes towards recreational drug 
use, and an increase in cultural accommodations towards recreational drug use (Measham and 
Shiner 2009; Parker 2005; Parker, Aldridge and Measham 1998; Parker, Williams and Aldridge 
2002). The process of normalization involves changes in these five dimensions in an 
intersectional manner, whereby these five components work in interactive fashion and mutually 
influence one another in the social production of a normalizing drug trend (Parker, Aldridge and 
Measham 1998). Normalization has played an important role in several contemporary youth drug 
trends. Many drug scholars highlight the normalization of recreational marijuana use among 
youth (Duff et al. 2012; Hathaway 1997; Hathaway, Comeau and Erickson 2011; Mostaghim and 
Hathaway 2013; Parker, Aldridge and Measham 1998). This trend in normalization can be found 
through both quantitative studies that chart prevalence rates as well as qualitative based studies 
that demonstrate how youth define marijuana as easily accessible and socially acceptable to 
consume (Hathaway 1997; Hathaway, Comeau and Erickson 2011; Parker, Aldridge and 
Measham 1998; Parker, Williams and Aldridge 2002). Marijuana use has also been more 
commonly depicted in normalized ways within various forms of mainstream media and has also 
seen relaxed social policies aimed at decriminalizing and legalizing recreational marijuana use 
(Asbridge et al. 2016). Subsequently, normalization theorists claim that marijuana use has come 
to be constructed as an unremarkable feature of daily life and an accepted part of mainstream 
culture (Duff et al. 2012; Hathaway 2004). In addition to the normalization of marijuana, 
researchers also note how a subset of drugs commonly referred to as club drugs have also 
emerged as a relatively unremarkable feature of young adult’s leisure experiences (Duff 2005; 
Measham, Aldridge and Parker 2001; Parker, Aldridge and Measham 1998). Club drugs account 
for stimulant and psychedelic drugs like cocaine, MDMA, and LSD. Drug scholars demonstrate 
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that the recreational use of these substances has become normalized within particular youth 
subcultures (Duff 2005; Measham, Aldridge and Parker 2001; Parker 2005; Parker, Aldridge and 
Measham 1998; Parker, Williams and Aldridge 2002).  
 Criticism of the drug normalization thesis point out that while the theory has utility in its 
original conceptualization it is too expansive and homogenizes many aspects of drug use while 
excluding others (Shildrick 2002). So, while some drug scholars note the normalization of young 
adults recreationally using marijuana and club drugs, others highlight this drug normalization as 
a site of privilege for  predominantly white middle and upper class youth (Measham and Shiner 
2009; Pennay and Moore 2010). This is particularly visible in the persistence of high marijuana 
arrests among minority youth compared to white youth (Golub, Johnson and Dunlap 2007; 
Nguyen and Reuter 2012; Ramchand, Pacula and Iguchi 2006). In this way, experiences of drug 
normalization are relative not only to specific drugs and drug practices, but also the social status 
of the user (O’Gorman 2016). MacDonald and Marsh (2002) have introduced the term 
“differentiated normalization” to highlight how certain types of drug use and drug users are 
constructed as normalized amongst particular groups of people. This updated version of the 
theory is a bit more dynamic in that it recognizes aspects of both structure and agency (Measham 
and Shiner 2009).   
 Building off criticism on the homogenizing aspects of drug normalization research, I 
argue that the theories attention towards drug use within a “leisure-pleasure landscape” 
significantly limits the scope of psychoactive substances and use practices that can be understood 
as normative. By solely focusing on drug use as leisure based activity, the normalization thesis 
obscures how youth incorporate psychoactive substances into aspects of productivity. This 
chapter provides data that extends the application of the normalization thesis to make meaning of 
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drug use outside of the context of leisure. While prior research notes the high prevalence rates of 
illicit psychoactive medication use among young adults (Kelly et al. 2013; McCabe et al. 2014; 
SAMHSA 2016), no prior work has set out to explicitly demonstrate the normalization of this 
drug trend. The remainder of this chapter presents data that details how youth construct the illicit 
consumption of psychoactive medications as a common feature of everyday life, particularly 
within the context of education and employment.     
 
The Normalization of Illicit Psychoactive Medication Use 
 Those interviewed very commonly engaged in framing these medications and their illicit 
consumption as a normalized aspect of their social lives.  
 
Yeah generation Rx, I mean, it’s so real. If you go into any parent’s medicine cabinet, they have 
everything seemingly for no reason. It’s just so normal. If you’re stressed out, you take a Xanax. 
It’s not a big deal. Or, if you need an Adderall; Jesus fucking Christ, I mean the colleges are just 
swimming in them. Everyone adores it cause you can just get so much done. And that is just so 
casual. I feel like Adderall is the most casual of them all, because Adderall is for dorks. I mean 
my best friend, she does not do drugs, but she does Adderall, which she doesn’t really 
acknowledge is a drug. And I think a lot of people feel that way about Adderall, in particular. You 
know, Adderall is weirdly socially acceptable to talk about. They’re so trend. They’re so okay to 
talk about... I always say jokingly whenever I enter a really stressful situation,“ I need a Xanax,” 
and everyone just laughs, and they understand. It’s just this weird acceptable thing to take a 
Xanax, it’s just like not a big deal. And Adderall isn’t a big deal. (White/Middle Class/Male; 
30015) 
 
This young man articulates how psychoactive medications and their illicit use are 
recognized as an unremarkable part of navigating daily life. First and foremost, he refers to his 
generation as “generation Rx”, a label applied to the largest U.S. cohort of children to receive 
psycho-pharmaceutical treatment (DeGrandpre 1999; Quintero, Peterson and Young 2006; 
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Sharpe 2012). Interestingly though he notes how the high rate of prescriptions among his 
generational cohort is in some ways a reflection of their parents medicinal consumption 
practices. The label “generation Rx” also denotes how normalized taking psychoactive 
medications has become for an entire generational cohort that came of age in a highly 
pharmaceuticalized society (Loe 2004). The pharmacetuicalization of U.S. society (Abraham 
2010a; Fox and Ward 2008; Williams, Gabe and Martin 2012; Williams, Martin and Gabe 2011), 
as particularly experienced by a generation of youth, provides the cultural context from which 
the normalization of illicitly consuming these medications emerges.   
As a result of the high prevalence of prescriptions received by college aged youth, this 
young man claims that Adderall is very accessible on college campuses and that it’s also socially 
acceptable to engage in as well as talk about illicitly consuming them. He even states that the 
illicit use of this particular medication has become so trendy that some people do not even 
acknowledge that it’s illegal to take it without a prescription. The man cited above also claims 
that these medications are highly valued on college campuses for their ability to enhance 
productivity. In addition to highlighting the normalization of stimulant medications, this young 
man claims that consuming Xanax has become so much of a common cultural practice that it’s 
referred to casually in conversation as a mundane way in which to highlight stressful situations 
and experiences. These statements clearly demonstrate many of the key components of the drug 
normalization thesis like, high drug availability and use, as well as lax attitudes and cultural 
accommodations regarding such prevalent use (Parker, Aldridge and Measham 1998).     
While some participants spoke of psycho-pharmaceuticals as being normalized in society 
at large, others were more specific about particular segments of society for whom they saw 
consumption to be normalized among.  
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You know it’s also by culture too. I think that certain people can get their hands on prescription 
drugs easier than other drugs. Coming from an East Coast middle class background, growing up 
you saw a lot of it and, because it is prescribed, those prescriptions just filter through all your 
friends and family. I think that it has to come from a background of people who go to the doctor. 
Where they would go to somebody who would be able to prescribe that. I mean that’s a very 
middle, upper middle class thing. For people who can access those drugs I think that it became 
kind of a cultural norm. I hadn’t actually thought about that. Why maybe the culture I come from 
has become so enamored of them. (White/Middle Class/Female; 30096) 
--  
I tend to do them by myself. I enjoy Xanax. It’s my main way to calm myself down. Xanax is 
obviously like the one that people tend to use the most just because it is such a wonderful way to 
take the edge off. You know pop a couple Xanax and have a glass of wine at home and it’s almost 
like it fits into the social fabric of life. You know, it’s like they’re [Xanax] so casual. All these 
people that I’m friends with are very high functioning, very productive members of society, and 
it’s just one of those things, some pills and a bottle of red wine is what you want to do tonight. 
(White/Middle Class/Female; 30127)  
 
 These excerpts demonstrate the ways some youth saw these medications and their illicit 
consumption as a common cultural feature among a particular class of Americans. Specifically, 
one young woman notes that psychoactive medications are more of a cultural norm among the 
middle and upper middle class. Scholars have highlighted how certain forms of cultural capital 
typically possessed by those from a higher socioeconomic class not only informs access to 
medical professionals, but also engagement with them in ways that shape the diagnosis and 
treatment of illness (Shim 2010; Simoni and Drentea 2016). As such, the influence of social and 
cultural capital on access to pharmaceuticals may also shape the normalization of illicitly 
consuming psychoactive medications among particular groups of people. One young woman 
notes how the uptake of these medications is a prevalent and valued consumption trait of those 
from middle and upper middle class cultural backgrounds. Similarly, another young woman 
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quoted above details how the consumption of psychoactive medications by successful peers to 
help relax is made meaningful as a uniquely common cultural practice. This highlight how the 
illicit consumption of psychoactive medications can also be made meaningful as a symbolic 
conveyor of social status and identity as this young woman attributes it as a consumption 
practice of valued members of society (Bauman 1988; Beck 1992). 
Both of these young women construct the illicit use of psycho-pharmaceuticals as useful 
and normative cultural technologies whose consumption is embraced by conventional segments 
of society. These claims also confirm that drug consumption as a normalized behavior is 
embedded within larger cultural patterns of consumption and lifestyle (Pennay and Moore 2010). 
This trend in normalization also mirrors the research revealing marijuana use as an increasingly 
mundane part of mainstream consumer culture (Duff et al. 2012; Hathaway 2004). The distinct 
ways these youth make sense of consuming these medications as a common cultural practice 
among conventional adults demonstrates how they value their normalization. These findings, 
while indicative of the normalization of psychoactive medications, also verify recent criticisms 
of the normalization thesis whereby processes of normalization may only be attributable to 
certain privileged populations (MacDonald and Marsh 2002; O’Gorman 2016; Shildrick 2002). 
However, while this data highlights that only certain populations may experience the illicit 
consumption of these medications as normalized, it also reveals how this particular drug trends 
normalization may extend beyond the transitional phase of young adulthood and into the lives of 
conventional and successful adults.  
In analyzing how youth go about constructing the illicit consumption of these 
medications as an unremarkable aspect of daily life, I find that the family emerges as a unique 
institution within which these medications become normalized. The next set of quotes reveal 
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how youth talk about the family as a common context within which these medications and their 
illicit consumption are experienced as a normalized feature of everyday life.  
 
So, for like a kid growing up whose mom takes Xanax every day or you know whose little brother 
is getting Ritalin because he’s acting up. You’re like “okay well you know they’re prescribed this 
so like I’m gonna take this if I need to do my work”. I don’t know, it’s become kind of a cultural 
norm. (White/Middle Class/Female; 30139) 
-- 
My parents take pills. They don’t use them recreationally. They’re not using them with a whole 
bunch of people to have orgies, but I mean like if my mom’s stressed she’ll take a Valium. If my 
dad’s back hurts he’ll take a codeine. You know, if I wanna be able to sleep or if I’m not feeling 
well I’ll take what’s around. (White/Upper Middle Class/Male; 30209) 
-- 
I have a relative [I get Klonopin from], and it’s easy. In my family, everybody’s like, “Oh, you’re 
feeling something, oh, you should take something!” It’s a family thing. Everybody does the same 
thing. (White/Middle Class/Male; 30229) 
 
These three quotes all highlight how youth report being exposed to these medications 
through their family members’ consumption of them. Experiences with these medications within 
the context of family certainly serves to inform these youth of the value of consuming them, 
even without a prescription. The mundane presence of these pills within the home draws 
attention to the family as an important context within which the normalization of their illicit use 
emerges. The sociological significance of pharmaceuticals increasing presence within domestic 
life has been covered in terms of the pharmaceuticalization of sleep, sex, and appetite (Fox and 
Ward 2008; Williams, Coveney and Gabe 2013). The youth above note that this may also extend 
to common experiences of stress, pain, and productivity. By growing up with parents and 
siblings who take these medications, youth learn not only where to access these medications, but 
also how to accommodate their consumption in strategic ways that help them with their own 
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problems in day-to-day life. This highlights how youth not only access these medications 
through family, but also access knowledge that positively reinforces their illicit use. In this way 
the normalization of illicit psychoactive medication use is found to be embedded within one of 
the fundamental structures of adult socialization, the family. While some youth reference their 
families as normalizing the illicit consumption of psychoactive medications, others identity 
another common institution of socialization as context for drug normalization, schools.   
The following quote from a young woman details how she came to learn that illicitly 
taking these medications is a normalized aspects of navigating everyday life.  
 
P: I feel like college is when you start to understand that everyone is on pills. So, once you’re in 
college that’s about the time you’re like, “oh yeah you can take a pill”! It’s a (snaps fingers) 
quick fix. It’s like “oh I don’t feel good, I’m gonna take a pill. I feel lonely, I’ll take a pill. If I 
want to be able to get all this work done, I’ll take a pill”. You can really take a pill for anything 
now. It is kind of the future in a way, if you think about it. 
 
I: In college in particular? 
 
P: No, just in general. Any age group. Everyone’s on fucking pills. Everyone’s on pills. So, I 
don’t think teenagers really quite grasp it yet, but once you’re in college everyone’s medicating 
themselves. I would have to say taking pills is very normal. It’s just as normal as getting coffee. 
(White/Upper Middle Class/Male; 30209) 
 
 This young woman notes how she learned that taking psychoactive medications was an 
unremarkable aspect of navigating daily life while in college. She claims that she had a 
realization as a young adult that everyone, both inside and outside of the context of college, was 
taking psychoactive medications as an effective and efficient way in which to feel better and be 
productive. In this way, her description of the normalization of these medications also signifies 
her embrace of pharmaceuticalization, a process whereby many mundane problems are made 
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meaningful as opportunities for pharmaceutical intervention (Abraham 2010a; Bell and Figert 
2012; Williams, Martin and Gabe 2011). The popularity of pharmaceutical remedies at large in 
U.S. society no doubt shape the emergence of illicitly using these particular medications as an 
unremarkable feature of dealing with everyday problems. However, as illicit consumption is 
distinguished by the absence of a medical expert making medical decisions to authorize the 
medical use of these pharmaceuticals, this drug normalization trend also entails challenging these 
aspects of medical authority and control. In fact, decisions to rebel against medical authority are 
portrayed as occurring so regularly that these consumptive habits are compared to the common 
consumption of legalized drugs. This juxtaposition is quite revealing as this young woman 
associates psychoactive medications with other psychoactive substances that are socially 
acceptable to consume for purposes of enhancing productivity, like coffee. The importance of 
productivity as a normative context for this drug trend is particularly visible within youth’s 
accounts of illicitly consuming psychoactive medications as college students.  
 
College 
 In late modern societies, college has emerged as an important social institution for many 
young adults. Some studies note that close to half of all 18-24 year olds enroll in college in the 
United States (Snyder, de Brey and Dillow 2016). Many of the young adults interviewed spoke 
about their time in college in relation to their illicit use of psychoactive medications. They also 
made claims that highlight the ubiquity of these medications on college campuses as well as the 
normalization of illicitly consuming them as students. 
 
Well, I would say college you’re surrounded by it and its mass use and consumption. And it’s a 
totally socially acceptable norm for an entire group of people. I think I would have developed a 
very different attitude toward it if I had not gone. I just got out of finals three weeks ago. I 
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couldn’t get my work done and I was like “oh I’ll just pop some Adderall”. I mean it’s not hard 
to come by. I feel like a lot of other places it wouldn’t be like that. (White/Middle Class/Male; 
30045) 
-- 
Sedatives I think are great for school like as a coping mechanism. My older sister gave me all this 
Xanax that she had leftover. She was like “here”. I have friends who have very high Xanax 
prescriptions too. So, it’s very easy to get. (Latinx/Middle Class/Female; 30031)  
-- 
Things like Adderall and Ritalin, they’re so widely available in college. Lots of people take them 
for studying, you know finals or whatever. It’s not even an issue to get them. So many people take 
them. So, it’s not looked down upon or a weird thing. (White/Upper Middle Class/Male; 30078) 
 
These youth all frame the presence and illicit consumption of psychoactive medications 
as an unremarkable feature of college life. Moreover, all three young adults quoted above note 
that these medications are easy to obtain and socially acceptable to consume without a 
prescription. One young man in particular constructs the consumption of stimulant medications, 
like Adderall, as a distinct cultural practice among students and claims that he most likely would 
not make meaning of illicitly consuming them as normative had he not gone to college. Various 
epidemiological data support this claim. Prescriptions for psycho-stimulant medications are 
distinctly high for contemporary college students as rates of prescribing increased more than 
fivefold for those within and around this age range (Diller 1998; Diller 1996). College students 
have interestingly been found to divert stimulant medications more than other psychoactive 
medications (Garnier-Dykstra et al. 2012; Garnier et al. 2010). Furthermore, illicit consumption 
of stimulants is reportedly higher among those young adults attending college than those not 
(Ford and Pomykacz 2016). In this way, colleges act as unique sites for pharmaceutical leakage, 
whereby concentrated high rates of prescriptions provide the context from which illicit 
consumption for studying purposes emerges (DeSantis and Hane 2010; McCabe et al. 2005). The 
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normalization thesis states that certain drug behaviors become embedded within specific context 
(Measham, Aldridge and Parker 2001; Parker 2005; Parker, Aldridge and Measham 1998). 
While the normalization thesis has focused on drug use and drug meanings emerging within the 
contexts of recreation and leisure, these youth highlight similar processes unfolding for purposes 
of productivity on college campuses.  
The following quotes provide more details on how illicitly consuming psycho-stimulant 
medications are made meaningful as a normalized cultural practice on college campuses.       
 
I think it’s a very like “college” thing to do. I think it starts with that. At least for the stimulants 
like Adderall. Study drugs in my experience. Also, this idea of maybe being able to in some sense 
give yourself an edge. Feeling like you’re operating on a higher playing field mentally. 
(White/Middle Class/Male; 30156) 
-- 
I use Adderall and Ritalin to study and that’s very normalized in college. So many people do it. 
It’s very accessible. Everyone has it. You can just walk around the library for five minutes and 
find someone who will give it to you. So I think in a sense it’s just this kind of easy way to do 
better and have more energy.  (White/Middle Class/Male; 30321) 
 
 The above excerpts note how ubiquitous stimulant medications are on college campuses. 
They also articulate how the illicit consumption of these medications for purposes of studying 
are not only normalized within this context, but are constructed as consumption practices that are 
culturally unique to the role of being a college student, so much so that they are colloquially 
referred to as “study drugs”. Both of these young men note that consuming stimulant 
medications like Adderall and Ritalin enhances their capabilities to perform as students. While 
some scholars have framed the trend of illicitly consuming stimulant medications for purposes of 
education as a form of medicalization (Maturo 2013), others have preferred to frame it as a form 
of human enhancement as the application of pharmaceuticals is not intended to treat pathology, 
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but instead improve upon aspects of normative performance (Coveney, Gabe and Williams 2011; 
Levinson and McKinney 2013; Martin et al. 2011; Teter et al. 2005; Williams, Coveney and 
Gabe 2013). Healthy individuals consumption of psycho-stimulants to improve focus on 
intellectual tasks has come to be framed by some as a specific form of cognitive enhancement 
(Coveney, Gabe and Williams 2011; Martin et al. 2011; Williams, Coveney and Gabe 2013). In 
fact, studies of college students seeking to optimize their abilities to concentrate on schoolwork 
has been one of the few focus areas of human enhancement research (Elnicki 2013; Loe and 
Cuttino 2008). It is important to note however that regardless of the intent to treat illness or 
enhance performance, the use of these medications to improve academic performance is made 
meaningful as an increasingly embedded feature of college life. As such, this drug trend 
represents both the pharmaceuticalization of navigating college workloads as well as a process 
normalizing the illicit consumption of psycho-stimulants for purposes of cognitive enhancement.   
 The following young woman highlights how the dissemination of these medications on 
college campuses within social networks significantly contributes to the normalization of their 
illicit consumption.   
 
My friends who are prescribed it, they take a little bit more of their regular dosage to write 
papers. And they’re like, “Alright, this should help if you’re having trouble” …I could write so 
much better when I used it. So it was generally a good experience… Many of my friends have 
prescriptions for some reason. It’s just like a network of free pharmacies basically. Cause they’re 
all just loaded with pills. So, they’re always willing to give it out. You know for free. If I express 
that I need it (Asian/Poor/Female; 30287). 
 
 The young woman quoted above draws attention to the ways these psychoactive 
medications are shared with peers for free. Previous quantitative research confirms that it is very 
common to acquire these medications for free from friends (DuPont et al. 2008; Garnier-Dykstra 
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et al. 2012; Hurwitz 2005). Importantly, the practice of sharing these medications within peer 
networks as a personal favor represents a significant feature of drug normalization. Sharing 
particular drugs within specific situations can serve to normalize a drug’s use within that social 
context (Parker, Aldridge and Egginton 2001). Moreover, drug sharing behaviors are also made 
meaningful as a practice for facilitating in group solidarity (Kavanaugh and Anderson 2008; 
Pawson and Kelly 2014). While this specific feature of drug normalization has only been applied 
to the context of subcultural nightlife, it is also highly applicable to the experiences of peers 
navigating the demands of college with one another. As such, the pharmaceutical leakage of 
psycho-stimulants within the college setting stands as a significant source of its normalization 
within that context. This is significant as it reveals how medical markets shape aspects of drug 
normalization on college campuses, particularly for purposes of improving their academic 
performance.     
 Focusing on the important influence of peers, youth highlight how they are introduced to 
taking psycho-stimulant medications for purposes of accomplishing schoolwork. In this way, 
college represents an important context through which young adults come to socially learn and 
appreciate the benefits of illicitly consuming psychoactive medications.  
Fall semester of sophomore year.  So I was 20 then. That’s when I tried it [Adderall]. Somebody 
had come to me, a friend, and I don’t remember what friend it was. I was like, “I’m freaking out. 
I can’t concentrate. I’m having a hard time.” And honestly I was not aware of a medication that 
helped you with that. I was not aware. (Laughs) Yeah I know, “Where is she living?”, but I was 
not aware that everyone did this. I didn’t know anything about Adderall. And so my friend came 
and they were like, “You do know? Oh, have you never taken Adderall?” and I’m like “Oh 
what’s that?” And they told me and I was like “I need it”. Like, “I need that!” (Latinx/Working 
Class/Female; 30267) 
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 This young woman notes how she learned about Adderall and its ability to help her 
overcome here struggles concentrating on her school work as a college student. She also notes 
how she was naïve to the fact that everyone else on campus was illicitly consuming psycho-
stimulants to help them concentrate. Through her peers, she is not only able to learn about 
medications that can help her perform as a better student, but she is also able to access them in 
times of academic need in order to avoid experiencing academic failure. This demonstrates how 
the normalization of consuming psychoactive medications for purposes of productivity is 
socially learned through peer networks and positively reinforced within the context of achieving 
academic success.   
The following quotes provide more detail on other youth who recall learning to illicitly 
consume stimulant medications to help them navigate the challenges of academia. 
 
I had a roommate who had a prescription and that’s my entry point into stimulants. And I held off 
until halfway through college and I realized that life is actually a lot easier if you have those at 
your disposal. And it wasn’t like I was trying to abuse them necessarily in a heavy way, but 
certainly it’s on a kind of an as needed basis. Like you have a 30 page paper and you 
procrastinated the whole time and now you have 12 hours to do it. It [taking Adderall] does the 
trick. (White/Middle Class/Female; 30127) 
 --  
The entire school is really medicated and just swapped pills during finals, you can just buy 
Adderall in the library… definitely my entire college career, as soon as I was introduced to it, I 
never did work without Adderall, because it was the culture essentially at school. Everyone would 
be taking Adderall during finals. Everyone would be up at 5 o’clock in the morning.  
(White/Middle Class/Male; 30045) 
 
Peer networks have long been noted for facilitating decisions to engage in drug use 
(Akers et al. 1979; Akers and Lee 1996; Becker 1953; Becker 1963; Young 1972). Previous drug 
research confirms that this trend is also present among those who illicitly consume psychoactive 
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medications as those with peers who engage in this behavior report being more likely to also 
engage in it when compared to those whose peers abstain (Ford 2008). While much of the work 
looking at peer influences on illicit medication use has been quantitative in nature, the above 
excerpts highlight how peers are described as informing initiation into taking psycho-stimulant to 
study. Importantly, while youth claim that they access these medications through peers who have 
prescriptions, they also reveal the ways these peers teach them how to make use of these 
medications to improve their performance as college students. These data draw attention to the 
ways normalization is shaped not only by ones exposure to particular drugs, but knowledge, 
norms, and values regarding use practices as well (Parker, Aldridge and Measham 1998). In this 
way, the normalization of illicitly consuming psychoactive medications for purposes of 
improving academic performance emerges as an embedded cultural strategy that students learn 
through their immersion within college life and adoption of a college lifestyle.     
Based on their own experiences, some participants were more particular about which 
types of college settings these psychoactive medications were becoming normalized within. 
Specifically, some note that these medications and their illicit consumption was particularly 
pervasive while attending elite academic institutions.  
 
I went to an Ivy League school, and everybody is on it. I had never done Adderall or Ritalin when 
I was in high school, and I just worked really hard. Then I got to college and every single person 
I knew, literally everybody, had Adderall or Ritalin. Your roommate always had it. Your friends 
always had it. Everybody took it, all the time. Within the first month of school, I felt like there was 
no way. Even if I was the smartest person ever, like, how can I possibly keep up with these people 
who are able to stay up working on all this stuff so late? So, when I was 18, that was the first time 
I started taking Ritalin…I like being more productive, I like being more social, I like being able to 
get more stuff done. I like being skinny. I feel bad about it because I’m very consciously like in a 
very social issues way, totally aware of why it’s like total bullshit that I like feel pressured to be 
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all of those things, and I’m completely aware that it’s crap, but I feel like it’s impossible to not 
compete. I feel like socially career-wise, physically everything, fat, having something that makes 
you a little bit more of a superhuman is just very useful. And I like that. (White/Working 
Class/Female; 30306) 
 
 This particular young woman addresses how she felt compelled to illicitly consume 
psychoactive medications like Adderall and Ritalin as a result of needing to compete with others 
at an elite college who, as a result of consuming these medications, are able to stay up late and 
dedicate more hours to accomplishing their school work. This highlights how the normalization 
of illicitly using these medications on college campuses functions as a mechanism that forces 
others to also adopt this strategy as a means to remain competitive. Previous quantitative 
research notes that the prevalence of illicit psychoactive medication use is higher within colleges 
with more competitive admissions standards, like Ivy League schools (McCabe et al. 2005). 
Some scholars claim that a specific academic work ethic permeates certain collegiate institutions 
and may pressure students to make use of cognitive enhancements as a means to conform to the 
high expectations of performing well at competitive colleges (Loe 2008; Loe and Cuttino 2008; 
Simoni and Drentea 2016). The concept of an academic work ethic encompasses a set of core 
beliefs, behaviors, and learning styles that students adopt in order to meet the cultural 
expectations of being enrolled at highly competitive research institutions (Rau and Durand 
2000). Interestingly, by illicitly consuming stimulant medications in order to conform to these 
rigorous standards of collegiate expectations young adults inevitably play active roles in 
reinforcing and reproducing them.  
The academic work ethic at the Ivy League school this young woman attended is evident 
in how she proclaims that she likes being productive, and being able to accomplish more, but 
also resents feeling pressured to adhere to “super human” standards. Moreover, she also notes 
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how her illicit use of psycho-stimulants helps her conform to more than just high academic 
standards, but also high standards of bodily presentation and sociability. College is more than 
just a setting for accomplishing academic goals, it’s also a site for young adults to pursue and 
explore other aspects of adult life like sex, romance, and a career. As such, this young woman 
identifies stimulant medications like Adderall as enabling her to achieve all these highly valued 
goals within the context of college. This demonstrates how the normalization of these 
medications among college students is an embedded cultural feature of their heightened pursuit 
of both occupational and social goals during this stage of the life course (Arnett 2015; DeSantis 
and Hane 2010; Racine and Forlini 2010; Smith, Christoffersen and Davidson 2011). 
Furthermore, this normalizing drug trend highlights how youth make meaning of the challenges 
they face within competitive institutions of higher education as opportunities for pharmaceutical 
intervention, thus also demonstrating the possible pharmaceuticalization of collegiate life on 
highly competitive college campuses.      
The following excerpts highlight how others also describe experiencing pressure to 
illicitly consume stimulant medications while attending highly competitive academic institutions.     
  
Well I say that stimulants were highly abused in college. I think it had to do with the fact that I 
went to a very academically challenging school and there was a lot of pressure to perform well 
both from our peers and also from our parents. I think we felt a lot of time crunch, and there were 
a lot of times when you’re pulling an all-nighter and you would just use a stimulant in order to be 
able to get your work done; to focus and to concentrate. (Black/Upper Middle Class/Male; 
30126) 
-- 
I wouldn’t say that I ever crave to use Adderall. It’s never like an enjoyable experience. You 
don’t really use Adderall for fun. It would be if I’m at home doing work or something, but it’s 
definitely not a negative thing… In college if you were staying up all night it was almost kind of 
assumed [you were taking Adderall]. XXX State was a high pressure environment with a lot more 
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Type A personalities so it was kind of assumed that you were [taking Adderall]. (White/Middle 
Class/Female; 30106) 
 
Both youth above note that they attended colleges that were challenging and put pressure 
on them to perform well. Specifically, one young man notes that he experienced pressure to do 
well in school by both his peers and his parents. Previous research highlights how those who get 
into highly prestigious colleges and universities feel compelled to continue to meet high 
academic expectations, particularly from parents (Rau and Durand 2000; Zhang et al. 2011). Due 
to a perceived lack of time, both youth talk about needing to stay up late at night and put in long 
hours in order to meet high academic expectations, which was accomplished through the illicit 
consumption of others psychoactive medications. Social science researchers have drawn 
attention to the pervasive feeling that people lack time to meet all of their social obligations in 
late modern culture, an experience commonly referenced to as either a time crunch or time bind 
(Gergen 1991; Gubrium and Holstein 2000; Hochschild 1997; Maume Jr and Bellas 2001). 
However, these scholars have yet to acknowledge psychoactive medications as technologies that 
can help people, in particular college students, navigate this common conundrum by extending 
the hours one is able to stay awake and accomplish tasks. In fact, the young woman cited above 
notes that illicitly using stimulant medications to stay up was so prevalent and normalized that it 
was assumed that whenever someone did stay up late doing work that they were doing so under 
the influence of these pharmaceuticals. This normalizing trend again demonstrates how these 
medications have become embedded solutions for overcoming common academic challenges 
facing college student.  
Interestingly, we also see the young woman above engage in boundary work as she 
distinguishes her illicit consumption in college for purposes of productivity as distinctly different 
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from those aimed at experiencing pleasure. This boundary work highlights how even in contexts 
of drug normalization certain drug use practices are still framed as problematic. While much of 
the research on drug normalization is specifically contextualized within experiences of pleasure 
(Measham and Brain 2005; Measham, Aldridge and Parker 2001; Measham and Shiner 2009; 
Parker, Aldridge and Measham 1998), this young woman reveals the opposite to be true at a 
competitive college as she articulate her illicit use of these medications as explicitly not to 
produce pleasure, but instead improve academic performance. This may be a particularly feature 
reflective of the academic work ethic at competitive colleges, in which illicit consumption of 
drugs is made meaningful as normalized solely for purposes of enhancing productivity. This 
boundary work demonstrates that consuming these medications for purposes of productivity can 
also symbolize a form of identity work as it marks ones status as different from other types of 
drug users (Bancroft 2009). By privileging certain forms of consumption this young woman 
confirms how drug normalization is a process explicitly experienced by particular types of drug 
users over others (MacDonald and Marsh 2002; O’Gorman 2016; Shildrick 2002). So, while 
most drug studies focus upon the normalization of drug use for purposes of pleasure within 
leisure spaces, the above analysis highlights how academic culture at competitive colleges may 
normalize the illicit consumption of psychoactive medications for purposes of productivity at the 
possible expense of their normalization for purposes of pleasure.   
While talking about illicit psychoactive mediation use in college, others also engaged in 
boundary work as they drew distinctions between consumptions for pleasure versus consumption 
for productivity. 
 
I don’t use drugs recreationally, like going out. It’s more of a work thing. I used Adderall when I 
was in college so it got me through getting my shit together and trying to stay up late at night and 
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trying to focus… I don’t think it’s harmful, you know, there are days that people just need certain 
things. (Asian/Middle Class/Male; 30146) 
 
We see this young man declaring that he doesn’t recreationally use drugs. He instead 
states that he illicitly takes Adderall to do work. This boundary work highlights how 
consumption of these medications for purposes of pleasure are juxtaposed with those aimed at 
helping productivity. While this at first may seem to contradict trends in the normalization of 
recreational drug use, by articulating their purpose for production, these youth seek to 
differentiate themselves from populations for whom recreational drug use has become 
normalized. In this way, these youth consider their illicit use of psychoactive medication for 
purposes of productivity as morally superior to those use practices aimed at achieving 
experiences of pleasure. Historically, societies have been less likely to stigmatize psychoactive 
substances that enable and enhance productive capabilities (Young 1972). Nicotine and caffeine 
are both examples of drugs normalized within work culture that are made meaningful common 
ways in which to facilitate productivity (Young 1972). Similarly, this young man states that 
sometimes people need to consume psychoactive medications in order to accomplish certain 
tasks. Specifically, he claims a need to illicitly consume Adderall in order to stay up late and 
concentrate on completing work. This highlights how the consumption of these medications is 
made meaningful as a normative coping strategy that develops in college, but also carries over 
into the world of work. It also demonstrates an emerging dialectic between the normalization of 
these drugs for purposes of productivity and the possible pharmaceuticalization of daily life as 
illicitly consuming these medications is made meaningful as a necessary strategy for achieving 
societal conformity in the context of work.  
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Employment  
While some young adults do talk about how they, their friends, and their co-workers 
illicitly consume psychoactive medications regularly at work, it is not discussed as normalized in 
the detailed ways laid out in the normalization thesis. While I certainly support youths claims of 
these medications being normalized within the context of college, I frame the world of work as a 
context in which the illicit use of pharmaceuticals are emerging as a drug trend with significant 
potential for normalization. These findings on young adults’ integration of psycho-
pharmaceuticals into their role as workers highlight how illicitly consuming these medications 
may be a cultural practice that continues above and beyond the transitional stage of young 
adulthood in late modernity. As such, the world of work may prove an important context through 
which engagement in this drug trend persist well into adulthood.   
 
I mean, it depends, if it’s a really long day at work or something. I’ll take things to stay up or 
level out. I don’t take prescription drugs to party. Prescription drugs usually come in for being 
productive and managing stuff on my schedule at any given time. The kind of social culture I’m in 
does not really have room for people who are not functioning well. It’s very high functioning. So, 
if you’re on heroin or crack or something, there’s just not a space for you there. It certainly has 
to be very regulated and discrete. Mostly it’s like the Adderall, Ritalin, Dexedrine that kind of 
stuff, because everyone’s overbooked and overworked. They need to get things done and then all 
of us have personal projects that we’re working on. So, it’s like go to job number two, if you will. 
It’s like you work all day and then you come home and you’re like a painter and have to go to like 
studio and work on things. I mean it gets pretty tiring. I think mostly it’s a productivity thing. And 
then the sedatives are like an antidote to that, so, like, take a Valium, go to sleep after you’ve 
been up forever on Adderall and Ritalin or something like that. It’s like a real work oriented thing 
and the other stuff is like balancing out that kind of jittery nervousness (Latinx/Middle 
Class/Female; 30180) 
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This young woman speaks about how consuming prescription amphetamines and 
benzodiazepines are an embedded feature of the work culture she is a part of. In this context 
these medications are described as strategically helping people to navigate the late modern time 
bind in which people feel over-worked and short on time with which to accomplish it all (Schor 
2008). Specifically, the young woman above notes needing to juggle multiple jobs, passion 
projects, as well as the need to get some sleep, for which illicitly consuming drugs like Adderall 
and Valium help her to effectively navigate and perform. The application of these medications 
reveal their role in aiding a dialectical process of maximizing both states of productivity as well 
as relaxation. Previous research has contextualized these consumption behaviors as aiding in the 
performance of a work hard; relax hard lifestyle (LeClair et al. 2015). 
This young woman also engages in boundary work as she not only identifies the illicit 
consumption of these medications as normative for purposes of work, but also designates the 
social spaces she occupies as not conducive to the use of illicit drugs like crack or heroin. As 
such, we see how this young woman is careful to draw distinctions between certain drugs that are 
socially acceptable to consume for purposes of work and others that are stigmatized due to their 
incompatibility with needing to be “high functioning”. Complying with previous drug 
normalization research not all drug users are afforded the destigmatized experience of drug 
normalization (Measham, Aldridge and Parker 2001; O’Gorman 2016; Parker, Aldridge and 
Measham 1998). So, while drug addiction remains problematized in normalized context of 
recreational drug use, we similarly find that hard drug users like heroin and crack users are 
problematized in work contexts where the normalization of illicitly consuming psychoactive 
medications may be taking place. As such, this boundary work significantly highlights how these 
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youth define and maintain the distinctions between normalized and problematized drug 
consumption of purposes of production. 
The following young woman provides an insightful account of how she makes meaning 
of her Adderall consumption in terms of her work life and identity.  
 
All my friends who take Adderall take it to work and that’s kind of either you’re tired one day or 
you’ve got a lot to do. We’re all kind of “taking on the world” types. So, we all have way too 
much to do…Adderall is just kind of like a necessary part of my life at this point. I’ll go several 
weeks without using it at all cause I just don’t have that much to do, but then you go one night 
with working all night and get two hours of sleep. And I could power through the day, drink a cup 
of coffee and just struggle, or I could take a little bit of Adderall and not have to work so hard 
cause in the grand scheme of things I wanna do everything. Even the past couple days, you know, 
working all night on one project, showing up for another job in the morning, practicing, and then 
working on another project, and then going through a normal work day and then performing.  
Adderall’s my favorite because it’s the one that’s helps sustain my life the most (White/Upper 
Middle Class/Female; 30038) 
 
This young woman notes that she and her friends are very out-going and productive 
people who illicitly consume Adderall to help them work. This young woman describes herself 
as a documentary film maker who also performs in a dance troupe. She sees Adderall as allowing 
her to effectively juggle all the different occupational roles she takes on in a given week. She 
even makes meaning of her consumption of Adderall as the necessary mechanism that enables 
her to live her highly productive lifestyle. In this way, the normalization of psychostimulant use 
at work demonstrates not only a pharmaceutical strategy for navigating the late modern time bind 
(Schor 2008), but also a means through which to produce and perform a valued sense of self in 
relation to ones work (Loe and Cuttino 2008). For instance, this strategy is seen to be especially 
embraced by those who construct their identities in terms of being ambitiously productive, 
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responsible, and accomplished (Gergen 1991). Like those who seek to adhere to the rigorous 
academic ethics of elite colleges through illicitly consuming psychoactive medications, the 
normalization of this behavior for purposes of enhancing work productivity may be acutely 
experienced by those individuals who face a more pervasive and enduring time bind as they 
juggle multiple occupational roles and responsibilities (Schor 2008; Hochschilds1997).  
The young man below relates his illicit consumption of Adderall to aspects of his 
particularly demanding job and characteristics of his productive personality.  
 
I only started taking them [Adderall] maybe two and half years ago. I saw an instant change in 
my professional life… My job is stressful. I do 12 things at once, and two computers and phones 
and it helps me multitask incredibly more. I’m clearly doing a lot more than most people 
probably can… I mean it’s just who I am. I like getting things done, but it’s not always so easy. 
So, this [Adderall] is definitely helping me maximize my already existing personality trait, I 
guess, I’d put it. (White/Middle Class/Male; 30016) 
 
This young man notes how his illicit consumption of Adderall at work has made a 
positive impact on his ability to navigate his stressful job in the film industry. Specifically, he 
highlights how it helps him multitask and accomplish more than most people in his line of work 
are able to do without taking drugs. This reveals how similar to their use within the context of 
college, psycho-stimulants are made meaningful as technologies of human enhancement within 
the world of work as well. While this young man does not discuss the normalization of his drug 
consumption at work, he does demonstrate how the practices of enhancement that are normalized 
among college students (Coveney, Gabe and Williams 2011; Levinson and McKinney 2013; 
Teter et al. 2005) are found to extend to some young adults experiences as employees as well. 
This highlights the possibility that those illicit use practices learned and engaged in within the 
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context of college may spill over into aspects of employment, especially jobs that are 
experienced as being particularly demanding.   
This young man also constructs his consumption of Adderall as a mechanism through 
which he optimizes aspects of his personality as a productive person. This highlights how the 
illicit consumption of Adderall is made meaningful as enhancing some people’s ability to 
perform aspects of their personalities within constructions of their work identities. As such, these 
pharmaceuticals are not only enhancing aspects of one’s job performance, but are also enhancing 
aspects of one’s work identity. Previous research on medications and identity note how the 
consumption of psychoactive medications can at times be a way to reconcile identity conflict and 
preserve a sense of authentic selfhood (Loe and Cuttino 2008). The young man above similarly 
makes sense of his illicit Adderall consumption to help him succeed at work as enabling him to 
also fulfill a valued aspect of his identity as a very productive person. These data demonstrate 
how illicit psychoactive medication may become a normalized workplace practice aimed at 
enhancing the performance of ones work identity.    
The following quotes also discuss how the illicit consumption of psychoactive 
medications is helpful for enhancing the ability to perform particular forms of labor.  
 
I had a work retreat and particularly in a long setting in a circle with all of my co-workers, and 
bosses, and board members. It’s really important to be attentive and participate. And the fact that 
I hadn’t had much sleep, and I need to participate, meaning that I wanna be on my best. So, I 
popped half an Adderall.( Black /Middle Class/Male; 30122) 
-- 
I like Vicodin just because my part time job can be highly stressful. It’s a very public feeling with 
a lot of people running in and out. So I like taking it there at work. It’s like I’m so chilled out 
nothing can bug me at all. I’m just coasting and it’s not like if I’m stoned either. I’m just not 
hyper sensitive. I’m just, yeah, more chilled. So, I feel I can use Vicodin at work in a stressful 
situation. Working situations I just feel like I tense up.( Latinx/Working Class/Male; 30350) 
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Both the young men above comment on how they illicitly consume psychoactive 
medications in order to perform well within stressful work situations.  Specifically, they note 
illicitly consuming Vicodin or Adderall in order to navigate stressful social interactions within 
the workplace. Interestingly, one man identifies their use of psychostimulants at a work retreat as 
allowing them to participate and perform “my best” in the presence of work superiors. This 
highlights how some youth experience their consumption of psycho-stimulants as enhancing 
their sociability and how this trait is at times highly valued within the workplace. This again 
reveals how illicit consumption of psycho-pharmaceuticals is made meaningful as enhancing 
ones work performance through ones presentation of self, specifically an attentive and sociable 
self. So, while many youth demonstrate the normalization of illicitly taking these medications in 
order to perform as successful college students, we also see this use practice playing out within 
sites of employment as young adults seek to enhance their ability to perform sociable and 
productive work identities.    
The other young man quoted above similarly discusses his part time position at a grocery 
store as very stressful, however, not because of his close proximity to his superiors, but due to 
the close proximity of customers and how crowded it gets. He makes sense of his Vicodin 
consumption as allowing him to cope with the stressors and tension he experiences at work and 
actually enjoy his time there. This young man also notes that while Vicodin allows him to 
tolerate working in a very public setting, it importantly does not make him feel or appear 
intoxicated. As such, this young man values the discreet ways psychoactive medications enable 
him to not be tense at work. This highlights how the consumption of these medications are made 
meaningful as coping strategies for navigating interaction problems experienced in the 
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workplace, and as such may potentially become normalized strategies adopted within certain 
types of labor.  
  The following two excerpts demonstrate the ways these medications are applied to aid 
in the performance of emotional labor like that performed by servers in the restaurant industry 
(Hochschild 1983; Leidner 1999; Wouters 1989).  
 
Working in the restaurant industry gets pretty stressful. So where I worked there’s a ton of people 
there, and naturally y’all just become friends and we would all just do it [take Xanax] and then 
the night would go by quick. You don’t wanna be stressed you know. You wanna be nice. So, it’ll 
just mellow you out. You’ll just feel relaxed and you won’t be so stressed during the shift. 
(White/Middle Class/Male; 30229) 
-- 
I used to be a waitress at a restaurant and it was long hours and for a while I was definitely in 
the habit of doing Adderall every day I worked there and it kind of just made it fun. It made me a 
really fast waitress. I felt really efficient, which then took the stress off of it, and I was having a 
good time, which is good for tips…We’d have really intense brunch shifts, and I could just do it 
all, no problem. I just kind of felt really capable. Like I could just juggle everything at once and 
still be really fun. (White/Middle Class/Female; 30044) 
 
The above young adults talk about their illicit consumption of psychoactive medications 
like Adderall and Xanax in relation to their roles as servers in busy restaurants. One young man 
points out how he and his co-workers can’t behave towards customers in ways that reveal the 
stress they are experiencing when the restaurant is crowded. As such, he and his co-workers 
adopt practices of illicitly consuming benzodiazepines in order to cope with stress and perform 
as “happy” waiters and waitresses. This highlights how these medications enhance this young 
man’s ability to manage the performance of particular emotions while on the job. He also 
describes how this illicit consumption practice became a normalized strategy for staff navigating 
the stressful interpersonal aspects of working in the restaurant industry. Similarly, a young 
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woman frames her illicit use of stimulant medication as relieving the stress of working in a busy 
restaurant and allowing her to instead be fun, which in turn generated a financial reward from her 
customers. This highlights how psychoactive medications enable the ability to control ones 
performance of self for instrumental ends within the workplace. Both these stories draw attention 
to the ways these medications are made meaningful as enhancing ones capability to handle work 
related stress while also enabling the performance of pleasant social interactions with customers.  
These stories mirror those covered by Arlie Hochschild (1983) in her book on the 
performance of emotional labor in service industries. Emotional labor is defined by the bodily 
and discursive performance of particular emotions as an integral aspect of one’s occupational 
role (Hochschild 1983). While Hochschild’s work specifically focused on the experiences of 
flight attendants, restaurant servers similarly perform emotional labor in their interactions 
serving customers their meals. These findings reveal illicit medication consumption as a 
mechanism through which youth navigate having to perform emotional labor while enduring 
stressful working conditions. This practice also highlights how these pharmaceuticals are made 
meaningful as ways to protect ones sense of self at work while also being able to enact a 
situationally appropriate performance of a happy and fun service sector employee. The utility of 
medications like amphetamines and benzodiazepines in helping youth to perform emotional 
labor indicate the potential for their becoming a normalized cultural practice within stressful 
service oriented occupations. Though youth do not medicalize aspects of their roles as workers, 
by identifying psychoactive pharmaceuticals as ideal tools to enhance their ability to perform 
various work related tasks like working long hours, juggling multiple occupations, and 
performing emotional labor they are engaging in processes that pharmacetuicalize aspects of 
their employment situations. These trends of adapting the illicit use of psychoactive medications 
151 
 
within the context of work draw attention to the possibilities that they become embedded features 
of particular work identities and cultures.      
 
Conclusion 
Drug scholars note that specific drug use practices become embedded within specific 
cultural context and overtime emerge as normative attributes of those context (Measham and 
Shiner 2009; Parker 2005; Parker, Aldridge and Measham 1998; Parker, Williams and Aldridge 
2002). I highlight how youth draw attention to the embeddedness of psychoactive medications 
within important social institutions, namely the family, higher education, and employment. Drug 
normalization research establishes how various substances are increasingly becoming 
unremarkable aspects of young adults leisure pursuits (Parker, Aldridge and Measham 1998). 
This chapter reveals how trends in drug normalization are also present above and beyond 
landscapes of leisure and pleasure as youth make claims that highlight the normalization of illicit 
psychoactive medication use for purposes of productivity. By uncovering the pervasive way 
youth value these medications for enabling and enhancing productivity within context of 
education and employment, these findings significantly expand upon how drug normalization is 
contextualized and made meaningful as a part of late modern life. Particularly, these findings 
reveal how psychoactive substances are pervasively present in society for enhancing experiences 
of productivity as well as recreation.   
As this drug trend is significantly driven by the social structure of medical markets in 
U.S. society, the normalization of illicitly consuming these medications needs to be 
contextualized within larger societal processes of medicalization (Clarke et al. 2009; Conrad 
2008; Williams, Coveney and Gabe 2013). Specifically, this drug trend highlights a unique way 
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in which the pharmaceuticalization of everyday life is enacted through the illicit use of these 
medications at work and at college (Bell and Figert 2012; Fox and Ward 2008). Moreover, as 
youth reveal that their parents and peers are the mechanisms through which they acquire and 
learn to illicitly consume these medications the normalization of these pharmaceuticals under the 
supervision of medical experts directly informs and influences the normalization of their usage 
outside of that context. This is important as it reveals how medical markets shape aspects of drug 
normalization on college campuses that are possibly spilling over into the world of work as well.  
As such, these findings reveal a wide array of distinct cultural, political, and economic processes 
underpinning the normalizing trend of taking these medications for purposes of production. 
These findings also signify how challenging aspects of medical authority have become normative 
within the context of education and employment. This highlights how the norms and values of 
succeeding within these social institutions are at times prioritized over the laws that govern the 
distribution and use specific psychoactive substances.  
While previous research has drawn epidemiological connections between increasing rates 
of prescriptions for psycho-pharmaceuticals and increasing rates of their illicit use (Poulin 2007), 
these data lack the ability to address whether this represents an embedded feature of certain 
cultural context. The data presented above reveal how youth describe these medications as 
ubiquitously available at college and acceptable to consume for purposes of improving academic 
performance. This highlights how college campuses emerge as unique sites of pharmaceutical 
leakage that subsequently result in the normalization of illicitly consuming them for purposes of 
achieving academic success. In this way, these medications become embedded features of 
navigating the problems youth encounter in collegiate life. The illicit use of psycho-
pharmaceuticals also appears to be a practice perceived to be more common within highly 
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competitive academic institutions (McCabe et al. 2005). This may reflect how these particular 
students face even more challenging academic conditions. As a result of pressure to conform to 
rigorous expectations of academic performance, these students may be more likely to have 
access to and develop strategies how best to make use of them to enhance their academic 
capabilities. This demonstrates how the normalization of psychoactive medications among 
college students emerges as a cultural feature of their heightened pursuit of academic success and 
may be indicative of the pharmaceuticalization of a particular collegiate lifestyle.  
   The patterns of cognitive enhancement present within the context of college were also 
found to be practiced within the world of work. While the practice of illicitly consuming 
psychoactive medications to improve performances at work was not widely discussed in the 
same normalized sense as the context of college, they do represent the possible development of 
such a trend. This is particularly the case for certain kinds of jobs and particular types of 
workers. The young adults presented above note how juggling multiple occupational roles and 
succeeding in positions that require multi-tasking in high stress work environments are both ideal 
situations for illicitly consuming psychoactive medications. Moreover, some reveal the ways 
these medications enable them to successfully perform aspects of their personalities and work 
identities as productive people. Meanwhile, others note how these medications enable a more 
productively social and pleasant work experience in high stress situations. This was especially 
present in youths’ accounts of performing particular types of work in the service sector. 
Specifically, some young adults reveal how their roles as waiters and waitresses require the 
performance of certain emotional management techniques that can be enabled and enhanced 
through their illicit consumption of psychoactive medications like benzodiazepines and 
amphetamines.  
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These emerging trends highlight the importance of recognizing and analyzing drug use 
within the context of production. Specifically, future research should focus more on the types of 
work environments and stressors that motivate substance use as well as the particular practices of 
drug use that emerge to resolve these issues. Also, the ways in which drug use informs and 
influences identity work and performances of selfhood within sites of production is significantly 
lacking. While drug normalization research highlights how the sensible leisurely consumption of 
drug use shapes aspects of identity formation and accrual of social and cultural capital (Parker, 
Aldridge and Measham 1998; Warde 1994), the young adults in this study draw attention to the 
ways drug consumption for purposes of productivity similarly shape identity and the pursuit of 
capital accumulation. In some ways this illicit consumption practice shapes the construction of a 
specific productivity lifestyle that is valued by particular groups of people (Pennay and Moore 
2010).   
Some specific work on marijuana highlights how drug normalization trends can extend 
beyond the scope of young adulthood and become mundane aspects of conventional adult leisure 
culture (Asbridge et al. 2016; Duff et al. 2012). I claim that the illicit consumption of 
psychoactive medications may also represent a normalizing drug trend embedded within wider 
aspects of mainstream American culture, particularly within the context of higher education and 
employment. As people in general are becoming more knowledgeable about drug use, 
normalization scholars claim that this shapes the ways they accommodate and value particular 
aspects of drug use within certain cultural context (Parker 2005; Shildrick 2002). By widening 
the context within which we decide to analyze drug use we come to gain a more cohesive 
understanding of how psychoactive medications in particular are becoming embedded solutions 
for overcoming common challenges facing people in their everyday lives of productivity.  
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Chapter 8: Conclusion  
 
This dissertation takes seriously the experiences, practices, and perspectives of young 
adults who illicitly consume psychoactive medications. Significantly, this phenomenologically 
based dissertation sets out to uncover how youth make meaning of theirs and others illicit 
consumption of these controversial medications. In this way, these youth are made as experts of 
this drug trend. Too frequently drug trends are oversimplified and mischaracterized by those 
institutions tasked with researching them, reporting on them, and resolving them (Adler 1993; 
Bourgois 2003b; Bourgois and Schonberg 2009; Mohamed and Fritsvold 2010; Reinarman and 
Levine 1997). Comparatively, a micro level analysis of those intimately involved in this drug 
trend reveals a plethora of understudied use practices as well as the social meanings they 
commonly ascribe to them. More importantly, this dissertation demonstrates how the illicit use 
of these medications has become an embedded feature of many young adults’ everyday lives. 
The day to day circumstances certain consumption practices emerge from and the shared 
meanings attributed to them highlight how these particular practices have become a normative 
aspect of these young adults’ lives. These findings also indicate that this drug trend is 
representative of larger social processes of medicalization and drug normalization currently 
occurring in U.S. society.      
Constructionist frameworks for studying social problems provide helpful lenses through 
which to interpret much of how youth experience and make meaning of illicit psychoactive 
medication use. By analyzing youth’s narratives in terms of claims making activities, findings 
reveal how youth problematize psychoactive medications, specific consumption practices, and 
even particular processes of medicalization. For instance, while framing the availability of these 
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medications as a social problem, some youth engage in social problems work that assigns blame 
to key upstream players in the medical field. Specifically, they frame the pharmaceutical industry 
as problematically involved in producing and advertising addictive substances and also villainize 
medical experts for too readily relying on these medications and over-prescribing them to 
uninformed patients. In this way, youth not only problematize those players who profit off the 
rise in use of these medications, but also larger cultural and economic processes of 
pharmaceuticalization that drive this particular drug trend. As such, it is important to recognize 
that the everyday applications and meanings that youth construct for psychoactive medications 
are inevitably intertwined with the larger medical culture from which these pharmaceuticals 
emerge from.  
The illicit use of psychoactive medications is contingent upon the pharmaceutical 
companies that produce and market them, the regulatory systems that allow for them to be 
bought and sold, and the medical professionals whose medical knowledge and authority grants 
medical patients access to them (Lovell 2006). Without these mechanisms serving to provide a 
steady supply of psychoactive medications to medical patients there would not be medications 
available to illicitly consume. Significantly, youth were also critical of the recent diagnostic 
expansion of certain illnesses that are commonly treated with psychoactive medications, like 
ADHD, anxiety, and chronic pain. They saw these conditions as being over-diagnosed and also 
connected the prevalence of these conditions in society with the ubiquity of psychoactive 
medications and the subsequent rise in people developing drug addictions.    
While some problematized these medications and those who produce and prescribe them, 
others told stories that demonstrate the way they value psychoactive medications as tools that 
help them navigate problematic aspects of their day to day lives. This reveals how psychoactive 
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medication misuse is made meaningful not as a social problem, but as a social problems solution. 
One unexpected finding emerging from this dissertation is how youth problematize many aspects 
of their day to day lives in terms of medical discourse. Youth spoke of using their own medical 
knowledge obtained through family, peers, and the internet as informing their decisions to self-
diagnose themselves as suffering from symptoms related to such illnesses as ADHD, chronic 
pain, panic attacks, insomnia, anxiety, and depression. Many youth make meaning of their illicit 
medication use in terms of resolving these self-diagnosed medical problems and allowing them 
to feel normal and perform various roles successfully within their everyday lives.  
Youth’s construction of illness narratives, or what could also be called pharmaceutical 
narratives, reveal the expansion of particular illnesses occurring outside of the authority of a 
medical profession. Specifically, youth highlight psychoactive medications as mechanisms 
through which they learn to identify experiences of shyness, nervousness, worry, discomfort, and 
stress as illnesses in need of pharmaceutical treatment. Barker (2009) claims that patients in a 
highly medicalized society may socially learn to experience many unpleasant emotions in terms 
of illnesses in need of medical treatment. The self-medicalization of emotional states like being 
nervous and worrying represent significant examples of how illicit consumption of these 
pharmaceuticals inform and influence decisions to pathologies common yet unpleasant human 
experiences. Studies on the pharmaceuticalization of society note how particular medications can 
significantly alter the general public’s perceptions of normal versus pathological experiences and 
states of being (Coveney, Gabe and Williams 2011; Fox, Ward and O’Rourke 2005; Fox and 
Ward 2008; Williams, Coveney and Gabe 2013). As such, these youth highlight illicit 
psychoactive medication consumption as a notable feature of and nuanced contributor to the 
continued medicalization of everyday life (Busfield 2010; Conrad 2008; Fox and Ward 2008).    
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Significantly, these processes of medical expansion are taking place outside of the 
context of meeting with a medical professional to receive a medical diagnosis and prescription 
for treatment. Making a medical diagnosis and prescribing a medical treatment has long been 
identified as a key source of power and control that the medical field wields over patients (Jutel 
2014). By engaging in practices of self-diagnosis and self-treatment, these youth challenge 
aspects of medical authority even as their practices play a role in expanding the human 
conditions that are commonly made meaningful in terms of medical discourse and treatment. 
Through the democratization of medical knowledge and the expansion of psychoactive 
medication markets youth are empowered to make their own medical decisions. As they make 
use of their social networks supply of psychoactive medication prescriptions, they also take 
control over the management of their own experiences of health, illness, and productivity. 
Moreover, these youth stress how they value the agency and efficiency that illicit pharmaceutical 
consumption provides them in helping them to navigate problematic experiences like being too 
shy to socialize, or being too stressed out to concentrate on work, as well as being too anxious to 
get a good night sleep.  
Through the application of interactionist frameworks, this dissertation also demonstrates 
how particular practices of illicit psychoactive medication use are embedded within specific 
cultural context of social learning. For instance, many youth told stories of how a family member 
or a peer not only provided access to psychoactive medications, but also taught them to 
recognize certain symptoms appropriate for consuming these medications. Moreover, above and 
beyond the context of treating illness, many peers provided knowledge about how to make use of 
these medications for purposes of enhancement. The context of college emerged as a significant 
site where youth came to learn about the benefits of engaging in illicit psychoactive medication 
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use for the purposes of enhancing ones capabilities to succeed as a student. Specifically, peers at 
college were identified not only as conduits through which to access psychoactive medications, 
but also as sources of information on how best to make use of these medications to improve 
one’s academic performance. These practices were also constructed as normalized strategies 
through which to adhere to a rigorous academic work ethic, particularly at prestigious and highly 
competitive institutions (Loe 2008; Loe and Cuttino 2008; Rau and Durand 2000; Simoni and 
Drentea 2016).  
Interestingly, the illicit use of these psychoactive medications is at times made 
meaningful in terms of one’s identity or performance of self. Some youth engage in claims 
making that highlights how their illicit consumption of psychoactive medications enables them to 
treat some form of pathology and in turn access and perform a more authentic sense of self. 
Others make meaning of their illicit use of these medications as allowing them to enhance 
aspects of their personality and identity like being ambitious and productive. In this way, the 
illicit use of psycho-pharmaceuticals is revealed as a mechanism through which youth engage in 
identity work and authentic performances of selfhood. This was particularly visible within the 
context of college as many young adults went about describing the illicit consumption of these 
medications as a normative aspect of “being” a student. For some, it was even made meaningful 
as a necessary feature of navigating student life. The performative aspects of consuming these 
medications within the context of college also appear to be spilling over into the construction of 
some young adults’ work identities and performance of a productive self within the workplace. 
This was particularly present among those who juggle several occupations as well as those 
performing emotional labor within high stress service industry jobs.   
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The young adult psychoactive medication misusers interviewed frequently engaged in 
claims making activities that construct a set of “responsible” illicit psychoactive consumption 
practices. These practices directly relate to their sense of identity in that they sought to construct 
themselves as sensible drug users to be understood in distinction from problematic drug users. 
While illicitly consuming psychoactive medications for purposes of self-treatment and self-
enhancement were made meaningful as sensible and responsible use practices, illicit 
consumption for purposes of pleasure and recreation were problematized and constructed as 
practices that can result in a potential loss of self through the development of a debilitating drug 
addiction. So, as drug use may becoming more of a normative practice of the self it still 
nonetheless also evokes a deep seated sense of cultural anxiety as youth frequently felt it 
necessary to distinguish their drug use from that of a problematic other (Hathaway 2004). In 
some ways the construction of a responsible illicit psychoactive medication user demonstrates 
how youth engage in performing the antithesis of the drug addict as they seek to define their use 
practices as valued and normative means by which to achieve health and productivity. These 
findings demonstrate how a range of use practices and meanings reveal these medications role in 
facilitating the construction of identity, performance of self, and cultivation of status (Beck 1992; 
Bernauer and Rasmussen 1988).  
 These data also collectively draw attention to the continued significance of analyzing the 
context from which particular drug use practices and meanings emerge from (Duff 2003; Duff 
2007; Duff 2008; Golub 2005; Pawson and Kelly 2014). While the importance of drug set and 
setting has commonly been written about with regards to recreational drug use (Zinberg 1984), 
this dissertation highlights how youth produce shared understandings of drug use constructed 
within the cultural context which they are learned and practiced, sites of production. As such, 
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this drug trend goes well beyond the societal scope of previous drug trends, which are most often 
embedded within subcultural scenes, as it’s discussed by youth as a common practice occurring 
within mainstream institutions like the family, education, and employment. This stands as an 
important aspect of illicit psychoactive mediation consumption and more research is needed to 
understand its presence throughout adulthood in order to confirm its normalization above and 
beyond the experiences of young adults.   
Acknowledging a normalizing drug trend requires first taking drug users experiences and 
meaning making activities seriously. This phenomenologically based research reveals how these 
youth experience the “responsible” consumption of these psycho-pharmacetuicals to be a 
normative feature of navigating certain sites of production. Recognizing the trend of illicitly 
using psychoactive medications as a normative American drug consumption practice also 
requires that we reimagine how best to approach dealing with it as a society. Like many other 
drug trends, the emergence of illicitly consuming psychoactive medications highlights the 
ineffectiveness of criminalizing certain forms of drug use. In 2017, the U.S. made over 1.6 
million arrests for drug law violations, of which 85% were for drug possession (Wagner and 
Sawyer 2018). Criminalizing drug use has been shown to have little to no impact on rates of drug 
use, and some studies have even demonstrated that drug prohibition laws actually magnify the 
harms brought about by drug use (Bourgois and Schonberg 2009; Parker 2005). Further 
demonstrating the ineffectiveness of drug criminalization, this dissertation reveals the illicit use 
of psychoactive medications as a normative feature of young adults’ everyday lives. I and other 
drug scholars claim that societies cannot meaningfully address normalizing drug trends through 
processes of prohibition (Erickson and Hathaway 2010; Hathaway, Comeau and Erickson 2011). 
As such, other drug policy approaches need to be considered if we are to pragmatically address 
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the illicit use of psychoactive medications in society. The following section will review the harm 
reduction model and explore its application for psychoactive medication misuse, particularly as 
experienced by the young adults in this study.   
 
Limitations 
 This dissertation was based off of secondary data analysis. Limitations of the data at hand 
emerged through processes of analysis and dissemination. Particularly, as much of the data was 
analyzed after all the interviews had been conducted more in depth understandings of emerging 
themes was not possible. In this sense, a more grounded theory approach where the research 
questions could in some ways be informed and influenced by early phases of data collection 
would be more beneficial for gaining an even deeper theoretical understanding of this drug trend 
and the ways youth practice and experience it. Additionally, while the sample was diverse in 
terms of race, class, gender, and sexuality the specific ways in which these social attributes 
inform and influence psychoactive medication misuse was not thoroughly explored. While youth 
in general did not relate their illicit consumption of these medications with specific experiences 
of intersectionality, future research on this subject matter is needed.  
 
Harm Reduction  
 Harm reduction programs criticize current punitive strategies aimed at eradicating drug 
use as they see criminal law as counterproductive as drug use cannot be banned or legislated out 
of existence (Measham and Shiner 2009). Harm reduction is a social movement that shifts drug 
policies from a moral approach of criminalization to a more evidenced based approach of drug 
use surveillance and regulation. The harm reduction movement does not view drugs or drug use 
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as morally wrong. Instead, drug use is evaluated in terms of the harms it causes and the societal 
costs of these harms (Mugford 1993). As such, harm reduction strategies seek to effectively 
manage the social problems and reduce the economic costs associated with drug use (Des Jarlais, 
Friedman and Ward 1993; Erickson and Hathaway 2010).  
Within the harm reduction paradigm, drug users are seen as active agents that take 
responsibility for the informed choices they make regarding their drug use. Drug users are also 
recognized as key players to be relied upon to inform and facilitate aspects of drug prevention, 
harm reduction, and drug treatment (Erickson et al. 1997). In this way, harm reduction policies 
seek to integrate drug users into society rather than criminalize and marginalize them (O'Hare et 
al. 1992).  As the main focus of the harm reduction movement is to improve public health, harm 
reduction policies are by and large aimed at enabling drug users to act in socially responsible 
ways that decrease the health risks certain forms of drug use can pose. This highlights how harm 
reduction policies are aimed at empowering drug users to be more active in the surveillance of 
theirs and the larger drug using communities’ health and wellbeing (Rhodes 2002). As such, 
harm reduction very much embraces larger societal shifts in medicine from the external control 
of medical professionals over patients to the internal control increasingly exercised by medically 
informed lay individuals (Peterson and Lupton 1996). Specifically, the harm reduction 
movement aims to have drug users internalize strategies to control drug consumption and 
develop preferences for low risk drug use practices (Tammi and Hurme 2007).     
Common harm reduction strategies are the implementation of needle exchange programs 
for injection drug users, drug testing kits for identifying potentially dangerous adulterants, as 
well as the uptake of opioid maintenance medications and the dissemination of opioid overdose 
reversal medications (Des Jarlais, Friedman and Ward 1993; McGowan et al. 2018; Winstock, 
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Wolff and Ramsey 2001; Wodak 1999; Wodak and McLeod 2008). However, much of these 
harm reduction strategies are designed to focus on those whose drug use behaviors exposes them 
to the most significant and costly risks, like those experienced by injection drug users and opioid 
users. Subsequently, the majority of drug users whose use practices do not expose them to risks 
of infectious disease and overdose are largely neglected by much of the current harm reduction 
focus and efforts (Hammersley 2005; Hathaway and Erickson 2003). With specific regards to 
psychoactive medications, harm reduction messaging has largely focused on opioid medications 
as they represent a greater source of harm when compared to benzodiazepine and amphetamine 
medications (Lembke, Papac and Humphreys 2018). Moreover, harm reduction messaging also 
tends to focus on providing information regarding the higher risks of experiencing a drug 
overdose when mixing these medications with other drugs (NIDA 2016). In fact, much of the 
current harm reduction resources available for illicitly consuming psychoactive medications do 
not even acknowledge populations of drug users who do not consume these pills for purposes of 
pleasure. The lack of harm reduction strategies aimed at addressing other groups of users 
participating in this drug trend highlights current failures to conceive of illicit psychoactive 
medication use in more heterogeneous and dynamic ways (Duff 2004).  
Subsequently, at first glance, it may appear that the harm reduction model can offer little 
to the youth presented in this dissertation, particularly as they make meaning of many of their 
own illicit consumption behaviors as essentially harmless. However, an important aspect of the 
harm reduction model stresses the need to acquire more knowledge about particular drug use 
groups, context, and use practices (Erickson et al. 1997; O'Hare et al. 1992). By increasing our 
understanding of the different iterations of psychoactive medication misuse, a more diverse 
range of harm reduction resources can be implemented to help a wider portion of those involved 
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in this ongoing drug trend. In this way, this phenomenological study provides insight into how 
psychoactive medication misusers themselves can contribute to the development of new and 
innovative harm reduction practices. First and foremost, this dissertation reveals how many 
youth who illicitly consume psychoactive medications demonstrate their in depth knowledge of 
these medications effects, the potential risks they pose, as well as strategies to avoid or reduce 
experiencing these risks. In fact, the construction of “responsible” illicit use practices, as present 
in chapters 5 through 7, demonstrate how youth are already thinking and acting in ways that 
resemble the principles of the harm reduction model. For instance, young adults clearly are 
concerned about the addictiveness of psychoactive medications and implement strategies for 
limiting consumption as a way to minimize the risk of developing a drug addiction. The concept 
of responsible medication misuse also stresses the importance of being in control of the quantity 
and frequency of one’s illicit consumption. As such, many youth spoke of strictly partaking in 
the illicit use of these medications to address an immediate need appropriately related to the 
treatment of an illness experience or enhancement of one’s productive capacities. From these 
practices, harm reduction policies could develop guidance for the setting of personal limits of 
consumption and the means by which to attain and  maintain such moderation (Duff 2004).  
 
Future Implications 
The findings of this dissertation highlight how young adult psychoactive medication 
misusers are not just sources of social problems, but are also sources of solutions to these and 
other social problems they encounter in their everyday lives. This knowledge and the deeper 
understanding of the social and cultural dynamics of illicit psychoactive medication use it 
facilitates can be used to create informational resources that can guide current and future illicit 
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consumers of these medications on how best to go about minimizing the potential harms their 
use practices may expose them to. Specifically, conceptualizations of responsible use practices 
can be used to establish boundaries between sensible and potentially problematic consumption 
practices. Additionally, these harm reduction messages should be circulated within the contexts 
that youth discuss illicitly consuming these psychoactive medications. Moreover, harm reduction 
programs should seek to engage youth within these sites of illicit use. This would ensure that 
additional information about this evolving drug trend is gathered as a way to ensure that the 
development of new and improved strategies to minimize harm are continually sought and 
implemented.  
Contrasting drug interventions delivered by medical experts within professional settings, 
drug intraventions set out to meet drug using populations where they are and ground outreach 
work within the context of use in ways that cohere with the norms and values of the space and 
people occupying it (Friedman et al. 2004). In this way, intraventions seek to rearrange “cultures 
of risk” into “cultures of support” for risk reduction and risk avoidance (Des Jarlais, Friedman 
and Ward 1993; Friedman et al. 1987; Friedman et al. 2004). Intraventions have historically been 
delivered within the context of drug using subcultures as well as subcultural nightlife scenes. 
Subsequently, intravention based harm reduction programs have been relegated to the 
leisure/pleasure landscapes commonly outlined in the normalization thesis (Parker, Aldridge and 
Measham 1998). However, the findings from this study stress that harm reduction intraventions 
should seek to integrate themselves within sites of production like colleges, especially those 
highly competitive institutions (Rau and Durand 2000; Simoni and Drentea 2016). Youth may be 
more receptive to such harm reduction programs if they are delivered by fellow college students 
within the spaces they commonly consume these medications like libraries, dorm rooms, 
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computer labs, and art studios. Furthermore, these intraventions should not only seek to 
disseminate information, but also continue to collect data from current users and also provide 
information on and access to alternative resources to help college students achieve a successful 
academic work ethic without the use of psychoactive substances.   
Previous harm reduction advocates have signaled that harm reduction can and should aim 
to do more than simply reduce the problems brought about by drug use (Des Jarlais et al. 2009; 
Erickson and Hathaway 2010; Erickson et al. 1997; Hathaway and Erickson 2003; Mugford 
1993; Rhodes 2009; Tammi and Hurme 2007; Wodak 1999). They should also strive to promote 
social values that normalize responsible drug use practices while also advocating for the uptake 
of alternatives that can replace the role of drugs in certain societal context (Durrant and Thakker 
2003; Erickson and Hathaway 2010). The key challenge to moving forward with some of these 
policy suggestions involves convincing medical experts, the American public, and their political 
representatives to learn to morally accept and live with young people’s illicit use of psychoactive 
medications (Pearson 2001). Only through social acceptance and decriminalization can we focus 
more intently on understanding the perseverance of this drug trend for more than twenty years as 
we simultaneously seek to minimize the social harms it facilitates.   
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